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Genexprssionsprofile von vor dem Transfer biopsierten bovinen Endometrien und 
Embryonen als Prädikator für den Trächtigkeitserfolg beim Rind. 
 
Abweichende Genexpressionen sowohl des Embryos als auch des Endometriums sind ein 
Grund für verminderte Trächtigkeitsraten nach dem Embryotransfer beim Rind. Die 
Selektion der Embryonen einerseits und der Empfängertiere an Hand des Endometriums 
andererseits basierend auf den Genexpressionsmustern, stellt eine große Herausforderung 
dar. Um herauszufinden, ob Korrelationen zwischen der Genexpression des Endometriums 
vor dem Transfer und der des Embryos auf der einen Seite und einer erfolgreichen 
Trächtigkeit auf der anderen Seite, vorliegen, wurde eine globale Transkriptionsanalyse 
der Biopsien des Endometriums und des Embryos mittels des GeneChip® Bovine Genome 
Array und einem präimplantations spezifischen cDNA Arrays durchgeführt. Die 
Biopsieproben des Endometriums wurden an Tag 7 und Tag 14 des Vorzykluses der 
Versuchstiere (Simmental Färsen) genommen. Des Weitern wurden in vivo Blastozysten 
am Tag 7 gespült, eine Biopsieprobe genommen (ca. 30-40%) und die Embryonen auf die 
Empfängertiere übertragen. Diese Biopsieproben wurden nach der 
Trächtigkeitsuntersuchung den Gruppen der trächtigen Färsen (rezeptives Endometrium) 
und der nicht-trächtigen Färsen (nicht-rezeptives Endometrium) zugeordnet. Insgesamt 
wurden 1126 unterschiedlich exprimierte Gene zwischen den rezeptiven und nicht-
rezeptiven Endometrien an Tag 7 detektiert. Des Weiteren zeigten sich qualitative und 
quantitative Veränderungen in bedeutenden biologischen Prozessen und molekularen 
Pathways, wie in der zellulären Anordnung, posttranskriptionalen Modifikation, 
Signaltransduktion, Apoptose, im Zellzyklus und in der Imunantwort. Konträr zu diesen 
Ergebnissen waren an Tag 14 nur 14 Gene zwischen den Endometrien unterschiedlich 
reguliert. Im Bereich der Transkriptionsdynamik waren zwischen den Gruppen an Tag 7 
1867 Gene und am Tag 14 254 Gene unterschiedlich exprimiert. Diese relativ große 
Anzahl unterschiedlich regulierter Gene zeigt die Transkriptomplastizität des rezeptiven 
Endometriums. Zwischen den Biopsieproben der Embryonen, die zu einer Trächtigkeit 
führten und denen die keine Trächtigkeit induzierten zeigten 70 Gene eine unterschiedliche 
Expression. In der ersten Gruppe wurden 32 Gene, darunter SPAG17, PF6, UBE2D3P, 
DFNB31, AMD1, DTNBP1 und ARL8B expremiert und in der zweiten Gruppe 38 Gene 
darunter SGK1, GBF1, KRT8, DTX2, RNF34, ARL8B, RYBP und EEF1. Die vorliegende 
Arbeit zeigt demzufolge, dass das Genexpressionsprofil des Endometriums und der 
Embryonen vor dem Transfer als Vorhersage für den Trächtigkeitserfolg dienen kann. 
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Bovine pre-transfer endometrium and embryo transcriptome fingerprints as 
predictors of pregnancy success after embryo transfer 
 
Aberrant endometrial and embryonic gene expression is one of the causes of pregnancy 
failure in cattle. However, selecting cows with adequate endometrial receptivity and 
embryos of higher developmental competence based on the gene expression pattern has 
been a greater challenge. To investigate whether the pre-transfer endometrial and 
embryonic gene expression pattern has a direct relation with upcoming pregnancy success, 
a global endometrial and embryonic transcriptome analysis was carried out  in endometrial 
and embryo biopsy samples using GeneChip® Bovine Genome Array and preimplantation 
specific cDNA array, respectively. For this, endometrium biopsies were taken at days 7 
and 14 of the estrous cycle in Simmental heifers during the pre-transfer period. In the next 
cycle, in vivo produced day 7 blastocysts were transferred to the recipients at day 7 of the 
estrous cycle after taking 30-40% parts of the blastocyst as a biopsy for transcriptome 
analysis. After pregnancy diagnosis, the heifers were classified as calf delivery (receptive 
endometrium) and no pregnancy (non-receptive endometrium) groups. Subsequently, the 
endometrial biopsies (taken at days 7 and 14 of the estrous cycle) and the embryo biopsies 
were categorized as calf delivery or no pregnancy groups. The results revealed 1126 genes 
were differentially expressed between receptive and non-receptive endometrium at day 7 
of the estrous cycle. These differences were accompanied by qualitative and quantitative 
alteration of major biological process and molecular pathways including cellular 
localization, post-transcriptional modification, signal transduction, apoptosis, cell cycle 
and immune response. However, only 14 genes were differentially expressed between 
receptive and non-receptive endometrium at day 14 of the estrous cycle. Furthermore, the 
transcriptome dynamics of receptive and non-receptive endometrium between day 7 and 
14 of the estrous cycle revealed 1867 and 254 differentially expressed genes, respectively. 
The higher number of differentially expressed genes and functional categories between day 
7 and 14 of the estrous cycle in receptive compared to non-receptive endometrium 
revealed the transcriptome plasticity of receptive endometrium. In addition, the gene 
expression profile in embryos biopsies resulted in calf delivery and those resulted in no 
pregnancy revealed 70 genes to be differentially expressed between the two embryo 
groups. Among those, 32 genes including SPAG17, PF6, UBE2D3P, DFNB31, AMD1, 
DTNBP1 and ARL8B were elevated in calf delivery groups and 38 genes including SGK1, 
GBF1, KRT8, DTX2, RNF34, ARL8B, RYBP and EEF1 were elevated in no pregnancy 
embryo groups. Therefore, the present study highlights the potential of pre-transfer 
endometrial and embryonic gene expression patterns as predictors of pregnancy success in 
cattle. 
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1 Introduction 
 
Despite the wider application of embryo transfer technology in modern cattle breeding, 
several transfers end up without pregnancy establishment. This pregnancy failure has 
enormous economic implications by retarding genetic progress and increasing the cost of 
maintaining recipients.  
Pregnancy failure can be attributed to incompetency of the embryo and/or inadequate 
endometrial receptivity. The implantation incompetency of the embryo can be caused by 
poor quality oocytes associated with inadequate mRNA and protein storage during oocyte 
maturation, inappropriate expression of genetic information derived from the embryonic 
genome during embryonic genome activation or inability of the embryo to produce 
sufficient pregnancy signals and secretion during perimplantation period (Bettegowda et 
al. 2008, Kanka 2003, Latham and Schultz 2001, Schultz et al. 1999, Gandolfi et al. 2005, 
Senger 2003). Thus, abnormal genetic constitutions of the blastocysts or unsuccessful 
transitions from maternal to embryonic transcription could account for many failures of 
early embryonic growth and implantation. Hence, for successful implantation to occur in 
the receptive endometrium, the blastocysts must attain implantation competency through 
accumulation of  transcripts and secretions essential to control cell differentiation and 
maternal recognition of pregnancy (Spencer et al. 2008). Successful pregnancy is therefore 
the result of coordinated and synchronized crosstalk between the conceptus and the 
receptive endometrium in a temporal and cell specific manner (Carson et al. 2000, 
Gonzalez et al. 2000, Lim et al. 2002, Simon et al. 2001, Spell et al. 2001, Wolf et al. 
2003).  
Endometrial receptivity  is the status of the endometrium to be ready to accept the embryo 
for implantation (Swierz and Giudence 1997) and it comprises temporary and unique 
sequence of events that makes the embryo to adapt to the new environment (Bergh and 
Navot 1992). Thus, assessment of endometrial receptivity is required to identify 
endometrium that will be suitable for assisted reproduction technology. Similar to 
implantation competent embryos, the endometrial receptivity is also known to be affected 
by certain genes whose expression is induced or reduced overtime. In this regard, different 
sets of genes were reported to be expressed or suppressed during the window implantation 
in human endometrium (Giudice et al. 2002, Giudice 2004, Kao et al. 2002, Lessey et al. 
1996, Martin et al. 2002, Riesewijk et al. 2003). Thus, aberrant endometrial genes 
expression during critical period of pregnancy establishment could result in implantation 
Introduction 
_________________________________________________________________________ 
 
2 
 
failure and infertility (Tabibzadeh and Babaknia 1995, Tapia et al. 2008). Therefore, 
selecting cows having adequate endometrial receptivity and developmentally competent 
embryos based on the gene expression pattern may increase the number of calves borne 
following embryo transfer. Hence, investigating the endometrial and embryonic gene 
expression during the time of embryo transfer and relating this information to pregnancy 
outcome may provide a unique opportunity to generate molecular marker that are related to 
endometrial receptivity and embryo implantation.  
Despite enormous efforts in characterizing bovine endometrial gene expression during the 
estrous cycle and early pregnancy (Bauersachs et al. 2005, Bauersachs et al. 2006, 
Bauersachs et al. 2009, Mansouri-Attia et al. 2009, Mitko et al. 2008), the recipient 
endometrial gene expression patterns during the estrous cycle and the subsequent effect on 
the upcoming pregnancy outcome is not investigated. With regard to the embryo, 
previously it has been shown the possibility of establishing a direct connection between 
transcript abundance of in vitro produced bovine blastocyst biopsy and pregnancy success 
after transfer of embryos (El-Sayed et al. 2006). However, no information is available on 
the relationship between in vivo produced bovine embryo transcriptome profile and 
pregnancy success. Thus, investigating the gene expression of the endometrium and in 
vivo derived transferable embryos in relation to the pregnancy success can be useful in 
developing molecular markers associated with establishment of successful pregnancy. 
Therefore, this experiment was aimed at establishing a direct link between the pre-transfer 
endometrial or in vivo derived embryo gene expression and pregnancy outcome using 
endometrium and embryo biopsy technology in conjunction with the pregnancy outcome 
information. To achieve the main objective, the specific objectives were 
 
1. To identify pre-transfer cycle endometrial transcriptome profile changes and 
transcriptomic functional and molecular signaling alterations in heifers that resulted 
in calf delivery and heifers that resulted in no pregnancy.  
2. To investigate the diestrus endometrial transcriptome dynamics of heifers that 
result in calf delivery or heifers that resulted in no pregnancy. 
3. Characterization of selected candidate genes during the estrous cycle and early 
pregnancy period. 
4. To identify transcriptome profile and molecular signaling alteration in in vivo 
derived embryos that resulted in calf delivery and embryos resulted in no 
pregnancy.
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2 Literature review 
 
2.1 Oocyte quality and its effect on pregnancy success 
 
Oocytes development is one of the main consequences of coordinated and complex events 
of physiological events during the estrous cycle. Oocyte is a key regulator of multiple 
aspects of female fertility, including ovarian follicular development and early 
embryogenesis (Matzuk et al. 2002). Unlike spermatozoa, which are generated 
continuously from puberty onwards, the population oocyte is limited during the life times. 
Therefore, the number and developmental competence of oocytes reaching the ovulation 
phase determine the number of offsprings the female animal produces during the 
reproductive lifetime (Gandolfi et al. 2005). Thus, developmental competence of oocytes 
is acquired when the oocyte achieves nuclear, plasma membrane and cytoplasmic changes 
during the follicular phases of the estrous cycle (Albertini et al. 2003, Brackett 1985, 
Eppig et al. 1996, Krisher 2004).  
In vitro, the oocyte developmental process is dependant on many factors including 
maturation or culture media (Fouladi Nashta et al. 1998). For instance, different add-ins in 
the maturation and culture medium including fetal bovine serum, purified bovine LH 
hormones, amino acid and retinoic acid were found to increase the developmental 
competence of oocytes (Brackett et al. 1989, Hashimoto et al. 2002, Mohan et al. 2003, 
Watson et al. 2000). Amino acid supplementation of oocyte maturation media may serve 
as osmolytes, energy substrates, pH regulators and chelators of heavy metals and as 
precursors for protein synthesis (Gardner 1994, Gardner et al. 1996, Lee and Fukui 1996). 
In addition, embryonic development was reported from bovine oocytes aspirated from 
follicles greater than 2-8 mm in diameter (Blondin and Sirard 1995, Kruip et al. 2000, 
Lonergan et al. 1994, Yang et al. 1998). Similar studies in buffalo evidenced that the 
fertilization rate, cleavage and embryo development were significantly higher in COC’s 
aspirated from large follicles, followed by medium and small-sized normal follicles 
(Raghu et al. 2002). Moreover, higher proportion of goat oocytes aspired from larger 
follicles reached to MII stage and oocytes from small and medium follicles yielded 
significantly lower proportion of hatched blastocysts than large follicles (Crozet et al. 
1995). Thus, low developmental rates of oocytes from small follicles may be associated 
with their inability to reach complete meiotic and/or cytoplasmic competence, or they are 
from follicles already undergoing atresia. 
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Unlike to the in vitro counterparts, in vivo developmental competence of oocytes depends 
on the dietary system, ambient temperature, breed, parity and age of the animal. 
Alterations in the quantity of food consumed or the composition of the diet imposed solely 
during the pre-mating period can adversely affect oocyte maturity, blastocyst yield, 
prenatal survival and the number of offspring born alive (Ashworth et al. 2009). For 
instance, animals fed on rumen inert fat exhibited higher proportion of cleaved embryos 
than soya or linseed fed animals (Fouladi-Nashta et al. 2007). However, increased protein 
and urea intake may affect blastocyst development by elevating ammonia concentration in 
the follicular fluid (Adamiak et al. 2005, McEvoy et al. 1997a, Powell et al. 2006). This 
may adversely affect the oocyte developmental competence by inhibiting the growth and 
metabolism of the oocyte-supporting granulosa cells (Rooke et al. 2001). Similarly, long 
chain n-6 polyunsaturated fatty acid high density lipoprotein found to be resulted in 
reduced embryo development in ewes (Wonnacott et al. 2010). Moreover, high fat feeding 
can improve significantly the blastocyst production, total inner cell mass and 
trophectoderm cells than the low-fat group (Fouladi-Nashta et al. 2007). Similarly, 
(Mantovani et al. 1993) reported that the yield of transferable embryos after superovulation 
in beef cattle was significantly reduced when heifers had access to concentrates ad libitum 
compared with restricted concentrates. In addition, the dietary energy levels were found to 
be affected both the morphology and the number follicle in ewes and heifers (Boland et al. 
2001, O'Callaghan et al. 2000).  The effect of feeding level on oocyte quality was reported 
to be dependent on the body condition of the animal, with the high level of feeding being 
beneficial to oocytes from animals of low body condition, but detrimental to oocytes from 
animals of moderately high body condition (Adamiak et al. 2005).  
Short time feed restriction and level of feeding can affect the oocyte quality and embryo 
survival. For instance, restricting energy intake before slaughter can enhance subsequent 
in-vitro development of the oocytes from small follicles (McEvoy et al. 1997b) and short-
term restrictions in dietary intake before mating increased subsequent pregnancy rates in 
cattle (Dunne et al. 1997). Furthermore, restriction feed intake was found to reduce the 
expression of glucose transporter 3 (SLC2A3), sodium/glucose co-transporter 1 (SLC5A1) 
and Na+/K+ ATPase mRNA in oocytes, while expression of PTGS2, HAS2 and the leptin 
receptor in granulosa cells was increased (Schmidt et al. 2009). Similarly, (Pisani et al. 
2008) indicated that feeding ewes with 0.5 above maintenance requirements was found to 
alter the relative abundance of transcripts involved in oocyte metabolic activity. This can 
suggest that changes to the immediate environment surrounding oocytes and embryos can 
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alter the pattern of genes expressed, or epigenetic modifications that is heritable changes in 
gene function that occur without an alteration in DNA sequence in oocytes and embryos 
which in turn contribute to altered developmental potential (Burdge et al. 2007). 
The effect of season on oocytes developmental competence has been documented. The 
oocyte or embryonic developmental competence found to be increased during the cold 
seasons compared to the hot season (Rocha et al. 1998, Ryan et al. 1992, Zeron et al. 
2001). This may be associated with modifications of the physical and chemical properties 
of the membranes. For instance, heat stress induces apoptosis in bovine and rabbit embryos 
increased the expression of heat shock proteins in porcine and mouse embryos, disrupts the 
microtubule and microfilaments and alters the methylation status of imprinted genes 
histocompatibility 9 (H19) and insulin-like growth factor 2 receptor (Igf2r) in mouse 
embryos (Bernardini et al. 2004, Kim et al. 2002, Makarevich et al. 2007, Paula-Lopes and 
Hansen 2002, Rivera et al. 2004, Zhu et al. 2008). Similarly, the heat stress during El Nino 
periods was found to be associated with reduction in the average number of embryos 
recovered from donor cows, the proportion of live embryos and the quality of live embryos 
(Benyei et al. 2003). From this, it can be possible to summarize that inherent nature of the 
animal (genetic makeup), the nutritional status, the feeding level and type of nutrient as 
well as the seasonal variation in temperature can affect the developmental competence of 
the oocyte, embryo survival or pregnancy rate in cattle and other domestic farm animals.  
 
2.2 The role of oocyte mRNAs stores on oocyte quality 
 
Although the environmental conditions and the type of breed significantly influence the 
oocyte quality, the earliest stages of embryogenesis in mammals are regulated by 
maternally-inherited RNAs and proteins stored within the oocyte (Bachvarova 1985). 
Transcription and storage of maternal mRNA occurs during follicular development in 
which the oocyte synthesizes and accumulates large stores of the total RNAs and protein. 
These stored mRNAs and proteins are essential for completion of the meiotic cell cycle, the 
establishment of an embryonic genome and regulation of preimplantation embryo 
development (Bachvarova 1985, Bachvarova et al. 1985, Bachvarova 1992, Betts and King 
2001, De Sousa et al. 1998, Eichenlaub-Ritter and Peschke 2002, Kastrop et al. 1991, 
Levesque and Sirard 1995, Lonergan et al. 2003, Piccioni et al. 2005) 
The accumulated mRNA and protein by growing oocyte is followed by massive 
destruction during oocyte maturation. For instance, an estimated 85 pg of mRNA is 
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believed to be available in a GV-stage mouse oocyte, but polyadenylated mRNA declines 
during oocyte maturation by about 50 pg and about 30% of the total mRNA undergoes 
degradation (Paynton 1998). The polyadenylation may be associated with translational 
activation, whereas deadenylation is associated with translational silencing (Piccioni et al. 
2005). Further losses of maternal mRNA occur during early cleavage stages (Brevini-
Gandolfi et al. 1999, Brevini-Gandolfi et al. 2001, Piccioni et al. 2005).  
Although, the RNA transcribed during the period of cytoplasm maturation is very stable, 
the fates of different mRNA species are controlled at several levels (Wassarman 1996). 
Different species of mRNA are polyadenylated in different degrees. Those mRNA 
transcripts with long poly-A tails of ~150 A residues are utilized for immediate use and 
those with shorter poly-A tails of 90 A are used only after elongation of the poly-A tail 
(Bachvarova 1992). Therefore, the oocyte transcriptome is expected to reflect its potential 
to develop into an embryo (Thelie et al. 2009). Thus, the oocytes intrinsic quality and 
developmental competence is mainly influenced by the presence or absence of those 
transcripts in the oocyte (Bilodeau-Goeseels 2003). This in turn can affect the ability of the 
embryos further development and survival. 
2.3 Oocyte specific transcripts and their effect on embryonic development 
 
The stability of oocyte mRNA is crucial for normal development and any disturbance of 
this process can negatively affect oocyte developmental competence and cause blockage of 
further embryonic survival (Gandolfi et al. 2005). Although, the ability of an oocyte to 
develop into embryo depends on the accumulation of specific information and molecules, 
because of their importance role, more emphasis has been given to oocyte-specific 
transcripts (Eichenlaub-Ritter and Peschke 2002). Oocyte specific transcripts may differ 
between species and stage of pre-implantation development. Oocyte mRNAs with short 
poly (A) tails are translationally inactive and are activated upon extension of the tail during 
specific stages of embryo development (Brevini-Gandolfi et al. 2001). Many oocyte-
specific factors have been recognized to influence the acquisition of developmental 
competence. Maternal effect genes produce transcripts that form a pool of mRNA in the 
oocyte cytoplasm that can sustain post-fertilization development until the embryonic 
genome is activated (Memili and First 1999).  
The mammalian oocyte provides not only proteins that are essential for initial cell 
divisions in the embryo but also proteins and RNAs that are implicated in regulating the 
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paternal genome. Developmentally competent oocytes accumulate large pools of RNA in 
the cytoplasm and nucleus which stops when the oocyte reaches of diameter of 110 µm 
(Bachvarova 1992, Fair et al. 1996). The study in mouse oocyte indicated that mature 
oocytes with the diameter of 100-120 µm have an estimated amount of 2.4 ng total RNA 
and  40-60 pg mRNA (Bilodeau-Goeseels and Schultz 1997).  
The genetic programs within the oocyte play an important role in orchestrating the 
multiple events required for successful folliculogenesis, fertilization and early 
development (Dean 2002). In addition, oocyte specific genes are important for the initial 
cleavage divisions of embryonic development (Yao et al. 2004).  
The mammalian oocyte expresses  several genes specific to oocytes that can play a key 
role in regulation of fertility in mammals (Bettegowda et al. 2007). Some of those genes 
include growth differentiation factor 9 (GDF9), bone morphogenetic protein 15 (BMP15), 
bone morphogenetic protein 6 (BMP6), zona pellucida (ZP) genes, MLF1-interacting 
protein (MLF1IP), factor in the germline alpha (FIGα), B-cell translocation gene 4 (BTG4) 
and phosphotyrosine-binding protein (xPTB), Mater and JY-1 (Elvin et al. 2000, Tong et 
al. 2000, (Vallee et al. 2005). Among those, (FIGα) is required for expression of the zona 
pellucida genes that encode ZP1, ZP2 and ZP3 (Liang et al. 2007). Mater is found to be 
essential for embryonic development beyond the two-cell stage and females that lack the 
maternal effect gene Mater are sterile (Tong et al. 2000).  
In oocytes, some transcripts are required for oocyte-specific processes and metabolism, 
while others are presumably stored for use during early embryonic development, prior to 
the activation of zygotic expression (Li et al. 2006). For instance, the zona pellucida genes 
(ZP1, ZP2 and ZP3) are required during folliculogenesis, species-specific fertilization and 
passage of the early embryo down the oviduct (Rankin et al. 1996). Knockout mice lacking 
oocyte-derived zona pellucida protein 3 (ZP3) or ZP2 display defects in early antral and 
preovulatory follicle development, cumulus-oocyte complex formation, ovulation and 
unable to form a zona matrix despite synthesis of ZP1 and ZP2 (Rankin et al. 2001, Zhao 
and Dean 2002). Moreover, ZP1 null mice form zona pellucida with only ZP2 and ZP3, 
but the matrix is structurally flawed and some growing follicles have ectopic granulosa 
cells lodged between the oolemma and zona pellucida (Dean 2002). Later in 
folliculogenesis, Zp1 null follicles can develop accentuated perivitelline space prior to 
ovulation. Although, Zp1 null females are fertile, they have decreased fecundity due to 
precocious hatching of early embryos from the structurally compromised zona matrix 
(Rankin et al. 1999). Blastocysts derived from in vitro maturation and fertilization of eggs 
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from Zp2 or Zp3 knockout females are not capable of completing development after 
transfer to wild-type pseudo pregnant recipients (Zhao and Dean 2002).  
Other group of oocyte specific genes is the transforming growth factor beta (TGF-beta) 
members which are potent regulators of cell proliferation and differentiation. Three 
members of TGF- beta, growth differentiation factor 9 (GDF9), bone morphogenetic 
protein 15 (BMP15) and BMP6 are expressed by the oocyte and may mediate effects 
attributed to the oocyte. GDF9 is absolutely required for pre-antral follicle development, 
alters the periovulatory expression of granulosa cell genes and stimulates cumulus (Elvin 
et al. 2000). For example, in the mouse, growth differentiation factor (GDF9), is expressed 
only in oocytes and is required for early folliculogenesis and plays role in follicular 
development after the primary follicle stage (Dong et al. 1996). Moreover, BMP15, 
functions in a cooperative manner with GDF9 to govern ovulation and fertilization rates 
(Yan et al. 2001). For instance, animals homozygous for the BMP15 or GDF9 mutations 
are sterile due to arrested follicular development from the primary stage of growth. In 
sheep, GDF9 mRNA is present in germ cells before and after ovarian follicular formation 
as well as throughout follicular growth, whereas BMP15 mRNA is found in oocytes only 
from the primary stage of growth (McNatty et al. 2003). 
 
2.4 Embryogenesis and gene expression 
 
2.4.1 Preimplantation embryonic development  
 
The process by which fertilized oocytes divide and ultimately result in specialized tissues 
and organs of a mature organism is one of the greatest mysteries of life. To achieve this, 
the oocytes must first attain the cytoplasmic and nuclear maturation and reach to the 
metaphase II stage. Once the oocyte is matured, the process of fertilization starts when the 
sperm cell binds to the zona pellucida and fuse with the cell membrane of the oocyte. 
However, actual fertilization occurs when the sperm enter the oocyte cytoplasm and fuse 
its pronucleus with the oocyte pronucleus restoring the number of chromosomes that is 
typical of a given species. Since the resulting zygote is a large cell that has low nuclear to 
cytoplasmic ratio, the zygote divides without an increase in cell mass. Thus, in the process 
of its development to the blastocysts, the mammalian preimplantation embryo passes 
through distinct metabolic phases including changes in protein synthesis, changes in 
energy requirements and amino acid uptake. Apart from this, the preimplantation embryo 
undergoes morphological changes including compaction, cavitation and hatching (Crosier 
Literature review  
_________________________________________________________________________ 
 
9 
 
et al. 2000, Crosier et al. 2001). Compaction is the first step in the process of 
differentiation and is fundamentally important for the formation of viable blastocysts. 
In cattle, early cleavage occurs on day 2 after fertilization and between day 3 and 4 the 
embryo reaches to 8-16 cells stage (Morris et al. 2001). The embryo reaches compacted 
morula or blastocyst stage 5-6 days after fertilization. One of the major event during  
preimplantation development is the formation of blastocyst which later differentiated in to 
two distinct cell lineages, the trophectoderm cells (TE) and the inner cell mass (ICM) 
(Watson 1992). The ICM gives rise to the embryo, whereas the TE forms the placenta 
(Goossens et al. 2007). The TE, the first differentiated cell type of development, is a 
specialized tissue that initiates implantation or attachment and is the progenitor of the 
placenta. The ICM is the pluripotent progenitor of the embryo proper (Rossant 2004, 
Yamanaka et al. 2006). A blastocyst is therefore characterized by the presence of fluid 
filled sac called blastocoels. Therefore, the body plan of the embryo proper is established 
when the pluripotent epiblast gives rise to the germ layers ectoderm, mesoderm and 
endoderm (Russ et al. 2000). Compaction is the first step in the process of differentiation 
and is fundamentally important for the formation of viable blastocysts.  
 
2.4.2 Preimplantation embryonic losses 
 
Embryonic mortality significantly limits the success of establishment and maintenance of 
pregnancy in cattle and it is a major impediment to the adoption of a range of assisted 
reproductive technology in the cattle breeding industry. The higher proportion of  embryo 
loss  occurs in the first 8-19 days after artificial insemination (AI)  when early embryo is 
completely dependent on the oviduct and uterine environment for its survival (Morris and 
Diskin 2008).  
Understanding the root causes of preimplantation and postimplantation fetal losses is 
required to design strategies towards improving the efficiency of in vitro fertilization and 
preimplantation genetic diagnosis. Embryo losses can be caused by several factors 
including the maternal environment (hormonal, gene expression, production performance), 
the intrinsic quality of the embryo including chromosomal abnormality and other 
environmental factors. These factors can be grouped as those of genetic, physiological, 
endocrine and environmental origin (Ashworth 1994 , Bazer 1994). Among these, 
chromosomal abnormalities causes marked alterations in the genetic make up or genome 
of the embryo and interferes with the course of embryo development during the embryo 
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and the maternal communication.  For instance, it is believed that about 50% of 
postimplantation embryo losses are due to chromosomal abnormalities and that 
cytogenetic abnormalities account for 23-71% of preimplantation losses (Plachot et al. 
1988). In addition, the progesterone level is one of the determinants of embryo survival 
and development. The level of progesterone has been implicated in embryonic deaths 
during four phases of pregnancy, during the early postovulatory period (before day 6 after 
mating), during days 4 to day  9 after mating, during maternal recognition of pregnancy 
(day 14 to 17) and during the late embryonic period (day 28 to 42) when placentation and 
attachment are in progress (Inskeep 2004). It has been suggested that the proportion of 
pregnancy failure in cattle is due to failure of the embryo to produces adequate amounts of 
interferon-τ (IFN-τ) to block uterine prostaglandin F2α production (Thatcher et al. 1989).  
 
Table 1: Cattle embryo losses during different gestation periods 
 
 
Fertili
zation 
    Cumulated loss (%) by  
         gestation week 
 
  1 2 3 4 5-8 Reference 
Beef heifers AI 13 4  - 47 Diskin and Sreenan 1980 
Beef heifers AI -  6 21 19   - Roche et al. 1981 
Beef heifers AI 24  16 - -   - Maurer and Chenault 1983 
Beef cows AI 16  3 - -   - Maurer and Chenault 1983 
 
2.4.3 Embryonic genome activation and embryonic development 
 
Fertilization brings together the haploid genomes of two highly differentiated cells into the 
oocyte cytoplasm. After fertilization, the genome of the newly formed embryo is first 
transcriptionally inactive and the embryo depends on the stored RNA and protein during 
oocyte maturation (Jeanblanc et al. 2008b).  Studies in cattle and mouse have shown that 
cattle and mouse embryos are able to survive until 8-cell and 2-cell stage embryos, 
respectively despite inhibition of polymerase dependent transcription by alpha-amanitin 
during the earliest stages of embryo development (Memili and First 2000, Natale et al. 
2000, Plante et al. 1994, Telford et al. 1990). However, after some stage of development, 
the embryo depends on the newly synthesized RNA or protein as the maternal mRNA is 
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rapidly degraded and < 30% of the original mRNA could be available until 2-cell stage 
embryo (Clegg and Piko 1983b, Clegg and Piko 1983a). Hence, the embryo is dependent 
on stored maternal mRNA until the maternal-zygotic transition. After this time, the new 
genes are expressed by overcoming the transcriptional repression and embryonic 
developmental program is guided by a new program (Gandolfi and Gandolfi 2001, 
Meirelles et al. 2004). Thus, failure to initiate the embryonic genome transcription may 
result in lower embryonic development. Study by Salilew-Wondim et al. (2007) have also 
indicated that bovine zygotes exhibited better developmental competence to the blastocyst 
stage were found to be enriched with AURKA, DDX10, NASP, DNMT1 and SMARCA5 
genes compared to those that have lower developmental potential. This may suggest lower 
genomic activation in lower developing groups compared to those exhibiting higher 
developmental potential. The embryo then need to reprogram the newly formed embryonic 
genome to a totipotent state (Duranthon et al. 2008). Hence, preimplantation embryo 
development and differentiation, which results  in the formation of a blastocyst, requires 
the activation of the embryonic genome to become implantation competent (Dey et al. 
2004). The key pre-implantation embryonic developmental process, compaction and 
differentiation of the morula into the blastocyst stage are the results of embryonic genome 
activation (Schultz et al. 1999).  
Embryonic genome activation can be classified into as minor and major genome activation 
depending on the species. During minor genomic activation, there is a reduced 
transcriptional activity and it does not require any specific transcription factor. Unlike to 
the minor genome activation, major genome activation is marked by rapid transcriptional 
activity and newly synthesized RNA/proteins which are essential for further embryonic 
development (Jeanblanc et al. 2008a). Moreover, major activation promotes a dramatic 
reprogramming of gene expression pattern coupled with the generation of novel transcripts 
that are not expressed in oocytes (Vallee et al. 2005). Therefore, as development proceeds 
after fertilization, embryogenesis depends on the expression of genetic information derived 
from the embryonic genome (Bettegowda et al. 2008, Kanka 2003, Latham and Schultz 
2001, Schultz et al. 1999). During this time, several maternal mRNAs are degraded and 
degradation eliminates gene products that might hinder further embryonic development. 
Elimination and silencing of some gene can be processed by means of chromatin-mediated 
repression, by limiting the transcription machinery and transcriptional repression (Schier 
2007).  
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Genome activation may occur in an orderly manner in which some genes being transcribed 
before the beginning of major genome activation and other being transcribed after the 
occurrence of major genome activation. The changes in chromatin protein content, 
particularly histone proteins, chromatin structure and cytoplasmic macromolecular may 
regulate the genome transcription and specificity of transcription (Latham 1999, Latham 
and Schultz 2001).  
The time of embryonic genome activation is species dependant (Misirlioglu et al. 2006). 
For instance, it occurs at the 2-cell stage in mice (Kidder and McLachlin 1985), 4-cell 
stage in humans, rats, pigs and  8- to 16-cell stage in cattle and sheep (Whitworth et al. 
2004). Minor genome activation is initiated as early as the 1-cell zygotic stage in bovine 
(Tesarik et al. 1987, Tesarik J 1987). It occurs  at the 6- to 8-cell stage in monkeys 
(Schramm and Bavister 1999) and in 4000 to 8000-cell embryos in Xenopus laevis (Etkin 
and Balcells 1985).  
In the absence of proper genome activation, the majority of bovine embryos stop 
developing within a few cell cycles after initiating cleavage. This developmental block 
arises in the bovine embryo at the eight-cell-stage (Whitworth et al. 2004).  
Embryos that are able to transcribe their own genome are able to differentiate and implant 
in the uterus due to its ability to overcome chromatin repression and/or ability to activate 
transcription of important developmental genes (Betts and King 2001). For instance, genes 
that are required for regulation of transcription, chromatin-structure, cell adhesion and 
signal transduction were increased at the 8-cell stage compared with 8-cell embryos treated 
with α-amanitin and MII oocytes (Misirlioglu et al. 2006). The situation of embryonic 
genome activation in embryos produced by somatic cell nuclear transfer (SCNT) may be 
different from those embryos produced by fertilization. In nuclear transfer embryos, the 
somatic nucleus has to be reprogrammed it self to restart and continue the developmental 
process. It is believed that the somatic nucleus substitute somatic gene expression program 
with embryonic gene expression necessary for normal embryo development (Han et al. 
2003). Generally, the early preimplantation bovine embryonic development (zygote to 8-
cell stage) largely depends on maternally derived mRNAs and proteins. However, when 
the embryo reaches to the 8-cell stage, the embryo starts to rely on transcripts derived from 
genome activation, afterwards the bovine embryo produces several transcripts that can be 
required for further development and establishment of implantation (Memili et al. 1998, 
Memili and First 1998, Memili and First 1999, Memili and First 2000, Telford et al. 1990). 
Therefore, the pre-implantation period of embryonic development is manifested by 
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dynamic quantitative and qualitative changes of mRNA and protein contents (Paynton 
1998, Temeles et al. 1984). However, those embryos that are unable to initiate gene 
transcription will fail to be implanted in the uterus and end up to demise.  
 
2.5 Transcripts required during blastocyst formation and differentiation 
 
Blastocyst formation is associated with trophectoderm cell differentiation, which arises 
through fundamental biological processes that are related to establishment of cell polarity. 
Blastocyst formation is required for implantation to occur and it is the most important 
morphological determinant of embryo quality prior to embryo transfer.  
Several physiological events and specific gene families are operating to regulate blastocyst 
formation (Watson et al. 1999). Genes expressed in the blastocyst stage are therefore can 
be candidates for controlling regulation processes that take place at the beginning of 
cellular differentiation (Ponsuksili et al. 2002). Identification of those genes participating 
in blastocyst formation and the analysis of their expression patterns may help to 
understand the mechanisms that control blastocyst formation (Goossens et al. 2007). Those 
gene families may include the E-cadherin-catenin cell adhesions, tight junction gene, 
Na+/K+-ATPase gene family, the aquaporin gene families, gap junction (connexin 43), 
transforming growth factor alpha (TGF-alpha) and epidermal growth factor (EGF) 
(Watson 1992, Watson and Barcroft 2001, Watson et al. 2004). These genes may encode 
different cellular activities such as cell polarity, active transport of Na+ and K+, cell 
junction, cytoskeletal, ion transporter and water channel gene that could be required by 
embryos during blastocyst formation  (Watson et al. 2004).  
Genes encoding for transcriptional factor activity are also expressed during blastocyst 
formation. The expression of transcriptional factor genes may be required to during 
embryos differentiation to the inner cell mass (ICM) and trophectoderm (Tr). Numerous 
transcriptional factors including RNA exonuclease 1 (Rex1), GATA-binding protein 3 
(GATA3), T-Box (eomesodermin), caudal type homeobox (CDX2), activating protein 2 
gamma (AP2γ), basic helix loop-helix (bHLH) and Mash2 are expressed in trophectoderm 
(Imakawa et al. 2004). Among those, the importance of eomesodermin (T-box) during 
mouse embryo differentiation into trophoblast has been described in Russ et al. (2000). 
Stage dependant expression of pattern of caudal type homeobox 2 (CDX2), OCT4, NANOG 
homeobox (NANOG), GATA binding protein 3 (GATA3) and GATA binding protein 6 
(GATA6) also found to be essential during the mouse embryonic development. For 
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instance, OCT4 is expressed in all stages of embryos before the late morula and (NANOG) 
is specifically induced during late morulae. Similar to NANOG, CDX2 is expressed in the 
late morulae and is required for the repression of OCT4 and NANOG in the trophectoderm 
of the blastocyst. On the other hand, GATA6 is expressed in the primitive endoderm of the 
late blastocyst, when the expression of OCT4 and NANOG are repressed (Wang and Dey 
2006). This may suggest the preimplantation embryo development and blastocyst 
formation are triggered by induction and reduction of the expression pattern of certain 
genes at temporal fashion. Furthermore, (Ho et al. 1995) also described the expression 
Na+/K+-ATPase, Sp1 (Sp1 transcription factor), TATA box-binding protein (TBP), IGFI, 
IGFII, IGFI receptor and IGFII receptor which are associated with blastocyst development, 
blastocyst hatching. Apart from these, the importance of STA3 (Takeda et al. 1997), DNA 
polymerase delta  (Uchimura et al. 2009), Ped (Warner et al. 1987, Warner et al. 1988).  
Gene targeted experiments in bovine embryo revealed several genes to be essential for 
blastocyst formation. For instance, targeted knockdown of baculoviral inhibitors of 
apoptosis repeat-containing 6 (BIRC6), survivin (BIRC5), KRT18, OCT4, MSX1 and E-
cadherin were associated with reduced blastocyst formation in vitro  (Goossens et al. 2010, 
Nganvongpanit et al. 2006, Salilew-Wondim et al. 2010, Tesfaye et al. 2010). 
Genes that are required in blastocyst formation can vary depending on the culture 
condition and the source of the embryo in vitro. For instance, nuclear transfer and 
chromatin transfer are enriched with genes assumed to be involved in metabolism, 
signaling and apoptosis compared to blastocysts derived from in vitro fertilized  embryos 
IVF (Zhou et al. 2008). In an attempt to investigate abnormal gene expression patterns in 
embryos of SCNT blastocysts, a global gene expression analysis showed that 28 genes to 
be differentially expressed between SCNT and AI blastocysts (Aston et al. 2009). 
Furthermore, several studies demonstrated that in cloned bovine blastocysts, the 
expression levels of specific genes including, DNA (cytosine-5)-methyltransferase 1 
(DNMT1), fibroblast growth factor 4 (FGF4), fibroblast growth factor 2 (FGF2), 
Interleukin 6 (IL6), heat shock protein (HSP) and interferon tau IFN τ are different from in 
vivo developed embryos. This difference is mainly influenced by donor cells type (Daniels 
et al. 2001) and cell fusion methods (Niemann et al. 2002, Wrenzycki et al. 2001).  
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2.6 Estrous cycle and pregnancy establishment  
 
2.6.1 Physiology of the estrous cycle and its implication in pregnancy success 
 
Although the transcripts stored during oocyte maturation, the status of embryo genome 
activation, the type and nature gene expressed during blastocyst formation influence 
embryo survival and implantation, the physiological phenomena that occur during the 
estrous cycle is the backbone pregnancy establishment. 
The average length of the bovine estrous cycle is 21 days for mature cows and 20 days for 
heifers. According to the typical characteristics of uterine structure and function, the 
estrous cycle can be divided into four stages: estrus, metestrus and diestrus, proestrus (Tan 
et al. 2003). During estrus, the estrogen and FSH are declining accompanied by LH surges 
during standing estrus. During this time, the theca cells start producing progesterone to 
inhibit LH and FSH release and ovulation occurs 12-18 hours after the end of estrus. 
Estrus phase is followed by metestrus which is the time of luteal development. The FSH 
surge that occurs during this time may recruit the first follicular wave for the next cycle. 
Diestrus is the longest phase of the estrous cycle. It lasts from days 5-17 of the estrous 
cycle and is marked by the presence of the mature corpus luteum. Progesterone is 
produced by large and small luteal cells. Corpus luteum is composed of small and large 
luteal cells. The large luteal cells are derived from granulosa cells and the small luteal cells 
are derived from the thecal cells. The large luteal cells produce most of the progesterone 
and have the prostaglandin receptors, while the small luteal cells have LH receptors. 
Nearly at the end of late luteal phase (day 17-18), in the absence of pregnancy recognition 
signal, prostaglandin is released and causes luteal regression. With the loss of progesterone 
inhibition, GnRH rises and causes stimulation of LH and FSH. The follicles mature by the 
influence of FSH. The growing follicle produces estrogen in the granulosa cells to induce 
signs of estrus in the cow. Inhibin is also produced by the growing follicle and prevents 
other smaller follicles from growing. This inhibition of smaller follicles assures selection 
of a single follicle to ovulate. The estrogen causes progesterone receptor synthesis, which 
allows LH binding to luteal cells. Therefore during these different phases of the estrous 
cycle, gonadotropins influence folliculogenesis, ovulation, corpus luteum function and 
steroidogenesis in the ovary (Kojima 2003). The physiological and hormonal changes that 
occur during the estrous cycle prepare the reproductive tract of the female animal for the 
period of sexual receptivity, ovulation and implantation. Therefore, understanding the 
biological mechanisms, the physiology, hormonal regulation and molecular events of the 
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bovine estrous cycle is essential for increasing the pregnancy rates of farm animals. Thus, 
estrous cycle has a direct impact on the reproductive performance of the cattle or other 
farm animals as it gives repeated opportunities for female animal to become pregnant 
throughout its productive lifespan. 
The estrous cycle is marked by morphological, histological and hormonal changes of the 
reproductive tracts. Among which, the uterine histology and morphological changes during 
the estrous cycle has special association with pregnancy success. These may include 
changes in the height of the surface epithelium, the height of the glandular epithelium, the 
size of the gland lumen, the development of the gland, secretion in the gland lumen and 
stromal edema (Marinov and Lovell 1968). The histological characteristic of the uterus 
varies depending on the fertility status of the animal. For instance, the presence of uterine 
histological differences between the normal cyclic cows and repeat breeders have been 
described (Ohtani and Okuda 1995). The authors have indicated that on day 1 of the 
estrous cycle, the uterus of repeat breeder exhibited glandular secretions and supranuclear 
vacuolation that were not were not observed in the normal cows. Moreover, the stromal 
indices, the stromal mitoses and pseudodecidual reaction were absent in the repeat 
breeders during day 8 of the estrous cycle. Similarly, the histological changes of the uterus 
during the estrous cycle including, the presence of metrorrhagia on days 0 to 1, mitoses in 
glandular epithelium on day 5, basal vacuolation in the surface epithelium between day 5 
to 6 and stromal mitoses on days 9 to 12 has been described (Ohtani et al. 1993). This may 
suggest that the uterine morphology during the estrous cycle to be an indicator of fertility. 
In addition to changes in histology and morphology, neutrophil concentration changes 
have been observed in the uterus of dairy cows during the estrous cycle (Subandrio et al. 
2000). 
Estrous cycle irregularities and inadequate estrus detection has been one of the major cause 
of reproductive wastage in cattle. In dairy cows, estrus detection is showing a declining 
trend due to directional selection (Figure 1). A decrease in estrous detection rates in 
Holstein and Jersey dairy herds has been reported (Harrison et al. 1989, Harrison et al. 
1990, Washburn et al. 2002). Another study showed that higher yielding cows exhibit 
weaker signs of estrus than lower yielding cows consequently resulted in longer calving 
interval (Harrison et al. 1990). The physiological mechanism for negative correlation 
between high milk production and estrus duration traits is not clear. However, the 
hypothesis can goes to the relationship between feed consumption, energy allocation and 
hormonal regulation.  For instance, cows selected for high milk yield are more often prone 
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to negative energy balance as they spend a relatively large proportion of the available 
nutrients on milk production, which can cause fertility problems during a period of 
negative energy balance (Chagas et al. 2007). Thus, decrease estrus duration in high 
producing cows may be related to the altered energy metabolism that can disturb the 
endocrine signaling and circulating concentrations of estrogen that ultimately resulted in 
inhibiting estrous behavior (Lopez et al. 2004, Roche 2006). Moreover, changes in 
reproductive physiology that are associated with high milk production may in part be 
explained by elevated progesterone and estrogen clearance rates he liver of a lactating cow  
due to increased feed intake which can lead to an increased liver blood flow and metabolic 
activity (Boer et al. 2010).  
 
 
MP= Milk production (kg.day) 
DE= Duration of estrus (hr) 
SH= Standing heat (n) 
ST= Standing time (s) 
DP= Days postpartum (d) 
 
 
Figure 1: Characteristics of estrus in high (black bar) and low milk producing cows 
(white bar). Compiled from Lope et al. (2004).  
 
2.6.2 Hormonal events during the estrous cycle and its effect on pregnancy establishment 
 
The physiology of estrous cycle uncovers coordinated functional activities of different 
segments of reproductive system, the nervous and endocrine systems (Jainudeen and Hafez 
2000 ). The type and level of hormones participating in the regulation of the estrous cycle 
and pregnancy has been indentified and characterized for several years. The measurements 
of hormone levels in different parts of the uterine and ovarian vasculature revealed the 
presence of regulating mechanism in the estrus cycle and pregnancy (Koziorowski and 
Stanisława 2007). 
The concentration and regulation of the ovarian and uterine hormones changes depending 
on the phase of the estrous cycle via feed back mechanism of luteinizing hormone and 
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follicle-stimulating hormone from the gonadotrophins of the anterior pituitary (Hewitt et 
al. 2003, Kojima 2003, Richardson et al. 2006). For instance, on the onset of preovulatory 
gonadotrophin surge, the number of LH and estrogen receptors increase in the theca and 
granulosa cells accompanied reduction of FSH receptors. Thus, between days 3 and 7 of 
the estrous cycle, a single estrogen-active follicle develops  and peak estrogen can be 
observed in plasma around this time (Glencross et al. 1973).  
Estrogen is believed to increase the vascular growth of the endometrium and plays a major 
role in triggering the gonadotropin surge. This increased level of estrogen maintains higher 
estrogen/progesterone ratio and greater magnitude of uterine blood flow during the estrous 
cycle (Ford et al. 1979, Ford 1982, Roman-Ponce et al. 1983). Progesterone is the major 
hormone secreted by the corpus luteum in a pulsatile manner, pulses coinciding during the 
luteal phase with those of follicle stimulating hormone (Walters et al. 1984). The level of 
progesterone start to increase at day 5 and reach peak at day 14 of the estrous cycle (Diaz 
et al. 1986) and high progesterone concentrations during the luteal phase inhibit the 
estradiol-induced gonadotropin surge by reducing pituitary responsiveness to gonadotropin 
releasing hormone (Attardi et al. 2007, Richter et al. 2005). Moreover, the presence and 
the amplitude of progestrone in the luteal phase influences the time interval between rise 
of estrogen levels and the induction of estrous behavior or the LH surge (Skinner et al. 
2000). On the other hand, the level of progesterone decreases to basal concentrations 
starting on days 17 to 18 (Schams et al. 1977). The decrease progestrone is associated with 
the loss of progesterone receptor and increases in epithelial estrogen receptor and oxytocin 
receptor in the endometrial cells (Goff 2004). Oxytocin from the pituitary and corpus 
luteum, stimulates the pulsatile release of the prostaglandin F2α (PGF2α) via the oxytocin 
receptor in the luminal epithelium of the endometrium, resulting in regression of the 
corpus luteum (McCracken et al. 1999). On the other hand, during the time of low 
progesterone, there is a pulse increase of estrogen concentration (Fata et al. 2001, Schedin 
et al. 2000). On the other hand, PGF2α secreted from the uterus or particularly in the 
endometrial luminal and superficial glandular epithelium resulted in the demise of the 
corpus luteum (LaFrance and Goff 1990).  
The trans-action of hormone of the ovary and uterine origin limits the number of off 
springs the female animal can produce during its productive lifetime. However, it is 
necessary to understand the mechanism how the hormones of the ovarian origin act on the 
uterus and hormones of uterine origin acts on the ovary. As reviewed by (Koziorowski and 
Stanisława 2007), in cow, the mesovarium venous vessels runs in a closer apposition to the 
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ovarian artery. The majority of uterine and ovarian arteries and arterioles running in the 
area of mesovarium are enmeshed by a dense net of venous vessels forming veno-venous 
network. Moreover, the presence of lymphatic system structures in the mesovarium and 
mesometrium may participate in the local hormones exchange and the estrous cycle 
regulation. The concept of transfer of uterine PGF from the uterine vein to the ipsilateral 
artery by a counter current exchange mechanism was also suggested (Peters 1985).  
In uterus, the estrogen and progesterone receptor systems maintain the level of those 
hormones and transmit information into timely relevant developmental responses. The 
coordinated action of those entities resulted in follicular growth and development, 
follicular atresia, estrous cycle functioning and ovulation, corpus luteum functioning or 
pregnancy establishment. Thus, a better understanding of the physiology and 
endocrinology of the estrous cycle will improve reproductive management of dairy cows 
and facilitates the successful application of estrous synchronization and embryo transfer 
technologies.   
 
2.6.3 Endometrial molecular events during the estrous cycle  
 
The bovine uterus walls consist of the endometrium tunica muscularis or myometrium and 
the tunica serosa or perimetrium. The endometrium is the inner lining of the uterus 
consisting of the luminal epithelium, uterine glands and connective tissue. The 
endometrium is subdivided in caruncular and intercaruncular parts. The endometrium 
prevents the adhesions of the opposite walls of the myometrium by maintaining the 
patency of the uterine cavity. It is the main organ playing a crucial role in early embryo-
maternal communication and pregnancy establishment (Bauersachs et al. 2005).  
During the estrous cycle, the endometrium exhibits substantial gene expression changes 
that are associated with different functions. On this regard, the gene profile study indicated 
that at late estrus of the estrous cycle, the bovine endometrium is enriched with transcripts 
whose function is associated with cell-to-cell adhesion, cell motility and extracellular 
matrix. However, at day 12 of the estrous cycle (luteal phase), the endometrium is enriched 
with genes whose function is associated with transport proteins and ion (Bauersachs et al. 
2005). Similar study also indicated that genes which are highly expressed at estrus are 
related to extracellular matrix remodelling, transport and cell growth and morphogenesis, 
whereas immune response and metabolic pathways were overrepresented in genes 
increased at diestrus (Mitko et al. 2008). The study in human endometrium (Kao et al. 
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2002) also revealed that those genes whose expression were increased during the secratory 
phase were related to cholestrerol trafficking, signal transduction but genes which are 
down regulated in proliferative phase are related to transcription factor activity and 
immune modulating. Moreover, the endometrial gene expression between secratory and 
proliferative phase of Rhesus monkey also indicated that the expression level of certain 
genes including PLK, SAT2, SLPI and MT1G to be higher in proliferative phase, where as 
the mRNA level of TGFBI or BIGH3,  PENK, CSRP2, COL7A1, SFRP4, PGRMC1, 
CXCL12 and BGN to be higher in secratory phase (Ace and Okulicz 2004). These 
transcriptome abundance differences can be attributed to differences in the level of 
progesterone or estrogen hormones. Estrogen is known to affect the gene repression and 
gene stimulation by acting through its nuclear receptors. For instance estrogen  has been 
found to down regulate the expression of cyclin G2 (CCNG2) resulting in  the recruitment 
of the co-repressor N-CoR (NCOR1) and histone deacetylases leading to a hypo acetylated 
state of the chromatin (Stossi et al. 2006). Similarly, others (Hewitt et al. 2003, Hong et al. 
2004, Moggs et al. 2004, Watanabe et al. 2003), reported that cyclin-dependent kinase 
inhibitor 1B (CDKN1B) and growth arrest specific 1 (GAS1) were down regulated during 
the first 1–8 h after estrogen administration.  
Despite the accumulated evidences that many endometrial or ovarian gene expression 
changes during the estrous cycle are mainly regulated by progesterone and estrogen levels, 
the progesterone level can be in turn regulated by other genes. For instance, the Booroola 
(FecB) gene found to control the progesterone level during the estrous cycle and across 
pregnancy (Xia et al. 2003). The Booroola phenotype is associated with a point mutation 
in the kinase domain of the bone morphogenetic protein receptor 1 B (BMPR1B) and is 
known to involve in differentiation of ovarian follicles leading to the production of large 
numbers of ovulatory follicles that are smaller in diameter than wild-type follicles (Souza 
et al. 2003).  
 
2.7 Endometrial receptivity towards embryo implantation 
 
Uterine or endometrial receptivity refers the status of the uterus or endometrium ready to 
accept the blastocyst for implantation (Swierz and Giudence 1997). It comprises temporary 
and unique sequence of events that makes the embryo to adapt to the new environment 
(Bergh and Navot 1992).  
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Assessment of endometrial receptivity is required to identify endometrium that will be 
suitable for assisted reproduction technology. Therefore, identification of the receptive 
endometrium may help to correlate the changing endocrine, biochemical and 
morphological endometrial parameters with endometrial receptivity. Thus, understanding 
the significance of endometrial receptivity helps to achieve a better understanding of its 
relationship to fertility. Moreover, for optimal results in assisted reproductive technology, 
it is critical to recognize the time of embryo transfer that would best corresponds with the 
implantation time. However, the mechanism of uterine receptivity is a biological mystery 
that remains unsolved despite enormous advancements in understanding its physiology, 
structural, biochemical and molecular aspects associated with development and function 
(Makker and Singh 2006). 
In humans, in addition to Pinopodes, several non invasive assessment of endometrial 
receptivity including high resolution transvaginal ultrasonography (US), three-dimensional 
US, Doppler US, three-dimensional power Doppler US, magnetic resonance imaging and 
endometrial tissue blood flow has been used to determine the endometrial receptivity 
(Elnashar and Gamal 2004). Moreover, the dominant features of the receptive phase 
endometrium can be marked by its plasma membrane transformation of luminal 
epithelium, glandular secretion, stromal decidualization and changes of the immune cell 
populations.    
 
2.7.1 Signaling pathways and molecules triggering endometrial receptivity 
 
Understanding the molecular changes that occur during the period of endometrial 
receptivity may help to develop molecular markers associated with endometrial receptivity 
and pregnancy success. The qualitative and quantitative measurement of endometrial 
receptivity is lacking in cattle and other ruminants. However,  the information from mice 
with delayed implantation, (Reese et al. 2001), uterine gland knockout ewe (Gray et al. 
2002, Spencer et al. 1999) and several gene targeted studies have contributed substantial 
information to get  insight into potential markers of uterine receptivity and molecular 
mechanisms occurring during embryonic implantation into the maternal endometrium.  
The receptive state of the endometrium may be characterized by the expression of  genes 
that permits endometrium to respond to the embryo and allow the attachment (Sharkey and 
Smith 2003). The use of global gene expression approach such as microarrays and 
proteomic methods in the endometrium provided enormous information regard to the 
Literature review  
_________________________________________________________________________ 
 
22 
 
endometrial receptivity at the molecular level. Recently, several molecules have been 
reported whose function is essential for uterine receptivity in rodents and primates. 
Differential expression of genes by uterine epithelial and stromal cells in response to 
progesterone may influence uterine receptivity to implantation in mammals (Bazer et al. 
2009b). From this standpoint, several human endometrial gene expression profiles have 
performed to have a clue about the molecular mechanism endometrium during the 
secratory or luteal phase. Wang and Dey (2006) have summarized the gene profile from 
different experiment (table 2) and several commonly differentially expressed genes that 
believed to involve in human endometrial receptivity. However, the higher progesterone 
does not necessary indicate the endometrium is at receptive stage. 
 
Table 2: Differentially expressed genes between high and low progesterone peaks in human 
endometrium 
 
  Comparison of five independent studies 
Gene LH+(8–10) 
vs. LH-(4–6) 
LH+(7–9) vs. 
LH+(2–4) 
LH+7 vs. 
LH+26 
LH+(6–8) vs. 
LH-(3–5) 
LH+8 vs. 
LH+3 
ANXA4 +  +  + 
APOD + + + +  
C1R +   + + 
DAF +  + + + 
DF +  + +  
GBP3  + + +  
IL15 + + +  + 
MAP3K5  + + + + 
SERPING1   + + + 
SPP1 + + + + + 
TGFB + +  +  
CCNB + + +   
FRPHE + +  +  
GATA2 +   + + 
MSX1 +  +  + 
MSX2 + + +   
Upregulated genes during the time of high progesterone (Italics) and genes down regulated in low  
progesterone (Times New Roman) 
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Temporal and spatial expression of specific endometrial genes may contribute for the 
establishment uterine receptivity by making endometrium hospitable to the implanting 
blastocyst (Lessey 1998). Many factors involve in preparation of endometrium to accept 
the embryo. Among these, many genetic factors are likely to be involved in the success or 
failure of implantation. The study from mouse model indicated that the biochemical 
markers of endometrial receptivity may include endometrial adhesion molecules, 
endometrial anti-adhesion molecules, endometrial cytokines, endometrial growth factors, 
endometrial immune markers and others (Wang and Dey 2006). Therefore, the next 
section of this review focuses on various biochemical and molecular events that occur in 
the endometrium during its preparation for implantation. 
2.7.1.1 The role of endometrial adhesion molecules in endometrial receptivity 
 
Endometrial receptivity involves molecules that facilitate embryo adhesion to initiate the 
window of receptivity and anti-adhesion molecules that close the widow implantation 
(Tabibzadeh 1998). Several adhesion molecules  include  cadherins, selectins, members of 
the immunoglobulin super family and integrins have been reviewed (Lessey and Young 
1997). Among these, little is known about the role of cadherins or selectins in endometrial 
receptivity.  
The integrin family of cell adhesion molecules are a major class of receptors for the extra 
cellular matrix and participate in cell-cell and cell-substratum interaction (Albelda and 
Buck 1990) and they bind ligands found in the extracellular matrix (Lessey 1997). 
Integrins are a family of transmembrane glycoproteins, formed by the association of two 
different, non-covalently linked, α and ß subunits. Both α and β subunits contain two 
separate tails, both of which penetrate the plasma membrane and possess small 
cytoplasmic domains (Humphries 2000). The integrins including α1β1, α4β1and αvβ3 are 
expressed during the secratory phase of human endometrium. Integrins are believed to be 
involved in embryo-endometrial interaction at the time of implantation (Lessey 1998).  
The spatial and temporal distribution of integrins in bovine endometrium showed that, the 
luminal epithelium was found to express integrin subunits β1, α3, α6 and integrin αvβ3. Of 
these, α6 and αvβ3 exhibited estrous cycle-dependent and strongest expression in the 
luminal epithelium, basement membrane region and underlying sub epithelial stromal cells 
at proestrus, estrus and metestrus. However, α3
 
and
 
α4
 
exhibit estrous independent 
expression distribution (Kimmins and MacLaren 1999).  
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Integrins are largely accepted as markers of uterine receptivity in humans (Lessey 1998). 
For instance biopsies from women with unexplained infertility had reduced significantly 
beta 3 expression suggesting abnormal endometrial integrin expression can be associated 
with  unexplained infertility (Lessey et al. 1995 ). In the rabbit, the alpha (v) beta integrin 
is expressed in the embryo and trophoblast and it may be involved in early embryo-
maternal interaction (Illera et al. 2003). In addition, the αvβ3 integrin appears implicated in 
placental invasion into the maternal vasculature (Zhou et al. 1997). 
 
2.7.1.2 The role of cytokines in endometrial receptivity 
 
Early embryo signaling as the result of maternal hormonal or cytokine-mediated 
preparation may be the step forward to permit adequate proliferation of the stroma for 
successful implantation (Ledee et al. 2007). Cytokines comprise a group of proteins that 
separately or in concert modulate a variety of cellular functions, such as cellular 
proliferation and differentiation (Achache and Revel 2006). They are implicated in critical 
reproductive events such as ovulation and implantation. Since implantation failure is a 
major causes of pregnancy failure, a better understanding of the cytokine-receptor in 
relation to  pregnancy success may help to improve the diagnosis and treatment of 
infertility (Kauma 2000). Cytokines are small glycoprotein that involve in several 
activities including mediating communication between cells. Cytokines were discovered 
and investigated in the immune and hematopoietic systems and they are produced and act 
on in several cells of diverse lineages. Both pleiotropy and redundancy may exist within 
the cytokine families, but all cytokines act by binding to specific receptors belonging to a 
variety of classes that utilize different signal transduction pathways (Ledee et al. 2007, 
Salamonsen et al. 2000). 
The uterine glandular or luminal epithelium or in the decidualized stromal cells is believed 
to be an important site for cytokines and cytokine receptors (Salamonsen et al. 2000). 
Numerous cytokines and their receptors are implicated in mammalian implantation embryo 
implantation (Lim et al. 2002). Among these, leukaemia inhibitory factor (LIF), interleukin 
1 (IL1), interleukin-2 (IL2) interleukin 6 (IL6) interleukin 12 (IL12), interleukin 15 (IL15), 
interleukin18 (IL18) hepatocyte growth factor (HGF), stem cell factor (SCF), macrophage 
colony-stimulating factor (MCSF), colony stimulating factor 1 (CSF1), granulocyte-
macrophage colony-stimulating-factor (GMCSF) and insulin-like growth factors (IGF) 
play a major role during implantation (Kauma 2000). Cytokines such as CSF1, GMCSF, 
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IL1 and IL6 were found to be important for increasing the numbers of implantation sites or 
litter sizes (Salamonsen et al. 2000). On the other hand, the expression of some specific 
cytokines in the endometrium including IL12, IL15 and IL18 reported to be resulted in 
abnormal uterine receptivity (Ledee et al. 2007).  
Among the cytokine family, gene targeting, reciprocal embryo transfer and expression 
studies show the essential role of maternal LIF in uterine preparation and blastocyst 
attachment in mice (Lim et al. 2002, Stewart et al. 1992). (Stewart et al. 1992) using a 
mouse model indicated that mouse lacking functional LIF protein appeared to be fertile, 
but their blastocysts failed to implant (Lim et al. 2002). Inactivation of gp130, a signaling 
partner for the LIF receptor, also results in implantation failure (Salamonsen et al. 2000). 
Leukaemia inhibitory factor (LIF) is produced by the receptive phase endometrium (Chen 
et al. 1995) and its expression can be reduced by antiprogestin, mifepristone (Danielsson et 
al. 1997). The effect of LIF on rabbit endometrial receptivity and embryo implantation also 
indicated that transfer of embryos to LIF treated rabbit recipients significantly increased 
pregnancy rate compared to the control and significantly decreased when embryo transfer 
was done to LIF and mifepristone-treated recipients (Liu et al. 2001). The mechanism by 
which LIF participates in the endometrial receptivity and implantation events was 
addressed using LIF-deficient mice (Song et al. 2000). The authors reported that although 
the normal expression of genes related to uterine cell-specific proliferation, the epidermal 
growth factor (EGF) including amphiregulin (Ar), heparin-binding EGF-like growth factor 
(HBEGF) and epiregulin, were not expressed in LIF homozygous null uteri before and 
during the time of implantation. This may suggest that dysregulation of specific EGF-like 
growth factors in the uterus contributes to implantation failure in mice lacking LIF. 
 
2.7.1.3 The role of growth factors in endometrial receptivity 
 
The temporal and cell-specific manner expression of various growth factors and their 
receptors in the uterus are important for implantation (Carson et al. 2000, Cross et al. 1994, 
Lim et al. 2002, Norwitz et al. 2001, Paria et al. 2001a). The epidermal growth factor 
(EGF) family of growth factors comprises several proteins including transforming growth 
factor alpha (TGFα), heparin-binding EGF-like growth factor (HBEGF), amphiregulin, 
betacellulin, epiregulin and neuregulins (Das et al. 1997, Lim et al. 1998). Among these, 
HBEGF was found to be expressed in the uterus at the implantation sites in mice before 
the time of implantation (Das et al. 1994) and the expression of betacellulin, epiregulin, 
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neuregulin-1 and cyclooxygenase 2 (COX-2) were found to be detected around the time of 
the attachment reaction of the implantation process (Chakraborty et al. 1996, Das et al. 
1997, Lim et al. 1998). Furthermore, HBEGF influences blastocyst activities for 
implantation in paracrine and juxtacrine manners (Raab et al. 1996).  
 
2.7.2 The role of hormones in endometrial receptivity 
 
Several endometrial factors controlled by ovarian steroid hormones, estrogen and 
progesterone are known to regulate uterine receptivity resulting in successful implantation. 
In rodents and primates, the implantation window is established when estrogen affects the 
endometrium that has been under the influence of progesterone (Imakawa et al. 2004). 
However, the requirement of ovarian hormones for endometrial receptivity may be species 
dependant. For instance, estrogen is required for preparation of the progesterone-primed 
uterus for implantation in mice and rats, but in other species  estrogen alone does not lead 
to  the maturity of the endometrium(Yang et al. 2001). In addition, the study by (Levi et al. 
2001) indicated that  exposure of developing endometrium to higher level of estrogen may 
result in loss of on endometrial receptivity. Similarly, excessive administration of  estrogen 
post ovulation found to hinder  implantation (Morris and Van Wagenen 1973). Thus, the 
low endometrial receptivity and embryo implantation in part may be caused by elevated 
level of estrogen (altered estrogen to progesterone ratio) (Forman and Estilow 1988).  
Unlike to estrogen, progesterone is believed to initiate implantation in hamster, guinea pig, 
pig and rabbit (Paria et al. 2001a). Exogenous progesterone has been shown to exert utero-
relaxing effects and it has been hypothesized that progesterone supplementation before 
embryo transfer may improve receptivity in IVF (de Ziegler et al. 1998) and progesterone 
is one of the factor which influences the probability of success or failure. Lower 
concentrations of progesterone 6 days after mating was associated with failed pregnancy in 
cows (Henricks et al. 1971). The report of (Lamming and Darwash 1998) also 
demonstrated increased progesterone level in cows that get pregnant compared to those 
failed to be pregnant. 
Not only the concentration but also the time of progesterone peak affects the pregnancy 
success in cattle. Because delayed progesterone rise facilitates luteolysis at the normal time 
resulting in a reduced length of the period of progesterone secretion and lower conception 
rate in cattle. Lamming and Darwash (1995) reported that, after day 5 every one day delay 
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in the time of the progesterone rise there is a 0.7 day shortening of the subsequent luteal 
phase.  
Progesterone, acts on the uterus to stimulate blastocyst preimplantation growth and 
elongation and also regulates several genes (Mann and Lamming 2001). The study by 
(Forde et al. 2009) indicated that P4 supplementation found to be altered the expression of 
fatty acid binding protein (FABP), diacylglycerol O-acyltransferase 2 (DGAT2), myostatin 
(MSTN) and crystalline gamma S (CRYGS) that are associated with triglyceride synthesis, 
glucose transport that may contribute to the composition of histotroph. Moreover, other 
study has also revealed  that early P4 treatment increased blastocyst growth on days 9 and 
12 accompanied by changes in the expression of genes involved in endometrial WNT 
system (Satterfield et al. 2008). Although the  effect of progesterone on the endometrium 
is antagonistic to those of estrogen, both estrogen and progesterone are required to 
maintain acceptable level of estrogen to progesterone ratio for embryo implantation may 
required to  maintain the adaptation of embryo in the new environment as  deviations from 
ideal values of this ratio might affect the chances for successful embryo implantation. 
Therefore uterine differentiation to support embryo development and implantation is 
coordinated by progesterone and estrogen in a spatiotemporal manner (Huet-Hudson et al. 
1989).  
In addition to the ovarian hormones, the gonadotropin hormones do have substantial 
influence on endometrial or uterine preparation for receptivity. The increase in the uterine 
LH receptors and LH level in the perimplantation period has been explained (Bonnamy et 
al. 1993) suggesting the importance of LH in determining endometrial receptivity for 
implantation and subsequent decidualization.  
 
2.8 Embryo competency for implantation 
 
Following embryonic genome activation, the embryo grows faster to form a blastocyst. In 
bovine, blastocyst formation occurs seven days after fertilization (Guillomot 1995). By the 
time the embryo reaches to the blastocyst stage, it sheds its zona pellucidae to gain 
implantation competency. The differentiated and expanded blastocyst is composed the 
outer polarized epithelial trophectoderm, the primitive endoderm and the pluripotent inner 
cell mass which is the future cell lineages for the embryo proper (Dey et al. 2004). Within 
two weeks after fertilization, trophoblast elongates from 150 µm to 300 mm (Guillomot 
1995) and placentation is initiated with apposition to the uterus (Bertolini et al. 2002, 
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Viebahn 1999). The process of trophoblast expansion depends on cell multiplication, cell 
growth and cell shape remodeling and cellular differentiation (Wintenberger-Torres and 
Flechon 1974). The formation of the trophectoderm and its subsequent development into 
trophoblast tissue are crucial steps for the initiation of implantation and the establishment 
of pregnancy. Trophoblast cells produce a variety of growth factors, cytokines and 
hormones that influence the conceptus and maternal physiology in an autocrine, paracrine 
and/or juxtacrine manner (Petraglia et al. 1998, Roberts et al. 1999). The blastocyst 
intrinsic characteristics such as its genetic constitution, morphology and hatching ability 
are one of the major components successful implantation. Abnormal genetic constitutions 
or unsuccessful transitions from maternal to embryonic transcription could account for 
many failures of early embryonic growth and implantation. Thus, successful implantation 
to occur in the receptive endometrium, the blastocyst must attain implantation competency 
and/or the blastocysts must be activated. For this, the blastocyst need to be enriched with 
transcripts and molecular signaling required for controlling cell differentiation and 
maternal recognition of pregnancy (Spencer et al. 2008). To this end, a global gene 
expression study showed that implantation competent blastocysts could be molecularly 
distinguishable from those which can not be activated for implantation. For instance, 
increased expression  level of  Hgf1 (which encodes heparin-binding EGF-like growth 
factor (HBEGF), ErbB1 and ErbB4 were found to be enriched in activated blastocysts 
compared to the dormant mouse blastocysts (Wang and Dey 2006). In addition, the gene 
expression analysis on elongated bovine blastocyst at day 17 after fertilization also 
indicated that the expression level of OCT4, NANOG, IFN-τ, EOMES, FGF4, SOX2 and 
CDX2 were found to be expressed in IVP embryos. However, NANOG, EOMES and 
FGF4 were reduced and IFN-τ was found to be over expressed in cloned embryos 
(Rodriguez-Alvarez et al. 2010). Similarly, TXN2 deficient mice embryos exhibited 
markedly increased apoptosis and die during mid gestation around E10.5 (Yamamoto et al. 
2003). Further more homozygous mutants for thioredoxin die shortly after implantation 
and the conception were resorbed prior to gastrulation is associated with a dramatically 
reduced proliferation of inner mass cells (Matsui et al. 1996). This may suggest that 
cytosolic (TXN1) and mitochondrial (TXN2) thioredoxins are found to be essential during 
embryonic development. Apart from those, disruption of p97, proteins involved in vesicle 
and organelle biogenesis, cell-cycle regulators and transcription factors resulted in death 
embryo at peri-implantation stage (Muller et al. 2007). Moreover, the study on 
phospholipid hydroperoxide glutathione peroxidase (PHGPx), an intracellular antioxidant 
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enzyme that can directly reduce lipid hydroperoxide in membrane, indicated that mouse 
embryos homozygous for PHGPx-null die between 7.5 and 8.5 days post coitum 
suggesting the importance of  PHGPx in early gastrulation stage and for normal mouse 
development (Imai et al. 2003). Similarly, the coordinated expression of uterine 
polyamine-related genes may also be important for embryo implantation. The study by 
(Zhao et al. 2008) showed that embryo implantation was significantly inhibited by α-
difluoromethylornithine, an ODC inhibitor due to by the up-regulation of S-
adenosylmethionine decarboxylase gene expression. In addition, in an attempt to 
investigate the gene expression pattern of blastocyst that develop to terms, (El-Sayed et al. 
2006), identified some genes including COX2, CDX2, ALOX15, BMP15, PLAU and 
PLAC8 to be associated with embryos resulted in calf delivery. On the other hand, genes 
including KRT8, OCLN, PGK1 and AKR1B1 were enriched in embryos resulted in 
resorption and EEF1A1, MSX1, PTTG1, PGK1, AKR1B1 and CD9 were found to be 
enriched in embryos resulted in no pregnancy at all. 
In addition to several molecules, the role of endocannabinoids, a group of lipid mediators 
that are ligands for the cannabinoid receptors CB1 and CB2 and N-
arachidonoylethanolamine (anandamide) are also required during the mammalian embryo 
implantation process (Mechoulam et al. 1998). The reduced level of endometrial 
anandamide and embryo/blastocyst CB1 levels during the commencement of implantation 
may suggest its role in  regulating  implantation  process (Lim et al. 2002). Therefore, low 
levels of anandamide are stimulatory and high levels of anandamide inhibit blastocyst 
growth and induce spontaneous abortions (Lim et al. 2002, Paria et al. 2001b). The 
blastocyst competency for implantation can be facilitated by its own secretions. Those 
secretions are species dependant and they are required to establish maternal recognition of 
the presence of the embryo the secretion (Table 3).  
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Table 3: Pregnancy recognition factor in cattle and other species 
 
Species Pregnancy 
recognition factor 
Critical days after 
ovulation 
Time of attachment (days 
after ovulation) 
Cow bIFN-τ (bTP-1) 15-16 18-22 
Ewe oIFN-τ (oTP-1) 13-14 15-18 
Sow Estradiol (E2) 11-12 14-18 
Woman hCG 7-12 9-12 
Bitch None needed - - 
                   Adapted from Senger 2003 
 
IFN-τ promotes uterine implantation by increasing protein synthesis in glands (Imakawa et 
al. 1987, Spencer et al. 1996). For instance, the ovine blastocyst begins to secrete oFN-τ 
immediately after hatching, continues during the elongation phase and reaches peak when 
the conceptus attachment to the uterus is initiated on day 16 (Imakawa et al. 2004). These 
temporal and spatial expression patterns indicate the existence of an early, trophoblast 
specific, regulatory mechanism for IFN-τ gene expression. In cattle and other ruminants, 
interferon tau (IFN-τ), is the conceptus cytokine secreted by the trophoblast cells into the 
uterine lumen (Roberts 2007). It is maintains pregnancy and facilitates the process of 
maternal recognition of pregnancy by decreasing endometrial oxytocin receptors, 
ultimately reducing the stimulation of PGF2 alpha synthesis and to preventing luteolysis 
(Imakawa et al. 2004, Spencer et al. 1996). 
If the pregnancy signal [interferon tau (IFN tau)] or also called bovine trophoblastic 
protein 1 (bTP-1) is not received by the corpus luteum, then the prostaglandin that has 
been synthesized by the uterus is transferred to the ipsilateral corpus luteum by a local 
utero-ovarian countercurrent exchange mechanism. The prostaglandin then binds to the 
large luteal cells and causes luteal death via either direct action or a vascular constriction. 
The prostaglandin also causes release of oxytocin from the large luteal cells, which causes 
the uterus to release more prostaglandin (Figure 2). Estrogen from the dominant follicle is 
important in that it induces the uterine prostaglandin synthesis and the uterine oxytocin 
receptors. IFN-τ induces signal transduction through the JAK-STAT pathway (Darnell et 
al. 1994). Implantation involves a complex sequence of signalling events, consisting in the 
acquisition of adhesion ligands together with the loss of inhibitory components, which are 
crucial to the establishment of pregnancy.  
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Figure 2: Interferon tau production and maternal conceptus communication. IL3 and 
GMCSF exhibited increased expression by estrogen and progesterone, 
respectively. As the result, these cytokines increase the expression of interferon 
tau through their respective receptors by intra cellular signaling pathway 
through the protein kinase C system (PKC). Adapted from Imakawa et al. 
(2004) 
 
 
2.9 Process of embryo implantation 
 
The blastocyst stage embryo and uterine differentiation to the receptive phase  are  the 
major requirement for successful establishment of the embryo-uterine communication 
during embryo implantation processes (Paria et al. 2001a). The bidirectional interaction 
between embryo and endometrium is mediated by paracrine signals that pass from 
endometrial tissue to the embryo and vice versa. Therefore, successful implantation 
requires a receptive endometrium, implantation competent blastocyst and a synchronized 
dialogue between maternal and embryonic tissues (Aplin 2000). During this period, 
various cellular activities like elongation of embryonic tissues, cell-cell contact between 
the mother and the embryo and various molecular changes take place (Ushizawa et al. 
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2004). Implantation therefore, involves a series of steps leading to an effective reciprocal 
signaling between the blastocyst and the uterus. It requires  the trophoblast attachment via 
its apical plasma membrane to the apical plasma membrane of the uterine epithelium 
(Denker 1993). 
The implantation processes is variable depending on the species and this difference is one 
of the causes to formulate a unifying theme for the molecular basis of embryo 
implantation. The process and phases of embryo implantation in ruminants and other 
animal is described by several authors (Aplin 2000, Bazer et al. 2009a, Spencer et al. 1996, 
Spencer et al. 2007). According to these authors, the process of implantation has 5 phases. 
In phase 1, the blastocyst sheds its zona pellucida and the spherical blastocyst continues to 
expand. Afterwards, the elongated blastocyst migrates and changes its from a spherical to 
tubular and filamentous form (ruminants) or remain spherical prior to implantation. In 
phase 2, the blastocysts migrate and undergo orientation without apparent cellular contact 
between the trophectoderm and endometrial epithelia. Phase 3 is the apposition phase 
during which the conceptus trophectoderm associates closely with endometrial luminal 
epithelium for unstable adhesion. In ruminants, the conceptus develops papillae that extend 
into the superficial ducts of the uterine glands for adhesion and absorption of histotroph 
(Figure 3). Phase 4 is the adhesion phase characterized by the trophectoderm becoming 
firmly adhered to endometrial luminal epithelium. In ruminants, this is the period of inter 
digitation of trophectoderm and endometrial luminal epithelium. During this phase, several 
molecules secreted by the endometrial epithelia, including glycosylated cell adhesion 
molecule (GLYCAM1), galectin 15 (LGALS15) and secreted phosphoprotein 1 (SPP1 or 
osteopontin), interact with receptors (integrins and glycoconjugates) on the apical surface 
of trophectoderm and LE to facilitate adhesion. In cattle implantation is non-invasive and 
exhibits an extended preimplantation period and during this time the endometrium secretes 
histotroph (proteins, carbohydrates, sugars, lipids and ions (Burghardt et al. 2002). During 
phase 5, trophoblast giant binucleate cells are formed that begin to differentiate from 
mononuclear trophoblast cells and then migrate to and fuse with the luminal epithelium to 
form multinucleated syncytial plaques. 
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Figure 3: Phases of blastocyst implantation. Pre-attachment blastocysts undergo shedding 
of the zona pellucida (Phase 1) and precontact orientation (Phase 2). Phase 3 
includes apposition and transient attachment. Phase 4 is marked by adhesion of 
trophectoderm to endometrial LE. Phase 5 involves formation of trophoblast 
giant binucleate cells that begin to differentiate from mononuclear trophoblast 
cells and then migrate to and fuse with the LE to form multinucleated syncytial 
plaques. Adapted from Spencer et al. (2007). 
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3 Materials and methods 
 
3.1 Materials 
 
3.1.1 Animals 
 
During the experimental period, 54 Simmental cyclic heifers were used for endometrial 
sample collection and embryo transfer. Ten Simmental cows were used for superovulation 
and in vivo embryo production. Eighteen cyclic Simmental heifers were slaughtered at 
different days of the estrous cycle and three heifers were slaughtered at day 50 of gestation 
period. All animals were selected based on general clinical examination and normal 
ovarian cyclicity and housed in a free-stall barn with slotted floors and cubicles, lined with 
rubber mats and they were fed a total mixed ration. Animal handling and management was 
adhered to the rules and regulations of the German law of animal protection 
3.1.2 Embryos and endometrial biopsies   
 
Day 7 blastocysts produced by superovulation and the endometrial biopsies collected at 
day 7 and 14 of the estrous cycle were used for the study. 
 
3.1.3 Materials for laboratory analysis 
 
3.1.3.1 Chemicals, kits, biological and other materials  
 
During this experiment, the following chemicals and biological materials from various 
manufacturers were used. 
 
Chemicals or biological materials Manufacturer/Supplier 
4', 6'-diamidino-2-phenylindole hydrochloride 
(DAPI)  
Burlingame, CA, USA 
10x PCR buffer                                       Promega, WI, USA 
2x rapid ligation buffer Promega, WI, USA 
2-Mercaptoethanol Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
E. coli competent cells Stratagene, Amsterdam, The 
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Neatherlands 
5x First-Stand buffer Invitrogen Life Technologies, 
Karlsruhe 
Acetic acid Roth, Karlsruhe, Germany 
Agar-Agar Roth, Karlsruhe, Germany 
Agarose                                                         Sigma-Aldrich Chemie GmbH, 
Munich 
Ampicillin Roth , Karlsruhe 
BME (essential amino acids) Gibco BRL, life technologies, 
Karlsruhe 
Boric acid Roth , Karlsruhe, Germany 
Bovine serum ablbumin (BSA) Promega, Mannheim, Germany 
Calcium chloride 
Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
Cy3 conjugated Goat anti-mouse lgG + lgM (H+L) Jackson ImmunoResearch 
Laboratories, PA, USA 
Chloroform Roth , Karlsruhe, Germany 
Dimethyl sulfoxide (DMSO) Roth , Karlsruhe, Germany 
dNTPs Roth , Karlsruhe, Germany 
DTT 
Invitrogen Life Technologies, 
Karlsruhe, Germany 
Dye terminator cycle sequencing (DTCS) Beckman Coulter, Krefeld, 
Germany 
Ethanol Roth, Karlsruhe, Germany 
Ethidium bromide Roth, Karlsruhe, Germany 
ExoSAP-IT USB, Ohio, USA 
Ethylenediaminetetra acetic acid  Roth , Karlsruhe, Germany 
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Formaldehyde 
Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
Fluorescein isothiocyanate (FITC) Conjugated 
goat anti-rabbit secondary antibody 
Lifespan Biosciences, WA, USA 
Glycogen for sequencing Beckman Coulter, Krefeld, 
Germany 
Hemi-calcium lactate Promega, WI, USA 
Hydrochloric acid Roth, Karlsruhe 
Hepes Sigma-Aldrich Chemie GmbH, 
Munich 
Hydroxylamine Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
Hypotaurin Sigma-Aldrich Chemie GmbH, 
Taufkirchen, Germany 
Isopropyl -D-thiogalactoside (IPTG) Roth, Karlsruhe, Germany 
Igepal Roth, Karlsruhe, Germany 
Isopropyl β-D-thiogalactoside (IPTG) Roth, Karlsruhe, Germany 
L-Glutamine Sigma-Aldrich, Germany 
Magnesium chloride Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
MEM (non essential amino acids) Gico BRL, life technologies, 
Karlsruhe 
Mineral oil 
Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
Mous anti-human monoclonal antibody against 
TIMP3 
LifeSpan biosciences inc, WA, 
USA 
Oligonucleotide primers MWG Biotech, Eberberg, 
Germany 
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Pepton Roth , Karlsruhe, Germany 
Penicillin Sigma-Aldrich Chemie GmbH, 
Taufkirchen 
pGEM®-T vector Promega, WI, USA 
Phenol red solution (5% in D-PBS) Sigma-Aldrich Chemie GmbH , 
Munich 
Potassium chloride 
Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
Rabbit polyclonal primary antibody against IRF6, 
ITPR1, PTGS2 or MMP2 
Santa Cruz Biotechnologies Inc.,  
CA., USA 
Random primer Promega, WI, USA 
Ribo-nuclease inhibitor (RNasin) Promega, WI, USA 
RNA later Sigma-Aldrich, MI, USA 
RQ1 RNase-free DNase Promega, WI, USA 
RNasin Promega, WI, USA 
Sample loading solution (SLS) Beckman Coulter, Krefeld, 
Germany 
Sequagel XR Sequencing Gel Beckman Coulter, Krefeld, 
Germany 
Sodium acetate Roth , Karlsruhe, Germany 
Sodium chloride Roth , Karlsruhe, Germany 
Sodium dodecyl sulfate (SDS) Sigma-Aldrich Inc, MO, USA 
Sodium hydrogen sulphate Sigma-Aldrich Inc, MO, USA 
Sodium lactate solution (60%) Sigma-Aldrich Inc, MO, USA 
Sodium pyruvate Sigma-Aldrich Inc, MO, USA 
Streptomycin sulphate Sigma-Aldrich Inc, MO, USA 
Superscript II reverse transcriptase Invitrogen,  CA, USA 
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iTaq SYBR Green Supermix with ROX  Bio-Rad laboratories, Munich, 
Germany 
T4 DNA ligase Promega, WI, USA 
Taq DNA polymerase Sigma-Aldrich Inc, MO, USA 
Tris Roth ,Karlsruhe, Germany 
Triton X-100 Roche Diagnostics GmbH, 
Mannheim, Germany 
Yeast extract Roth, Karlsruhe, Germany 
yeast tRNA Sigma-Aldrich Chemie GmbH, 
Munich 
X-Gal (5-bromo-4-chloro-3-indolylbeta-D-
galactopyranoside) 
Roth, Karlsruhe,  Germany 
RNeasy mini kit Qiagen, Hiden, Germany 
RNA 6000 Nano LabChip® Kit 
Agilent Technologies Inc, CA, 
USA 
MEGAscript® T7 Kit  Applied Biosystems, CA, USA 
Eukaryotic poly-A RNA control kit Affymetrix, CA, USA 
AmpliScribe T7 transcription kit  Epicentre technologies, WI, USA 
CyScribeTM GFXTM Purification kit  
Amersham Biosciences, 
Freiburg, Germany 
Amersham post-labelling kit  
Amersham Bioscience, Freiburg, 
Germany 
CyScribeTM GFXTM Purification kit  
Amersham Biosciences, 
Freiburg, Germany 
(DOP)-PCR master kit  
Roche Diagnostics GmbH, 
Mannheim, Germany 
QIAquick PCR Purification Quigen, Hiden, Germany 
PicoPureTM RNA isolation kit  Arcturs, CA, USA. 
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3.1.3.2 Reagents and media  
 
During this experiment, the following reagents and media formulation were used. 
 
CR1-aa culture medium (50 ml) Hemi-calcium lactate 0.0273 g 
 Streptomycin sulphate 0.0039 g 
 Penicillin G 0.0019 g 
 Sodium chloride 0.3156 g 
 Potassium chloride 0.0112 g 
 Sodium hydrogen carbonate 0.1050 g 
 Sodium pyruvate 0.0022 g 
 L-Glutamine 0.0073 g 
 Phenol red solution (5% in D-
PBS) 
100 µl 
 Sodium hydrogen carbonate 0.080 g 
Modified parker medium HEPES 0.140 g 
 Sodium pyruvate 0.025 g 
 L-Glutamin 0.010 g 
 Gentamicin 500 µl 
 Medium 199 99 ml 
 Hemi calcium lactate 0.06 g 
 added to water 110 ml 
Prehybridization BSA 0.5 g 
 10 % SDS 0.5 ml 
 20 % SSC 7.5 ml 
 Add water till 50 ml 
Hybridization buffer Deionized formamide 20 m 
 50 X Denhardt’s solution 5 ml 
 20X  SSC 12.5 ml 
 Sodium pyruvate 22 mg 
 Tris-HCL (pH 7.5 2.5 ml 
 10% SDS 0.5 ml 
 Millipore water until 50 ml 
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LB-agar Sodium chloride 8.0 g 
 Peptone 8.0 g 
 Yeast extract 4.0 g 
 Agar-Agar 12.0 g 
 Sodium hydroxide (40 mg/ml) 480.0 µl 
 ddH2O added to 800.0 ml 
LB-broth Sodium chloride 8.0 g 
 Peptone 8.0 g 
 Yeast extract 4.0 g 
 Sodium hydroxide (40 mg/ml) 480.0 µl 
 ddH2O added to 800.0 ml 
BSA (3%) Bovine serum albumin 0.15 g 
 added to PBS+PVA 5 ml 
DEPC-treated water (1000 ml) DEPC 1 ml 
 added to water  1000 ml 
Lysis buffer (100 µl) Igepal (0.8%) 0.8 µl 
 RNasin 5 µl 
 DTT 5 µl 
 added to water 100 µl 
TAE (50x) buffer, pH 8.0 Tris  242.0 mg0  
 Acetic acid   57.1 ml  
 EDTA (0.5 M) 100.0 ml00 
 ddH2O added to 1000.0 ml 
TE (1x) buffer Tris (1 M) 10.0 ml 
 EDTA (0.5 M) 2.0 ml 
X-gal ddH2O added to 1000.0 ml 
 X-gal 50.0 mg 
(16%) Para formaldehyde (10 ml) N, N’-dimethylformamide 1.0 ml 
 Para formaldehyde  1.6 g 
 added to water  10 ml 
PBS + PVA (50 ml) Polyvinyl alcohol (PVA) 
PBS added to 
300 mg 
50 ml 
Permeabilizing solution (10 ml) Triton X-100 5 µl 
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 Glycine + PBS added  10 ml 
Physiological saline solution  Sodium chloride 9 g 
 added to water 1000 ml 
Agarose loading buffer Bromophenol blue 0.0625 g 
 Xylencyanol 0.0625 g 
 Glycerol 7.5 ml 
 ddH2O added to 25 ml 
dNTP solution dATP (100 mM) 10.0 µl 
 dCTP (100 mM) 10.0 µl 
 dGTP (100 mM) 10.0 µl 
 dTTP (100 mM) 10.0 µl 
 ddH2O added to 400.0 µl 
IPTG solution IPTG 1.2 g 
 ddH2O added to 10.0 µl 
3M Sodium Acetate, pH 5.2 Sodium Acetate  123.1 g 
 ddH2O added to 500 ml 
1M EDTA, pH 8.0 EDTA 37.3 g 
 ddH2O added to 1000 ml 
Phenol Chloroform  Phenol : Chloroform 1 : 1 (v/v) 
0.2% Triton-X100: Triton 2 ml 
 10x PBS : added to 1,000.0ml 
0.3% BSA in PBS BSA 3 g 
 10x PBS : added to 1,000.0 ml 
3% BSA in PBS BSA 30g 
 10x PBS : added to 1,000.0 ml 
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3.1.4 Equipements  
 
During this experiment, the following reagents and media formulation were used. 
 
Equipment Manufacturer 
Ultrasonography (Pie Medical, 5 MHz) Pie Medical 
Bovine preimplantation embryo specific 
 cDNA array 
Laval University 
ApoTome microscope  Carl Zeiss MicroImaging, Germany 
Cytobrush Gynobrush, Hamburg, Germany 
CH15 embryo flushing Cather Immuno Systems 
Inverted fluorescence microscope DM IRB Leica, Germany 
Stereomicroscope SMZ 645 Nikon, Japan 
Centrifuge Hermel, Wehing 
Electrophoresis BoRad, Munich 
My Cycler Thermal cycler  Bio-RadLaboratories, CA, USA 
SHKE6000-8CE refrigerated Stackable Shaker Thermoscinentific, IWA, USA 
CEQTM 8000 Genetic Analysis BeckmanCoulter,Krefeld, Germany 
ABI PRISM® 7000 SDS  Applied Bio systems 
Affymetrix®GeneChip™3000 scanner Affymetrix, CA, USA 
Affymetrix®GeneChip Fluidics Station 450 Affymetrix, CA, USA 
Affymetrix®GeneChip Hybridization oven 
640 
Affymetrix, CA, USA 
Agilent 2100 bioanalyzer Agilent Technologies , CA, USA 
GAPSII Corning (Amsterdam) 
Nanodrop 8000 Spectrophotometer  Thermo Fisher Scientific, DE, USA 
Axon GenePix 4000B scanner Axon Instruments, Foster City, CA 
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Four well dishes 
Thermo Fisher Scientific, Nunc, 
Roskilde, Denmark 
Rigid thin wall 96 X 0.2 ml skirted  
microplates for   real-time PCR 
STARLAB GmbH (Ahrensburg) 
GeneChip® Bovine Genome Array  Affymetrix, CA, USA 
 
3.1.5 Programs (soft wares) and statistical packages used  
 
Programs (soft wares) 
 and statistical packages 
Source of the programs (soft wares) 
 and statistical packages 
GeneChip® Operating System  Affymetrix, CA, USA 
R statistical computing and 
graphics software 
http://www.r-project.org/ 
Bioconductor packages 
Library (affy), Library (marray) 
Library (GCRMA), Library 
(LIMMA)  
Library (sma), Library (anotate)  
Library (gostats), Library (Go) 
Library(qualityMetrix) 
 Library(gplots) 
http://www.bioconductor.org/ 
GNU Image Manipulation 
Program (GIMP) 
Spencer Kimball, Peter Mattis und das GIMP-
Entwicklerteam 
SAS (version 9.2) SAS Institute Inc., NC, USA 
GenePix Pro (ver. 4.0) Axon Instruments, Foster City, CA 
KEGG  pathway http://www.genome.jp/kegg/pathway.html 
Ingenuity's pathway analysis Ingenuity® Systems, www.ingenuity.com 
Entrez Gene http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene 
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AxioVision Carl Zeiss International 
EndNote X1 Thomoson 
Primer Express ® software Applied Biosystems, Foster city, CA, USA 
Primer 3 (version 4) http://frodo.wi.mit.edu/primer3/ 
BLAST program http://blast.ncbi.nlm.nih.gov/Blast.cgi 
Prism for windows (ver.5.0) GraphPad software, Inc. 
 
 
3.2 Methods 
 
 
3.2.1 Pre-transfer endometrial gene expression in relation to pregnancy outcome  
 
3.2.1.1 Endometrial biopsy collection 
 
The design and experimental setup of the present study is indicated in Figure 4. Prior to 
endometrial biopsy collection, experimental heifers were estrous synchronized by intra 
muscular administration of 500 mg of the prostaglandin F2α (PGF2α) analogue 
cloprostenol (Estrumate, Munich, Germany) twice within 11 days. Two days after each of 
the PGF2α treatments, animals received 0.02 mg GnRH-analogue buserelin (Receptal) 
(Intervet, Boxmeer, the Netherlands). Two PGF2α treatments were performed on day 14 
and 17 followed by administration of 0.02 mg GnRH at day 18 to induce ovulation. 
Common signs of estrus were monitored by visual observation three times per day 
followed by careful palpation of ovaries to check the presence of corpus luteum. Following 
this, endometrial biopsies were collected from experimental animals using a cytobrush 
technique. Cytobrush technique is a consistent and reliable method for obtaining 
endometrial samples for cystologic examination and gene expression analysis from dairy 
cows (Gabler et al. 2009, Kasimanickam et al. 2005, Kaufmann et al. 2009). For collecting 
the endometrial samples, 20 mm in length and 6 mm in diameter brush (Gynobrush, Heinz 
Herenz, Hamburg, Germany) protected by a one-way catheter was inserted via the cervix 
into the uterine body. Inside the uterus, the brush was pushed gently out of the catheter and 
rolled along the uterine wall. Thereafter, the brush was retracted into the catheter to protect 
it from contamination during the passage through the genital tract. For each animal, 
endometrial samples were collected at days 7 and 14 of the estrous cycle during the pre-
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transfer cycle (one cycle prior to embryo transfer). The endometrial samples were stored in 
RNA later (Sigma-Aldrich, Mi, USA) until further use. Day 7 and 14 of the estrous cycle 
were chosen for two main reasons. Firstly, most often embryo transfer in cattle is 
performed using blastocyst stage embryo at day 7 of the estrous cycle (Bauersachs et al. 
2009, Hill et al. 2000, Mansouri-Attia et al. 2009, Rodriguez-Alvarez et al., Rodriguez-
Alvarez et al. 2010) or in case of artificial insemination, most of the embryos reach to the 
uterus and develop to the blastocyst stage at day 7 of the estrous cycle. Moreover, day 7 of 
the estrous cycle is marked by formation of corpus luteum. Secondly, in the absence of 
embryo in the uterus, the uterine prostaglandin F2α (PGF2α) increases at day 14 of the 
estrous cycle leading to corpus luteum regression (Shemesh and Hansel 1975).  
 
3.2.1.2 Superovulation and artificial insemination 
 
Pre-synchronization was performed by i.m. administration of 500 mg of the prostaglandin 
F2α (PGF2α) analogue cloprostenol (Estrumate; Munich, Germany) twice within 11 days. 
Two days after each of the PGF2α treatments, animals received 0.02 mg of GnRH-analogue 
buserelin (Receptal) (Intervet, Boxmeer, The Netherlands). Twelve days after the last 
GnRH injection, cows received the first of eight consecutive FSH-injections over 4 days in 
decreasing dose. Two PGF2α treatments were performed 60 and 72 h after the initial FSH 
administration. Finally, 48 h after the first PGF2α application, ovulation was induced by 
administration of 0.02 mg of buserelin and  three artificial inseminations were performed 
within 12 h interval. The time of the second insemination (60 h after the first PGF2α 
application) was defined as Day 0.  
 
3.2.1.3 Blastocyst recovery and embryo transfer 
 
Blastocysts embryos were flushed 7 days after insemination by draining each uterine horn 
with 500 ml phosphate buffer saline solution (PBS) using CH15 embryo-flushing catheter 
(Wörrlein, Ansbach, Germany) connected to an embryo filter (Immuno Systems Inc., WI, 
USA). Good quality blastocysts were subjected to biopsying using a beaver micro blade 
(Minitüb, Tiefenbach, Germany) fixed to a micromanipulator under inverse microscope 
(Leica Camera Inc., Solms, Germany). Following biopsying, 60-70% portion of the 
blastocyst containing both inner cell mass (ICM) and trophectoderm cells (TE) was 
cultured in vitro in CR1 medium supplemented with amino acid for 2 h and transferred to 
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54 synchronized Simmental heifers as indicated above. The remaining 30-40% of the 
embryo biopsy containing both ICM and TE was washed twice in PBS and snap frozen in 
cryo-tubes, containing minimal amounts of lysis buffer [0.8% Igepal (Sigma-Aldrich, MO, 
USA), 40 U ml-1 RNasin (Promega, WI, USA), 5 mM dithiothreitol (DTT) (Promega, WI, 
USA)]. All frozen embryos were stored at -80 oC until RNA isolation. 
 
 
Figure 4: The overall experimental design applied in the study. Endometrial biopsies were 
taken during the pre transfer period. In the next cycle, blastocyst stage embryos 
were transferred to the recipients after part of the embryo as a biopsy. Following 
pregnancy diagnosis, the endometrial and embryo biopsies were classified 
according to the pregnancy outcome. Global transcription analysis was 
performed from embryo and endometrial biopsies. Numbers 1 and 2 represent 
the transcriptome analysis between receptive and non-receptive endometrium at 
day 7 and 14 of the estrous cycle whereas 3 and 4 represent the transcriptome 
dynamic analysis of receptive and non-receptive endometrium. 
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3.2.1.4 Pregnancy diagnosis and categorization of endometrial and embryo biopsies 
 
Pregnancy diagnosis was performed at days 28 and 42 using ultrasonography (Pie Medical, 
5 MHz) and at day 56 by rectal palpation. Those heifers returning to heat at day 21 were 
categorized as non pregnant or considered as non-receptive endometrium. Those heifers 
resulted in calf delivery were categorized as the calf delivery group or considered as 
receptive endometrium. At the end of gestation, the endometrial and embryo biopsies 
collected during the pre-transfer period were classified according to the pregnancy 
outcome information (Figure 4). Those endometrial biopsies collected at days 7 and 14 of 
the estrous cycle from calf delivery groups (receptive endometrium) were designated as 
CDd7 and CDd14, respectively. Endometrial biopsies taken at days 7 and 14 of the estrous 
cycle from those subsequently resulted in no pregnancy (non-receptive endometrium) were 
designated as NPd7 and NPd14, respectively. Similarly, the embryo biopsies were 
classified according to the pregnancy outcome information. Each embryo biopsied from 
blastocysts transferred to the recipients was snap frozen and stored separately. Following 
pregnancy diagnosis, the embryo biopsies were classified as those embryo biopsies 
resulted in calf delivery or resulted in no pregnancy group (Figure 4). During RNA 
isolation those embryo biopsies resulted in calf delivery were pooled in three replicates 
and those embryo biopsies resulted in no pregnancy were pooled in three other replicates. 
 
3.2.1.5 Total RNA isolation from endometrial biopsies  
 
Total RNA was extracted from three pools of endometrial sample from each category 
using RNeasy mini kit (Qiagen, Hilden, Germany) with slight modification. Briefly, three 
pools of endometrial cytobrush samples from each group, namely: CDd7, CDd14, NPd7 or 
NPd14 were transferred in 2 ml Eppendorf tube filled with 500 µl of RLT buffer 
containing 10% 14.3 M βeta mercaptoethanol (β-ME) (Thermo Fisher Scientific Inc., IL, 
USA). The samples were then vortexed for 10 minutes. Complete retrieval of the 
cytobrush contents were performed by three consecutive washings in 500 µl of RLT- β-
ME buffer. The samples were then centrifuged at 12575 rpm. The clear lysate was then 
retrieved to which 1 volume of 70% ethanol was added.  After mixing, 700 µl of the 
sample was then transferred to RNeasy spin column and centrifuged in refrigerated 
universal centrifuge Z233MK (Hermle Labortechnik, Wehingen, Germany) for 15 s at 
12575 rpm. The supernatant was discarded. Since the sample volume was exceeding 700 
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µl, successive aliquots were centrifuged in the same spin column. Following this, 700 µl 
RW1 buffer was added to the samples in the spin column and centrifuged for 15 s at 12575 
rpm. After removing the supernatant, 500 µl RPE buffer was added to the spin column 
followed by 15 s centrifugation 12575 rpm. This step was repeated for the second time and 
centrifuged at the same speed for 2 min. The spin column  was then transferred to a new  2 
ml collection tube and centrifuged at full speed for 1 min to eliminate any possible 
carryover of RPE buffer and residual flow-through remained on the  spin column. 
Following this, the RNeasy spin column was transferred to a new 1.5 ml collection tube 
and 40 µl RNase-free water was added directly to the spin column membrane. The spin 
column membrane was then centrifuged for 1 min at 12575 rpm to elute the RNA. One 
micro litter of the RNA was used to measure the concentration and quality using Nanodrop 
8000 Spectrophotometer (Thermo Fisher Scientific Inc, DE, USA). 
 
3.2.1.6 DNase treatment of total RNA samples 
 
Prior to subsequent application, the RNA samples were freed from any DNA 
contamination using RNA-qualified (RQ1) RNase-free DNase I (Promega, WI, USA). One 
unit of RQ1 RNase-free DNase and 1µl RQ1 RNase-free DNase 10x reaction buffers were 
used per 1 µg of total RNA. To this, RNase-free water was added to reach the required 
volume and incubated at 37 oC for 1 h. At the end of the incubation time, the reaction was 
purified using RNeasy mini kit (Qiagen, Hilden, Germany) following the manufacture’s 
recommendation. Briefly, the samples were first adjusted to 100 µl with RNase-free water 
and to this, 350 µl RLT buffer and 250 µl 100% ethanol were added. The samples were 
then transferred to RNeasy mini spin column placed in a 2 ml and centrifuged at 12575 
rpm for 15 s. After decanting the flow-through, 500 µl RPE buffer was added to the 
samples and centrifuged at 12575 rpm for 15 s. After the final wash with 500 µl RPE for 2 
min at 12575 rpm, any possible carryover of RPE buffer and residual flow-through 
remained on the RNeasy spin column was eliminated by centrifugation the spin column for 
2 min at full speed. Afterwards, 30 µl RNase-free water was directly added to the spin 
column membrane fixed in a new RNase free 2 ml collection tube and centrifuged at 
12575 rpm for 1 min. The RNA concentration and quality was analyzed using Nanodrop 
8000 Spectrophotometer (Thermo Fisher Scientific Inc, DE, USA). RNA integrity was 
evaluated using Agilent 2100 bioanalyzer with RNA 6000 Nano LabChip® Kit (Agilent 
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Technologies Inc, CA, USA). The ribosomal RNA ratio (28S to 18S) of the RNA samples 
was between 1.9 and 2.1 and the RNA integrity number (RIN) was between 7.5 and 8.4. 
 
3.2.1.7 RNA amplification from endometrial biopsies 
 
3.2.1.7.1 First cycle first and second strand cDNA synthesis 
 
Two cycles eukaryotic target labeling assay was performed following the recommendation 
of the GeneChip® expression analysis technical manual (P/N 702232). For this, 100 ng of 
total RNA isolated from endometrial biopsies resulted in calf delivery or no pregnancy was 
used as a starting material. The eukaryotic poly-A RNA control kit was used as a SPIKE-
IN control to monitor the entire target labeling process, The controls were then amplified 
and labelled together with the samples as each eukaryotic GeneChip® probe array contains 
probesets for several B. subtilis genes (lys, phe, thr and dap) that are absent in eukaryotic 
samples.  Prior to first strand cDNA synthesis, 2 µl of 50 µM T7-Oligo (dT) primer and 2 
µl diluted eukaryotic poly–A RNA controls were mixed and 16 µl of RNase free water was 
added to this mix to final volume 20 µl. From this, 2 µl was taken and added to the 100 ng 
total RNA and RNase free water was added to final 5 µl volumes. This mix was incubated 
for 6 min at 70 oC. After the end of the incubation period, 5 µl mix ( containing  2 µl 5x 1st 
strand reaction mix, 1 µl 0.1M DTT, 0.5 µl RNase inhibitor, 0.5µl 10 mM dNTP, 1 µl 
superscript II) was added to the reaction and incubated for 1 h at 42 oC. Afterwards, the 
enzyme was deactivated by heating the reaction at 70 oC for 10 min followed by cooling at 
4 oC for 2 min. Following the first cycle first strand cDNA synthesis, second strand cDNA 
was synthesized from first strand cDNA. For this, a 10 µl first cycle second strand master 
mix (4.8 µl RNase free water, 4 µl 17.5mM diluted MgCl2, 0.4 µl 10mM dNTP, 0.6 µl 
E.coliDNA polymerase and 0.2 µl RNase H) was added to this 10 µl first stranded cDNA. 
The reaction was incubated for 120 min at 16 oC and for 10 min at 75 oC. 
 
3.2.1.7.2 First cycle, IVT amplification of cRNA 
 
In vitro transcription (IVT) and RNA amplification was performed using MEGAscript® 
T7 Kit (Applied Biosystems, CA, USA) using dsCDNA as a template. For this a 30 µ IVT 
mix (5 µl each 10X reaction buffer, ATP solution, CTP solution, UTP solution GTP 
solution and enzyme) was added to the double stranded cDNA. The reaction was incubated 
at 37 oC for 16 h. At the end of the incubation period, the complementary RNA (cRNA) 
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was purified using GeneChip® IVT cRNA cleanup kit (Affymetrix, CA, USA). At this 
step, the concentration and quality of cRNA was determined using Nanodrop 8000 
Spectrophotometer (Thermo Fisher Scientific Inc, DE, USA). 
 
3.2.1.7.3 Second-cycle, first strand and double cDNA synthesis  
 
Second –cycle, first strand cDNA synthesis was performed using 600 ng cRNA resulted in 
first cycle of IVT amplification. For this, first 2 µl random primers (final concentration 0.2 
µg/µl) was added to the cRNA and RNase free water was added to final volume of 11 µl. 
This reaction was incubated for 10 min at 70 OC. Afterwards, 9 µl second–cycle, first-
strand master mix (containing 4 µl 5x 1st strand  reaction buffer, 2 µl 0.1M DTT, 1 µl 
RNase inhibitor, µl 10mM dNTP, µl superscript 11) was added to each sample and 
incubated for 1 h at 42 OC. After cooling at 4 OC for 2 min, 1 µl of RNase H enzyme was 
added to each sample. The reaction was incubated for 20 min at 37 OC followed by heating 
at 95 OC for 5 min. Subsequently, the T7-Oligo (dT) promoter primer was used in the 
second-strand cDNA synthesis to generate double-stranded cDNA template containing T7 
promoter sequences. For this T7-oligo (dT) primer (5 µM of final concentration) was 
added to the reaction and incubated for 6 min at 70 OC. After cooling at 4 OC for 2 min, 
125 µl second cycle second strand master mix (containing 30 µl 5x 2nd strand reaction mix, 
3 µl of 10 mM dNTP, 4 µl E.coli/DNA polymerase I) was added and incubated for 2 h at 
16 OC. The reaction was terminated after incubating the sample with 2 µl T4 DNA 
polymerase at the same temperature for 10 min. The samples were then purified using the 
sample clean up module and the double-stranded cDNA was eluted in 12 µl RNase free 
water. 
 
3.2.1.7.4 Biotin labeling and fragmentation of cRNA 
 
The resulting double-stranded cDNA was then in vitro transcribed and labeled using a 40 
µl biotinylated nucleotide analog/ribonucleotide mix (4 µl 10X IVT labeling buffer, 12 µl 
IVT labeling NTP mix, 4 µl IVT labeling enzyme mix, 8 µl RNase free water) in the 
second IVT reaction using GeneChip IVT labeling kit (Affymetrix, CA, USA). The 
reaction was incubated at 37 OC for 16 h. After the end of incubation period, the biotin 
labeled cRNA was purified and eluted with 11 µl RNAse free water. The concentration 
and quality of biotin labeled cRNA was determined using Nanodrop 8000 
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Spectrophotometer (Thermo Fisher Scientific Inc, DE, USA). Fifteen microgram biotin 
labeled cRNA was then fragmented at 94 OC for 35 min using 5x fragmentation buffer. 
The size distribution of fragmented biotin labeled cRNA samples were  analyzed using 
Agilent 2100 bioanalyzer with RNA 6000 Nano LabChip® Kit (Agilent Technologies Inc, 
CA, USA). 
 
3.2.1.8 Target hybridization  
 
The GeneChip® Bovine Genome Array (Affymetrix, CA, USA) was used for 
hybridization. For this, a hybridization cocktail consisting of 10 µg fragmented and labeled 
cRNA, control oligonucleotide B2 (3 nM), 20x eukaryotic hybridization controls (bioB, 
bioC, bioD, cre) (Affymetrix, CA, USA), 2X hybridization mix, DMSO and RNAse free 
water were mixed to a final volume of 200 µl. The mix was then heated at 99°C for 5 min 
followed by 5 min incubation at 45°C. Meanwhile, the probe arrays were wetted with 1x 
hybridization buffer and incubated at 45 °C for 10 min in hybridization oven with 60 rpm 
rotation. After removing the hybridization buffer from each of the probe arrays, 130 µl 
hybridization cocktail was filled to each probe array and placed in the hybridization oven 
at 45 oC with 60 rpm rotation. Hybridization was performed for 16 h. Three biotin labeled 
cRNA hybridizations were performed for endometrial samples of each category (CDd7, 
CDd14, NPd7 and NPd14).  
  
3.2.1.9 Washing and staining probe arrays 
 
The probe arrays were washed and stained using the Fluidics Station 450/250 integrated 
with GeneChip® Operating System as recommended in GeneChip® expression wash, 
stain and scan user manual (P/N 702731 (Affymetrix) as recommended in GeneChip® 
expression wash, stain and scan user manual (P/N 702731). Briefly, after 16 h of 
hybridization, the hybridization cocktail was removed and the probe array cartridge was 
filled with 160 µl wash buffer A. The probe arrays were then inserted in designated 
module of the fluidic station. Meanwhile, each of the vials containing 600 µl stain cocktail 
1 and 600 µl stain cocktail 2 were was placed in sample holder 1 and 2 of the Fluidics 
Station 450/250, respectively. Similarly, a vial containing 800 µl array holding buffer was 
placed in sample holder 3 in the fluidic station. Afterwards, the needle lever was pressed 
down and the needles were snapped into position to start washing. 
Materials and methods  
_________________________________________________________________________ 
 
52 
 
3.2.1.10 Scanning the probe arrays 
 
After washing, the probe arrays were scanned using affymetrix®GeneChip™3000 
confocal slide scanner (Affymetrix, CA, USA) integrated with GeneChip® Operating 
System as recommended in GeneChip® expression wash, stain and scan user manual (P/N 
702731).  
 
3.2.1.11 Affymetrix array data analysis  
 
The microarray data normalization and background correction was performed using 
guanine cytosine robust multi-array analysis (GCRMA) (Wu and Irizarry 2004). For this, 
we used R software, (www.r-project.org) and bioconductor packages 
(www.bioconductor.org). During normalization, the CEL files were first converted into 
expression set using the guanine cytosine robust multi-array average (GCRMA) 
considering probe sequence and the GC-content background correction. Starting with the 
probe-level data from a set of GeneChips, the perfect-match values were background-
corrected, normalized and finally summarized resulting in a set of expression measures. 
The raw and normalized data are available at Gene Expression Omnibus (GEO), 
http://www.ncbi.nlm.nih.gov/geo/ with accession number GSE21049 or GSE20974. The 
intensity distribution and uniformities between the arrays were evaluated by assessing 
Pearson correlation and heatmap, MA plots and density plots (Appendix 1). Differentially 
expressed (DE) genes were obtained using linear models for microarray data (LIMMA) 
which quires two matrices namely the design matrix which provides a representation of the 
different RNA targets which have been hybridized to the arrays and the contrast matrix 
which allows the coefficients defined by the design matrix to be combined into contrasts of 
interest (Smyth 2005). Genes were considered differentially expressed (DE) when the p < 
0.05 and fold change ≥ 2, FDR ≤ 0.27.  p-values were adjusted using the Benjamini–
Hochberg procedure that controls the false discovery rate (Benjamini and Hochberg 1995). 
Differentially expressed genes were further classified according to their gene ontology 
(GO) of molecular functions and biological processes using GO statistical analyses 
(GOstats) (Falcon and Gentleman 2007). Moreover, molecular pathways participated by 
DE genes were identified from the Kyoto Encyclopedia of Genes and Genomes (KEGG) 
database (http://www.genome.jp/kegg/). The molecular networks involved by the 
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differentially expresses genes was analyzed through the use of Ingenuity Pathways 
Analysis (Ingenuity® Systems, www.ingenuity.com).  
 
3.2.2 Expression profile of candidate genes during the estrous cycle and early pregnancy 
 
Following identification of differentially expressed genes between the receptive and non-
receptive endometrium, the expression pattern of selected candidate genes were examined 
at different phases of the estrous cycle and early gestation period. Candidate genes were 
randomly selected among those whose expression was increased in receptive endometrium 
[interferon regulatory factor 6 (IRF6), prostaglandin E receptor 4 (PTGER4), Inositol 
1,4,5-trisphosphate receptor type 1 (ITPR1), adenosine A2B receptor (ADORA2B), 
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase 
(PTGS2/ COX-2), tissue inhibitor of metalloproteinase 3 (TIMP3), cell division cycle 20 
homolog (CDC20), wingless-type MMTV integration site family, member 11 (WNT11 ] 
and 3 other genes whose expression was increased in non-receptive endometrium [signal 
transducer and activator of transcription 5A (STAT5A), matrix metalloproteinase 2 
(MMP2) and angiotensin II receptor, type 1 (AGTR1)]. This was aimed at evaluating the 
pattern of those differentially expressed genes at different stage of the estrous cycle and to 
assess whether the genes increased or reduced in receptive endometrium during the estrous 
cycle will continue or decay during early gestation period. For this, endometrial samples 
was collected from 18 normal cyclic heifers slaughtered at days 0, 3, 7, 14 and 19 of the 
estrous cycle following standard synchronization protocol and 3 animals were slaughtered 
at day 50 of the gestation period. Endometrial samples were collected from seven different 
positions of the uterus by scraping, namely ipsilateral cranial, ipsilateral middle, ipsilateral 
caudal, contralateral cranial, contralateral middle, contralateral caudal and corpus 
(Bauersachs et al. 2005). Blood samples were collected from each animal before 
slaughtering by jugular venipuncture. The blood samples were refrigerated at 4°C for 12-
24 hrs before being centrifuged at 1500 g at 4°C for 20 min. Serum was separated and 
stored at -20°C until assayed to determine progesterone concentration by time-resolved 
fluoroimmunoassay using an AutoDELFIA™ Progesterone kit (Perkin Elmer, Wallac Oy, 
Turku, Finland).  
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3.2.3 Immunohistochemical localization of candidate genes  
 
The protein expressions of IRF6, ITPR1, PTGS2, MMP2 and TIMP3 were localized in the 
ipsilateral middle part of the uterine tissue section at different days of the estrous cycle and 
at day 50 of the gestation period.  For this, the sections were washed in PBS and fixed in 
4% (w/v) para formaldehyde overnight at 4°C. The fixed specimens were permeabilized in 
0.5% (v/v) Triton-X100 (Sigma) in phosphate buffer saline solution (PBS) and blocked in 
3% (w/v) bovine serum albumin (BSA) (Roche Diagnostics, Basel, Switzerland) in PBS. 
The samples were incubated overnight using rabbit polyclonal primary antibody specific 
IRF6, ITPR1, PTGS2 or MMP2 and mouse anti-human monoclonal antibody specific to 
TIMP3. Rabbit polyclonal primary antibody (Santa Cruz Biotechnologies Inc., CA., USA) 
against IRF6 and PTGS2 was diluted at 1:100 and rabbit polyclonal primary antibody 
(Lifespan Biosciences, USA) against ITPR1 and MMP2 was diluted at 1:50 in blocking 
solution. Mouse anti-human monoclonal antibody (LifeSpan biosciences, Inc, WA, USA) 
against TIMP3 was diluted 1:100 in blocking solution. Fluorescein isothiocyanate (FITC) 
conjugated goat anti-rabbit secondary antibody (Lifespan Biosciences, WA, USA) diluted 
at 1:100 was used in all cases except TIMP3. Cy3 conjugated Goat anti-mouse secondary 
antibody (Jackson ImmunoResearch Laboratories, Inc. PA, USA), diluted at 1:100 used for 
TIMP3. Counterstaining was performed using 4', 6'-diamidino-2-phenylindole 
hydrochloride (DAPI) (Burlingame, CA, USA). After the final wash in PBS, the sections 
were mounted on glass slides and visualized on an ApoTome microscope (Carl Zeiss 
MicroImaging Inc., Germany). 
 
3.2.4 Pre-transfer embryonic gene expression in relation to pregnancy outcome  
 
3.2.4.1 RNA isolation from embryo biopsies 
 
Total RNA was extracted from 15 embryos that resulted in calf delivery or no pregnancy 
in three pools each consisting of five embryos using PicoPureTM RNA isolation kit 
(Arcturs, CA, USA). For this, 20 µl extraction buffer was added to each embryo biopsy 
followed by incubation at 42° for 30 min. At the end of the incubation time, embryos from 
the same treatment group were pooled together and 1 volume 70% ethanol was added to 
the pooled samples. The samples were transferred to the pre conditioned purification 
column. The RNA was then bind to the column by centrifugation for 2 min at 1057 rpm, 
immediately followed by a centrifugation at 13500 rpm for 30 s. After washing with 100 
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µl wash buffer 1 at 9475 for 1 min, on column DNase treatment was performed for 15 min 
using RNase-fee DNase (Qiagen, CA, USA). Following this, the samples were washed for 
15 s with 40 µl wash buffer followed 100 µl wash buffer 2 for one min at 9457 rpm. After 
the second wash with 100 µl wash buffer 2 at 13500 rpm for 2 min, the purification 
column was transferred to a new 0.5 ml microcentrifuge tube. The RNA was then eluted 
using 12 µl elution buffers. One micro litter of the RNA was used to determine the 
concentration and quality using Nanodrop 8000 Spectrophotometer. 
 
3.2.4.2 RNA amplification from embryo biopsies 
 
3.2.4.2.1 First and second stranded cDNA synthesis 
 
 First strand cDNA was synthesized from total RNA samples of embryo resulted in calf 
delivery and no pregnancy group using T7 promoter attached oligo (dT)21, superscript 
reverse transcriptase II (Invitrogen, CA, USA) and random hexamers as described 
previously (El-Sayed et al. 2006, Ghanem et al. 2007, Salilew-Wondim et al. 2007). 
Second strand cDNA was then synthesized using degenerated oligonucleotide primer 
(DOP)-PCR master kit (Roche Diagnostics GmbH, Mannheim, Germany) according to the 
manufacturer’s recommendation. Briefly, 1 µl DOP primer, 1 µl T7 primer, 40 µl 2xDOP 
master mix and 16 µl RNasin were added to 20 µl first cDNA and incubated at 95 oC for 5 
min, 94 oC for 1min and 30 oC for 2 min. Subsequently the temperature was increased at 
the rate of 0.2 ˚C /s until it reaches 72 ˚C and incubated for 3 min at this temperature. 
Afterwards, the global PCR amplification was continued for the rest of 10 cycles at 94 ˚C 
for 30 s, 60 ˚C for 30 sec, 72 ˚C for 3 min. The reaction was terminated after final 
extension at 72 oC for 7 min. Following this, the double stranded DNA (dscDNA) was 
purified using phenol-chloroform extraction method. For this, 80 µl phenol-chloroform 
was added to 80 µl dscDNA and centrifuged at 14000 rpm for 15 min. The aqua-phase was 
transferred to 2 ml tube to which 1 µl glycogen, 40 µl 5 M ammonium acetate, 200 µl 
100% ethanol were added. The samples were then kept at -20 oC over nigh. In the next 
day, the samples were centrifuged using refrigerated universal centrifuge Z233MK 
(Hermle Labortechnik, Wehingen, Germany) at 14000 rpm for 30 min. After removing the 
supernatant, the dsCDNA pellets were washed in 500 µl 70% ethanol. After removing all 
traces of ethanol, the pellets were dissolved in 10 µl of RNase free water. 
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3.2.4.2.2 In vitro transcription 
 
The double strand cDNA was in vitro transcribed and amplified using AmpliScribe T7 
transcription kit (Epicentre technologies, WI, USA). For this, a 10 µl in vitro transcription 
mix (2 µl 10x reaction buffer, 4µl dNTP mix [1 µl from each 0.1M ATP, 0.1M CTP, 0.1M 
GTP and 0.1M UTP), 2 µl DTT and 2 µl T7 RNA polymerase] was added to the 10 µl 
dscDNA. In vitro transcription and amplification was carried out at 42 oC for 3.5 h. 
Following DNase treatment at 37 oC for 30 min, amplified RNA was purified using 
RNeasy mini kit (Qiagen, Hilden, Germany). After the final wash, the aRNA was eluted in 
30 µl RNase free water. The concentration and purity of the aRNA was evaluated using 
Nanodrop 8000 Spectrophotometer (Thermo Fisher Scientific Inc, DE, USA). 
 
3.2.4.3 Aminoallyl labeling and dye coupling 
 
Minimum information about microarray experiments (MIAME) guidelines (Brazma et al. 
2001) was adhered to the experimental design. Three micrograms of amplified RNA from 
embryo resulted in calf delivery or no pregnancy was used as template in reverse 
transcription reaction. Aminoallyl-modified dUTPs were incorporated into the cDNA 
using the cyscribe post-labeling kit (Amersham Biosciences, Freiburg, Germany). The 
aRNA, anchored oligo (dT) and random nanomer primers were co incubated at 70 ˚C for 5 
min followed by 10 min incubation at room temperature. Following this, 10 µl reaction 
mix (containing 4 µl of 5x first strand buffer, 2 µl of 0.1 M DTT, 1.5 µl of dNTP mix, 1.5 
µl aminoallyl dUTP and 1µl CyScript reverse transcriptase) was added and incubated at 42 
˚C for 90 min. At the end of this reaction, 2 µl of 2.5 M NaOH was added to hydrolyse any 
rest of mRNA and incubated at 37 ˚C for 15 min. After adding 10 µl of 2 M HEPES, 
aminoallyl labelled cDNA samples were purified using CyScribeTM GFXTM Purification 
kit (Amersham Biosciences, Freiburg, Germany). The purified aminoallyl labelled cDNA 
samples were then eluted in 60 µl 0.1 M sodium bicarbonate and immediately labelled by 
CyTM fluorescent dyes using Amersham post-labeling kit (Amersham Bioscience, 
Freiburg, Germany). For this, purified aminoallyl cDNA in (0.1M sodium carbonate) was 
directly added into aliquot of CyTM fluorescent dyes using the cyscribe post-labeling kit 
(Amersham Biosciences, Freiburg, Germany), dissolved in DMSO. Those aminoallyl 
cDNA derived from those embryos resulted in calf delivery were labelled with N-
hydroxysuccinate-derived Cy5 dye and those samples of embryo resulted in no pregnancy 
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were labelled with Cy3 dye. To avoid variation due to dye coupling, aminoallyl labelled 
cDNA samples of the calf delivery group were labelled with Cy3 and no pregnancy groups 
were labeled with Cy5 dyes. The dye labelled samples was then incubated for 15 min at 
room temperature in dark. At the end of incubation, non reacting dyes were quenched by 
adding 15 µl of 4 M hydroxylamine solution (Sigma-Aldrich Inc, MO, USA) and 
incubated for 15 min at room temperature in dark. The reaction was then purified with 
CyScribeTM GFXTM Purification kit (Amersham Biosciences, Freiburg, Germany) and 
finally eluted in 60 µl elution buffer. 
 
3.2.4.4 Hybridization to the target probes 
 
3.2.4.4.1 Target clones 
 
Ready made bovine cDNA array (BlueChip version 3, kindly provided by Prof. Marc-
André Sirard, (Laval University, Quebec, Canada) was used for hybridization. The 
BlueChip array consisting of more than 3000 probesets (6766 spots) and about 2300 
targets genes derived from subtraction suppressive hybridization of bovine embryo and 
tissues. In addition to the target probesets, the BlueChip array consists of control clones. 
The name of control clones include, alien1 (530 spots), alien2 (540 spots), GFP (4 spots), 
Doublets (96), GFP (348 spots), GFP½ (30 spots), GFP1 (30 spots), GFP¼ (6 spots), 
GFP1/8 (6 spots), GFP 1/16 (6 spots) and H2O/DMSO (380), Negative (6 spots), plant 
(540 spots), vide (96 spots), tubulin (8 spots), ubiquitin (8 spots) and actin (12 spots). 
 
3.2.4.4.2 Probe preparation and hybridization 
 
Before hybridizing, the arrayed slides were placed in a corning GAPS II slide container 
containing 50 ml pre-hybridization buffer [0.5 g bovine serum albumin (Roche 
Diagnostics, Basel, Switzerland) + 0.5 ml 10% SDS + 7.5 ml 20% SSC + 42 ml sterile 
water] and incubated for 20 min at 55 oC. After the end of incubation, the slides were 
sequentially washed with boiled and cold water and isopropanol. The slides were then  
centrifuged at 2000 rpm for 2 min. Immediately before hybridization, dye labelled probes 
were dissolved in 55 µl formamid based buffer (15 µl hybridization buffer + 30 µl 100% 
formamid + 10 µl distilled water) to which 2.5 µl yeast tRNA and 2.5 µl human cot-DNA 
(Invitrogen, Karlsruhe, Germany) were added to avoid non specific hybridization. After 
denaturing at 95 oC for 5 min, the mix was then hybridized to the array and covered with 
Materials and methods  
_________________________________________________________________________ 
 
58 
 
cover slips (ROTH, Karlsruhe, Germany). A total of six hybridizations (three biological 
and three technical replicates as dyeswap) were carried out between the two sample 
groups. The hybridized array slide was then placed in the hybridization chamber (GFL, 
Dülmen, Germany) and incubated at 42 oC for 20 h in dark. At the end of the incubation, 
the slides were sequentially washed for 10 min with 2x SSC plus 0.1% SDS, 5 min each 
with 0.2x SSC and 0.1% SSC buffers, 1 min each with water and isopropanol and 
centrifuged at 2000 rpm for 2 min.  
 
3.2.4.5 Image capture and quantification  
 
Microarray slides were scanned using Axon GenePix 4000B scanner (Axon Instruments, 
Foster City, CA). The images of the spots were quantified to create reports of spot 
intensity data using GenePix Pro analysis software (version 4.0) (Axon Instruments, Foster 
City, CA). The images were saved as a multiple channel image and as a single image for 
both channels (Cy3 and Cy5) in 16-bit tagged image file format (TIFF). 
 
3.2.4.6 Microarray data analysis from embryo biopsies 
 
The normal expression and offset method was used to correct the background (Ritchie et 
al. 2007). LOESS normalization was applied to normalize within array variations (Smyth 
and Speed 2003, Yang et al. 2002) and scale-normalization was used to normalize 
differences between arrays due to changes in the photomultiplier tube setting of the 
scanner. A mean log2 transformed value of (Cy5/Cy3) was calculated from three replicates 
to obtain one value per clone. The raw and normalized data are available at Gene 
Expression Omnibus (GEO), http://www.ncbi.nlm.nih.gov/geo/ with accession number 
GSE21047 or GSE21049. Differentially expressed genes were obtained using linear 
models for microarray data (LIMMA) (Smyth 2005). Those genes whose average 
expression value ≥ 1.5 fold change and p < 0.05 were considered as differentially 
expressed genes. The heatmap of differentially expressed genes was drawn using the 
heatmap function of bioconductor. 
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3.3 Validation of differentially expressed genes using quantitative real time polymerase 
chain reaction (qPCR) 
 
3.3.1 Primer design and gene specific PCR amplification 
 
 In the current study, qPCR was used to validate differentially expressed genes and to 
quantify some candidate genes across the estrous cycle. For this, sequence specific primers 
were designed using primer express v 2.0 (Applied Biosystems, Foster city, CA) or primer 
3.0 online primer design tool (http://frodo.wi.mit.edu/primer3/) for candidate genes that 
were differentially expressed in endometrial biopsies (Table1) and embryo biopsies (Table 
2). All primers were purchased from Eurofins MWG synthesis GmbH (MWG Biotech, 
Eberberg, Germany) and diluted at 100 pm stock solution. The PCR reaction was carried 
out for each primer in  20µl reaction volume using 2 µl cDNA template, 4 µl of 10x PCR 
buffer (Sigma-Aldrich), 0.5 µl of dNTP, 0.5 µl of each specific primer (10 pmole forward 
and reverse), 0.5 µl of Taq polymerase (Sigma-Aldrich) and millipore water was added to 
complete the rest of the volume. After the end of the reaction, 5 µl of the PCR product was 
loaded onto ethidium bromide stained 2 % agarose gel run in 1xTAE buffer. The presence 
and specificity of DNA bands were observed under BioRad Chemidoc XRS Gel 
Documentation System (Biorad, Munchen, Germany). After confirmation of specific DNA 
bands, the amplified PCR product was sequenced to verify the identity of the gene. For 
this, the sequence reaction was carried out by using 2µl 10 pm reverse primer or forward 
primer to 5 µl PCR product. Subsequently, 4 µl master mix (DTCS) and 9 µl Millipore 
water was added to final volume of 20 µl. Afterwards, the sequence reaction was carried 
out for 30 cycles at 96 oC for 20 s, 50 oC for 20 s and 60 oC for 4 min. Afterwards, the 
sequencing reaction was transferred to a 5µl stop solution [1µl glycogen, 2 µl 3M NAOAc 
(PH 5.2), 2 µl 0.1M EDTA (PH 8)]. The mixed was homogenized by vortexing. After 
adding 60 µl 100% ethanol, the samples were centrifuged at 14000 rpm for 15 min at 4 oC 
in refrigerated universal centrifuge Z233MK (Hermle Labortechnik, Wehingen, Germany). 
After this, the supernatant was removed and again the samples were washed two times in 
200 µl 70 % ethanol and dried in room temperature. Finally, the pellets were dissolved in 
40 µl SLS and transferred to the sequencing plate, covered with mineral oil (Beckman 
Coulter, Krefeld, Germany) and immediately loaded to CEQTM 8000 Genetic Analysis 
(Beckman Coulter, Krefeld, Germany) sequencing machine. The similarity of the sequence 
result to the original sequence was verified using the NCBI/BLAST search tool 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi). 
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Table 4: Primers used for validation of differentially expressed genes between endometrial 
biopsies  
Gene name ACC. No 5-3 sequence     BP 
 
 
S100B 
 
NM_001034555 F: GTGAGCTGTGATGTTTGCCTA R: ATAAAATTCCCTGGCTTCACC 366 
 
S100A13 
 
NM_205800 F:  CTGAGACACGGATACAGCAAA R: ACTGCTGAGTGACCAGTTCCT 325 
 
TLR6 
 
NM_001001159 F: GTTTGGGAAAATGTTGCTGAT R: GCTCTAGAGTGCAGGCTCAGT 244 
 
PTGER4 
 
NM_174589 F:  AGGACAACCTAACGTGCTGAT R: AAGGCTAATCCTTCCACACCT 261 
PLK4 AC146966 
 
F: GGAGAGACCCCATTTTTGAAT 
R: GTTGTTTGACCCTCTGGTGAT 
 
230 
 
MYC 
 
NM_001046074 F: AGAGCAGCAAAAGCTCAAGTC R: TAAAGATCCAGCCAAGGTTGT 227 
 
IRF6 
 
NM_001076934 
 
F: CAAGGATAACATCGTTGCTCA 
R: GAAAGGCTTGAAAGCTGGTTA 
 
200 
IRF5 
 
NM_001035465 
 
F: ATTGTGGAGGGAAGGAACTCT 
R: GACTGTGAACCCAAGGATTGT 
 
248 
IL18 NM_174091 
 
F:  CATCAGCTTTGTGGAAATGAA 
R: GGGGTGCATTATCTGAACAGT 
 
208 
 
MMP2 
 
BC149404 F:  TTGGGAGCCAACAGAGACTAC R:  GGAAATGCAATGTCATAGTG 209 
 
AGTR1 
 
NM_174233 F:  AAGAGCTTAAGACTGCCATGC R:  AACATGACTACCTGGGACTGG 293 
 
PLCB1 
 
NM_174817 F:  GCCCCTCAGCTACCATATCTT R:  GTCAAGTCTGGAGATGGCTTC 208 
SLC25A5 NM_174659 
 
F:  CCAGATCCCAAGAACACTCAT  
R:  CATACAGGACAAGCACAAACG 
271 
ADORA2B NM_001046333 
 
F: ATAAACACAGCCATCCTCCTG 
R:  TTACTGAGCCTTCTCCTGGAA 
 
205 
 ACC. No = Gene bank accession number, BP= number of base pairs amplified 
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Table 4: Cont. 
 
 
Gene name ACC. No 5-3 sequence     BP 
 
 
CAMK2D 
 
NM_001046333 F:  TGCCTGCATAGCGTACATTAG R: AGGACCTTCACAACTTCATGC 229 
 
FUT8 
 
NM_177501 F:  CTTGGTCAGCTGGACTACACA R: GTTCGAGGTTCGTGAGGATAA 252 
 
B3GNT2 
 
NM_001102497 F:  AGTGACTGCTTTCCTGTTTCAG R:  TCCCCCAAAAGAGAACAGAT 216 
 
ALG8 
 
NM_001076125 F:  CGTACTGATTGACCCTCCTGT R:  TATGGAGGACAAGTGGCTTCT 231 
CDC2 NM_174016 
 
F:  TTTGGGCACTCCCAATAAT 
R:  AACACAGGGAAACTGTCAGA 
 
242 
 
CCNB2 
 
NM_174264 F:  TGGAGCTGACTCTCGTTGAC R:  CTGAGGAATCGTGCTGATCT 253 
 
NGF 
 
NM_001099362 F:  GGGAGAGGTGAACATCAAC R:  TCTTCCTGCTGAGCACAC 233 
 
RPS6KA5 
 
XM_580522 F:  GCTTTTCCTCCTGTAGTCA R:  ACTTCCTCTCTTGCATAGG 251 
 
MAPK12 
 
NM_001098953 F:  ATGGAATCTCTCTTGGAAGC R:  TCCTCAGCACAGTTCAG 241 
 
MAP4K2 
 
XM_869702 
 
F: GCTCACAGCAACCTCTACAT 
R: TGACAGCAGCTTCTTCTGGT 
 
264 
 
SFRP1 
 
NM_174460 
F: CTCCCTAAGGCATCTTGTCTG 
R: CAGGAATCTCGTCTGTGTCC 
 
213 
 
PRKACB 
 
BC149047 F: GTACGTCTTTGGCTGTCGAGT R: ATCAGCATGTTCTTGGGTCT 218 
 
WNT11 
 
NM_001082456 F: TTGTGCTTTGCCTCCACT R: ACAGAACATTCCGTTGAGGAC 266 
 
NGF 
 
NM_001099362 F: GGGAGAGGTGAACATCAAC R: TCTTCCTGCTGAGCACAC 233 
 
WNT11 
 
NM_001082456 F:  TTGTGCTTTGCCTCCACT R:  ACAGAACATTCCGTTGAGGAC 266 
AURKB 
NM_183084 
 
F: TTTCTGCTCTGGTGAGGATTT 
R: TCCAGTGGTTAGGACTCCAAG 
181 
                     ACC. No = Gene bank accession number, BP= number of base pairs amplified 
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Table 4: Cont. 
 
  
Gene name ACC. No 5-3 sequence     BP 
 
TIMP3 NM_174473 
 
F: AGCCAGCAGATAGACTCAAGG 
R: GCTTGCTCCAGACTCAGAAAC 
193 
CLD23 XM_592516 
 
F: GGAGAATGAAGGGACTAATGCT 
R: AACAGGTTCCATTTTGTTCCA 
102 
 
STAT5A 
 
AJ237937 
 
F:  TGTCTCCAACCTTGCTCACTA 
R:  AAGAGGCCCTATTCCAAGTTC 
 
230 
 
COLA2 
 
NM_174520 F:  TTGAAGGAGTAACCACCAAGG R:  TGTCCAAAGGTGCAATATCAA 320 
 
MAPK12 
 
NM_001098953 F:  ATGGAATCTCTCTTGGAAGC R:  TCCTCAGCACAGTTCAG 241 
 
MAP4K2 
 
XM_869702 F:  GCTCACAGCAACCTCTACAT R:  TGACAGCAGCTTCTTCTGGT 264 
 
SFRP1 
 
NM_174460 
 
F:  CTCCCTAAGGCATCTTGTCTG 
R:  CAGGAATCTCGTCTGTGTCC 
213 
 
ITPR1 
 
NM_174841 
 
F:  GCGCTAAATTAGAGGCTCAGA 
R:  GTAGCATGTTGGTTCCGATG 
218 
MYLK 
 
NM_176636 
 
F:  AGCCCCATGTAAAACCCTACT 
R:  GGCTTCTCCAAGACTGTTGAC 
262 
F2R 
 
NM_001103097 
 
F:  GACCAACATATGGTGTGGACAA 
R:  CACAGGAAGCAGTAACCCAAA 
135 
PRKACB 
 
BC149047 
 
F:  GTACGTCTTTGGCTGTCGAGT 
R:  ATCAGCATGTTCTTGGGTCT 
218 
 
RPS6KA5 
 
XM_580522 F:   GCTTTTCCTCCTGTAGTCA R:   ACTTCCTCTCTTGCATAGG 251 
 
                ACC. No = Gene bank accession number, BP= number of base pairs amplified 
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Table 5:  Primers used for validation of DE genes between embryo biopsies resulted in calf 
delivery and embryo biopsies resulted in no pregnancy.  
 
Gene name ACC. No 5’-3’ sequence BP 
 
SGK1 
 
NM_001102033 
 
F:  CCCTTTTATAGCCGAAACACA 
R: TGGGTTAAAAGGGGGAGTAAT 
 
236 
 
ARL8B 
 
NM_001046071 
 
F:  TCCTAATGCCTTGGATGAGA 
R: GGGATTAGGAAGGACCGTATT 
257 
 
RNF34 
 
NM_001014858 
 
F: GATTGATACCTGTCGGGAGAA 
R: CGTCTTCTGTGTTTGCTGAAG 
271 
 
ARL6IP1 
 
NM_001078157 
 
F: AGACTGCAAGTCTGGAAGAGC 
R: GAACAAGGTAGTCAGCCAAGC 
209 
 
UBE2D3P 
 
NM_001075135 
 
F:  CCAGAGATTGCACGGATCTAT 
R: 
GTGAATGAATGGAGGGAGGTA 
140 
 
AMD1 
 
NM_173990 
 
F: GAGTGGAATTCGTGACCTGAT 
R: GGCTTGAAGACTTCCACAACT 
212 
 
HSPA8 
 
NM_174345 
 
F: GCTGGAACTATTGCTGGTCTC 
R: TCCACCCAAGTGAGTATCTCC 
209 
 
STX8 
 
NM_001078037 
 
F: GGTGGAGAATACCGATGAGAA 
R: CTCGGCTTTACTCCATCTCTG 
288 
GAPDH NM_001034034 
 
F: AATGGAGCCATCACCATC 
R: GTGGTTCACGCCCATCACA 
 
240 
                           ACC. No = Gene bank accession number, BP= number of base pairs amplified 
 
3.3.2 Gene cloning and Transformation 
 
Once the specificity of each of the primers were confirmed by sequencing, the plasmid 
DNA containing the specific PCR product was prepared to be used as a serial dilution for a 
standard curve. For this, the PCR product was purified using QIAquick PCR Purification 
(Qiagen, Hilden, Germany) and  ligated to pGEM®-T easy vectors (Promega, WI, USA) 
that contains 3’-T overhangs. The ligation reaction was performed in 5 µl reaction mix 
containing of 3 µl of ligation buffer, 0.5 µl pGEM®-T vectors, 0.5 DNA ligase enzyme 
and 2 µl PCR product. The ligation reaction was incubated at 20 oC for 2 h. At the end of 
the ligation reaction, 3µl of the ligation product was transferred to 15 ml tube to which 100 
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µl competent (E.coli, JM109 strain) was added. The competent cells and the ligation 
product co incubated for 20 min in ice followed by 90 s heat shock at 42 oC and then 2 min 
cold shock in ice. Afterwards, 700 µl of Luria-Bertani (LB) broth was added to the cells 
and cultured at 37 oC in SHKE6000-8CE refrigerated Stackable Shaker 
(Thermoscinentific, IWA, USA) for 90 min at 110 rpm speed. After 70 min, 20 µl of IPTG 
and 20 µl of X-gal were uniformly distributed on the LB agar/ampicillin plate. After the 
incubation period, the bacterial culture was plated onto pGEM®-T easy vectors LB 
agar/ampicillin/IPTG/X-gal plate and incubated overnight at 37 oC. 
 
3.3.2.1 Blue/white screening of recombinants and colony picking  
 
 Insertional inactivation of the α-peptide allows identification of recombinants by 
blue/white screening on LB agar/ampicillin/IPTG/X-gal plate. Therefore, successful 
cloning of an insert into pGEM®-T Easy vector interrupts the coding sequence of β-
galactosidase resulting recombinants in white colony formation. Following this, four 
independent white colonies assumed to contain inserts were picked and inoculated to the 
30 µl 1xPCR buffer and the same colony was inoculated to the 600 µl LB broth continuing 
ampicillin. In addition, two independent blue colonies were picked and inoculated into the 
PCR strip containing 30 µl 1xPCR to be used as a control. The inoculums in 600 µl LB 
broth were incubated at 37 oC in SHKE6000-8CE refrigerated Stackable Shaker 
(Thermoscinentific, IWA, USA) until the result of M13 product was known. The bacterial 
suspension in the 30 µl 1xPCR was heated for 15 min at 95 oC. From this, 10 µl this lysate 
was used as a template for M13 PCR reaction to which a mix consisting of 0.5 µl dNTP, 
0.5 µl M13 forward primer (TTGTAAACGCGGCCAGT), 0.5 µl M13 reverse primer 
(CAGGAAACAGCTATGACC), 2 µl 10x PCR reaction buffer was added. M13 PCR 
reaction was carried out first by denaturing the at 95 oC for 3 min followed by 35 cycles 
that repeated at 95 oC for 30 s, 59 oC for 30 s, 72 oC for 1 min. M13 PCR reaction was 
termed after extension at 72 oC for 10 min. At the end of the reaction, 5µl of the M13 
product mixed with 2 µl loading buffer was loaded to 2% agarose gel stained with 
ethidium bromide. The colonies that contain PCR fragments (white colonies) were 
identified depending the distance travelled by DNA fragment in 2% agarose gel 
electrophoresis. The blue colonies were at lower position compared to the white colonies. 
Following this, the colonies confirmed for the presence of PCR fragment were transferred 
to 15 ml sterile tube and additional 5 LB broth/ampicillin was added. The bacterial 
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suspension was further cultured over night at 37 oC to increase numbers and therefore the 
amount of DNA. 
 
3.3.2.2 Plasmid isolation  
 
The plasmid was isolated using GenElute plasmid mini prep kit (Sigma-Aldreich, St.Lous, 
USA) according to the manufacture’s recommendation. Briefly, overnight cultured 
competent cells were pelleted by centrifuging at 13000 rpm for 1 min. The medium was 
removed and the pellets were lysed with 200 µl lysis solution. Afterwards, the lysate was 
incubated for 5 min at room temperature. Afterwards the cell debris were Precipitated by 
adding 350 µl neutralization/binding solution and centrifuging at maximum speed for 10 
minutes. Following this, the GenElute Miniprep binding column was inserted into a 
provided microcentrifuge tube and 500 µl of the column preparation solution was added 
followed by centrifugation at 13000 rpm for 30 s. The cleared lysate was then transferred 
to the column and centrifuge at 13000 rpm for 30 s. The filtrate was decanted and 750 µl 
of the diluted wash solution to was added to the column followed by centrifugation at 
13000 for 30 s. The flow-through liquid was decanted and the column was centrifuged 
again at maximum speed for 2 minutes without any additional wash Solution. Finally, the 
spin column was transferred into a collection tube to which 50 µl of Millipore water was 
added to the centre of the spin column membrane and centrifuged at speed of 13000 rpm 
for 1 min. To confirm the presence of the plasmid DNA, 5 µl of the plasmid DNA was 
analyzed in ethidium bromide stained 2% agarose gel electrophoresis running in 1x TAE 
buffer. The concentration of the plasmid was determined using Nanodrop 8000 
Spectrophotometer. 
 
3.3.2.3 Plasmid or M13 sequencing  
 
Although insertional inactivation of the α-peptide allows identification of recombinants 
with on LB agar/ampicillin/IPTG/X-gal plate, the specificity of gene cloning was further 
validated by sequencing of M13 PCR product or plasmids DNA isolated from overnight 
cultured recombinant bacteria. A 15 µl mix consisting 2 µl M13 (1.6 pmol) reverse primer 
or forward primer, 4 µl master mix (DTCS) and Millipore water was added to final volume 
15 µl. The thermocyler program, post reaction clean and loading of the samples to CEQTM 
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8000 Genetic Analysis sequencing machine was performed as indicated above for 
sequencing PCR products.  
 
3.3.2.4 Preparing serial dilution from plasmids 
 
The serial dilution consisting of 101 to 109 copy number of molecules was prepared from 
plasmid DNA using the online software, (http://molbiol.edu.ru/eng/scripts/h01_07.html), 
which converts known DNA concentration to copy number of molecules. Briefly, to 
determine the number of molecules, the plasmid concentration (ng/µl) and the nucleic acid 
size (the size of the pGEM®-T easy vectors + PCR fragment of each gene) were submitted 
to the software. The dilution that contains 109 molecules was then determined in 50 µl 
volume based on the number of molecules obtained in 1 µl plasmid DNA. Following this 
108 dilution was determined using 5 µl of 109 dilution and 45 µl Milipore water. The 
remaining 107-101 dilutions were determined in the similar way using 5 µl of the higher 
dilution and 45 µl of Millipore water.    
 
 3.3.3 Transcript level quantification 
 
The minimum information for publication of quantitative real-time PCR experiments 
(MIQE) guidelines were employed during measuring gene expression level using 
quantitative real time PCR (Bustin et al. 2009). According to the guideline, qPCR was 
used as abbreviation of quantitative real time PCR through the text. Following this, the 
cDNA samples used for qPCR were synthesized by reverse transcription of total RNA 
endometrial and embryo biopsy samples as described previously in our lab (El-Sayed et al. 
2006, Ghanem et al. 2007, Salilew-Wondim et al. 2007). Prior to qPCR, the concentration 
of the cDNA samples from each treatment group was determined using the Nanodrop 8000 
Spectrophotometer (Biotechnology GMBH, Erlangen, Germany). Similar amount of 
cDNA samples were used to compare samples from different treatment groups. The qPCR 
was performed in 20 µl reaction volume containing iTaq SYBR Green Supermix with 
ROX (Bio-Rad laboratories, Munich, Germany), the cDNA samples, the specific forward 
and reverse primer in ABI PRISM® 7000 sequence detection system (Applied Biosystems, 
Foster city, CA). The qPCR thermal cycling parameter was set as 95 oC for 3 min, 40 
cycles of 15 sec at 95 oC and 45 sec at 60 oC. At the end of the qPCR reaction, the 
specificity of amplification for each gene was evaluated by monitoring the dissociation 
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(melting) curve. Transcript abundance of the samples was determined using the relative 
standard curve method using a serial dilution of 101-109 copy numbers prepared from 
plasmid DNA. The data generated was considered for further analysis provided that the 
slope and the regression line (R2) of the standard curve were between (-3.2 to – 3.6) and > 
0.99, respectively. Following this, the copy numbers of the target genes were normalized 
against the housekeeping gene glyceraldehyde 3-phosphate dehydrogenase (GAPDH). The 
expression of GAPDH was not significantly different between the samples to be compared. 
The normal distribution was tested by the Kolmogorow–Smirnov method and those 
skewed expression values were log2 transformed prior to statistical analysis. The Student’s 
t-test or least significant difference test procedures of SAS version 9.2 (SAS Institute Inc., 
Cary, NC, USA) was used to determine mRNA differences between the samples. 
Differences with p < 0.05 were considered as significant.  
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4 Results 
 
4.1 Embryo biopsy transfer and success rate 
 
From 54 biopsied embryos transfers, 59% heifers returned to heat at day 21 and those 
heifers were designated as non pregnant or non-receptive endometrium. The remaining 
41% heifers were pregnant until day 56 and 27 % ended up with successful calf delivery. 
Those heifers ended up with successful pregnancy and calf delivery were designated as 
calf delivery group or receptive endometrium. Here the underline question was why some 
transfers resulted in calf delivery and others not despite similarities in breed, age and 
synchronization protocol. Thus, it was hypothesized that those two groups of heifers and 
the corresponding transferred embryos may have different molecular enrichments that can 
affect the embryo maternal communications for establishment pregnancy success. 
Therefore, to investigate the molecular mechanism associated with the endometrial 
receptivity and embryos implantation potential, the pre-transfer endometrial and 
embryonic gene expression was investigated in relation to the pregnancy outcome using 
endometrial and embryo biopsies techniques. The results of these comparisons are 
presented as follows. 
 
4.2 Pre-transfer gene expression in receptive and non-receptive endometrium 
 
4.2.1 Pre–transfer gene expression in receptive and non-receptive endometrium at day 7 of 
the estrous cycle  
 
Using the GeneChip® Bovine Genome Array, consisting of over 23,000 bovine 
transcripts, the gene expression differences were uncovered between the endometrium of 
heifers that resulted in calf delivery and heifers resulted in no pregnancy at day 7 of the 
estrous cycle during the pre-transfer period. For this, the gene expression profile of 
biopsies taken at day 7 the estrus cycle from those subsequently resulted in calf delivery 
[receptive endometrium (CDd7)] were compared to those endometrial samples taken at 
day 7 of the estrous cycle from those subsequently resulted in no pregnancy [non-receptive 
endometrium (NPd7)] following embryo transfer. The result revealed that from 8605 
detected genes in both receptive (CDd7) and non-receptive endometrium (NPd7), a total of 
1126 differentially expressed (DE) genes were identified between the two groups.  
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Figure 5: Pre-transfer endometrial transcriptome alteration between receptive (CDd7) and 
non-receptive endometrium (NPd7) at day 7 of the estrous cycle. (A): The 
number and fold change distribution of genes elevated in CDd7 or NPd7. (B): 
The heatmap and hierarchical clustering showing the expression pattern of DE 
genes in CDd7 and NPd7 endometrial samples. Labels in the horizontal axis of 
the heatmap, CDd7-1, CDd7-2 and CDd7-3 represent independent biological 
replicates in receptive endometrium and NPd7-1, NPd7-2 and NPd7-3 represent 
independent biological replicates from non-receptive endometrium groups. The 
horizontal dendrogram indicate the expression pattern of transcripts in CDd7 and 
NPd7. The vertical dendrogram elucidates the similarities or differences of 
transcript expression within the biological replicates and between CDd7 and 
NPd7 endometrial samples. Red and green colors in (B) indicate the high and 
low expression level, respectively. 
 
From the total 1126 DE genes, the expression level of 612 genes was abundantly expressed 
in receptive endometrium (CDd7) in which 81% exhibited 2 to 4 fold changes increase and 
29% of them exhibited 4.1 to 23 fold change increased compared to NPd7 (Figure 5A). 
The top abundantly expressed genes in CDd7 compared to NPd7 include CDC20, GCLC, 
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PLLP, COL4A4, TMEM163, LOC510320, MTTP, NETO2, CDC2, COX6B2 and 
PPP2R5A (Figure 6). On the other hand, the expression level of 514 DE genes was 
reduced in CDd7, but abundantly expressed in NPd7. From those 88.3 % exhibited 2 to 4 
and 10.7% showed 4.1 to 23 fold changes increases in NPd7 compared to CDd7 (Figure 
5A).The top abundantly expressed genes in NPd7 compared to CDd7 include HOXA9, 
COL1A2, NTRK2, COL3A1, GJA1, COL21A1, LHFP, IGJ, SPOP, OGN, COL6A1 and 
PARC (Figure 6)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: The expression pattern of DE genes exhibited ≥ 5 fold difference between CDd7 
and NPd7. Labels in the horizontal axis of the heatmap, CDd7-1, CDd7-2 and 
CDd7-3 represent independent biological replicates from receptive endometrium 
and NPd7-1, NPd7-2 and NPd7-3 represent independent biological replicates 
from non-receptive endometrium groups. The red and green colors indicate high 
and low expression pattern, respectively. 
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4.2.1.1 Differentially expressed gene clusters between receptive and non receptive 
endometrium at day 7 of the estrous cycle 
 
From the 1126, DE genes identified between receptive (CDd7) and non-receptive (NPd7) 
endometrium, there were several gene clusters whose expression was elevated either in 
CDd7 or in NPd7. Among those, the expression levels of  solute carrier genes, cell division 
or cell cycle related genes, adaptor related genes, kinesin genes, leucine rich repeats, coiled 
domains, ATPases, protein kinases and phosphatase gene clusters, transmembrane 
proteins, junctional adhesion molecules,  integrins and WD repeats were higher in CDd7 
(Figure 7). On the other hand, the expression levels of cluster of genes including cluster of 
differentiation molecules (CD), chemokine molecules, homeobox genes, collagen families, 
S100 calcium binding protein and zinc finger proteins were increased in (NPd7) (Figure 
8). Apart from these, the fold changes, the UniGene ID, the gene symbol and full name of 
the first 300 DE genes are described in appendix 2. 
   
 
Figure 7: Genes clusters exhibited increased expression level in receptive (CDd7) 
compared to non-receptive endometrium (NPd7) at day 7 of the estrous cycle. 
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Figure 8: Gene clusters exhibited reduced expression level in receptive endometrium 
(CDd7) but increased in non-receptive endometrium (NPd7) at day 7 of the 
estrous cycle. 
 
4.2.1.2 Transcriptomic functional alteration in receptive and non-receptive endometrium at 
day 7 of the estrous cycle  
 
To investigate the transcriptomic functional changes that have been occurred in receptive 
and non-receptive endometrium at day 7 of the estrous cycle, the gene ontology (GO) 
enrichment of biological process and molecular function was analyzed for those genes 
differentially expressed between CDd7 and NPd7. Thus, 15 and 13 biological processes 
were found to be overrepresented in those DE genes that were elevated in CDd7 and 
NPd7, respectively (Figure 9). The biological process overrepresented in CDd7 include, 
macro molecule localization or cellular material transport (FABP5, solute carrier genes, 
ITPR1, VDAC1, adapter related proteins, KIF20A, KIF4A), regulation of transcription 
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(PPARA, MYB, NR2F1, PPARGC1A, HEY1, TFDP2, ASF1B, MED27, IRF6), signal 
transduction (PTGER4, F2RL1, ADORA2B, SPHK1, ADAM10, ITGA2, PLCB1, RPS6KA5, 
RAB9B, WNT11), post translational modification (BMPR2, MAPK6, PLK1, MARK1, PPM1G, 
PTPN3, RNF144B, UBE2S), cell cycle or cell division related process (CDC2, CCNA2, 
CCNB2, AURKB, UBE2C, PTTG1, CDCA2, NUSAP1, CKS2, BIRC5) and apoptosis (BCL2, 
CDC2, BIRC5, GCLC). The representative biological processes of GO terms and the 
expression pattern of DE genes enriched in CDd7 is indicated in figure 10. On the other 
hand, cellular metabolic processes, response to stimuli, immune response and induction of 
apoptosis and chemokine activity were among the biological process overrepresented in 
those genes whose transcript level was elevated in NPd7 compared to CDd7 (Figure 9B). 
The representative GO terms and the expression patterns of DE genes enriched in NPd7 
are indicated in figure 12. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9: Ontological classification of DE genes that were elevated in CDd7 or NPd7 
according to their biological process. (A): Biological processes overrepresented 
in genes elevated in CDd7. (B): Biological process of overrepresented in genes 
elevated in NPd7. The vertical axis indicates biological processes and the 
horizontal axis indicate the number of DE genes involved in a specified 
biological process. DE = differentially expressed. 
 
A B 
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Figure 10: Representative biological processes overrepresented in DE genes increased in 
receptive (CDd7) compared to non-receptive (NPd7) endometrium. (A): Genes 
involved in gene transcription. (B): Genes involved in protein localization or 
transport. (C): Genes involved in cellular localization. (D): Genes involved 
post-translational modification. (E): Genes involved in anti-apoptosis. The 
number on top of each heatmap indicates the gene ontology accession number. 
Red and green colors reflect high and low gene expression levels, respectively. 
A B 
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Figure 11: Biological processes or molecular functions overrepresented in genes exhibited 
increased transcript level in non-receptive (NPd7) compared to receptive 
endometrium (CDd7) at day 7 of the estrous cycle. (A): Genes involved in 
immune system. (B): Genes involved in induction of apoptosis. (C): Genes 
involved in transcription regulation. (D): Genes involved in chemokine or 
cytokine activity. (E): Genes involved in extracellular matrix. The number on 
top of each heatmap indicates the gene ontology accession number. Red and 
green colors reflect the high and low expression, respectively. 
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In addition to the biological process, the DE genes were classified according to molecular 
functions describing different activities that occurred at the molecular level. Thus, several 
significant molecular functions were overrepresented in those genes elevated in CDd7 or 
NPd7 (Figure 12). Some of molecular function overrepresented by those genes reduced in 
CDd7 but elevated in NPd7 include protein binding, transcription factor activity 
(CREB3L4, STAT5A, ELF1, FLI1, NFIB, MYC, IRF5, SIX1, HOPX and HOXA11), 
kemokine activity (CXCL2, CXCL1, CXCL5, XCL1) (Figure 11D) extracellular matrix 
structural constituent (COL1A1, COL1A2, COL3A1, COL27A1) (Figure 11E). On the 
other hand, several molecular functions include binding activities (protein, ion, nucleic 
acid and ATP binding), transferase activity, transmembrane transport (ITPR1, solute 
carriers, transmembrane proteins, VDAC1), metal peptidase activities, symporter activity 
and kinase activity were overrepresented in genes elevated in CDd7 compared to NPd7 
(Figure 13).  
 
 
 
 
 
 
 
 
 
 
 
.  
` 
 
 
 
 
 
Figure 12: Molecular function overrepresented in genes enriched in receptive (CDd7) (left) 
and non-receptive endometrium (NPd7) (right) at day 7 of the estrous cycle. 
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Figure 13: Representative molecular functions overrepresented in genes enriched in CDd7 
compared to NPd7. (A): Genes involved in transporter activity. (B): Genes 
involved in calcium ion binding activity. (C): Genes involved in magnesium 
ion binding. (D): Genes involved in kinase activity. The number on top of each 
heatmap indicates the gene ontology accession number. Red and green colors 
reflect high and low expression, respectively
D 
 C 
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4.2.1.3 Molecular pathway identified in differentially expressed genes between receptive 
and non-receptive endometrium at day 7 of the estrous cycle 
 
To understand transcriptomic signaling and metabolic alteration in receptive and non-
receptive endometrium, the most important pathways involved by DE genes were 
identified from the Kyoto Encyclopedia of Genes and Genomes (KEGG) database. 
Accordingly, those genes that were differentially expressed between CDd7 and NPd7 were 
found to be involved in 25 molecular pathways (Table 6). Functionally, those pathways 
were classified broadly into 8 groups namely, cell communication (Integrin Signaling, 
tight junction and focal adhesion), signaling molecules and interaction (ECM-receptor 
interaction and cytokine-cytokine receptor interaction), signal transduction (MAPK 
signaling pathway and calcium signaling pathway), cell growth and death (p53 signaling 
pathway, cell cycle, apoptosis), nervous system (long-term potentiation), genetic 
information processing (ubiquitin mediated proteolysis) and immune system (Toll receptor 
pathway, hematopoietic cell lineage, antigen processing and presentation and T cell 
receptor) and endocrine system (insulin signaling pathway, PPAR signaling pathway and 
GnRH signaling pathway.  
From these, the tight junction, integrin signalling, inositol phosphate metabolism, calcium 
signalling pathway, glycan structures biosynthesis 1, focal adhesion, apoptosis, cell cycle, 
vascular endothelial growth factor (VEGF), long term potentiation and PPAR signalling 
pathways were enriched by genes increased in CDd7. The graphical illustration and the 
number of DE genes involved in one of those with highest number of DE genes, tight 
junction pathway is indicated in figure 14.  Similarly, T cell receptor pathway, cytokine-
cytokine receptor, p53 signalling pathway, Jak-STAT signaling pathway and cell adhesion 
pathways were dominated by DE genes whose expression was elevated in NPd7. 
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Figure 14: Differentially expressed genes between CDd7 and NPd7 involved in tight 
junction pathway. The claudin and junctional adhesion molecules (JAMs), 
which makeup the transmembrane protein of this pathway, were increased in 
CDd7. In the cytoplasmic plaque, aPRC, PP2A, PRKC, MYOSIN and RHO 
contains differentially expressed genes. Genes elevated in CDd7 are marked 
by red background and those elevated in NPd7 are marked with blue 
background. 
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Table 6: Molecular pathways containing genes elevated in receptive (CDd7) and non-receptive endometrium (NPd7)  
Name of molecular pathways     Differentially expressed genes                                                                                                          Pathway category 
Tight junction TIAM1, F2RL2, PRKCI, CLDN23, CLDN5, JAM3, JAM2,  CLDN7, ARHGEF2, PRKCQ, MRAS, MYLK       Cell communication                                                                                                          
Focal adhesion ITGA2, ITGA6, VEGFB, COL4A4, COL6A2, COL6A3, PPP1CC,  PPP1CB ,MYLK, COL1A1, COL1A2       Cell communication                                                                                                         
Integrin Signaling ROCK1, PPP1CC, TSPAN7, DIRAS3, ITGA2, MRAS, ITGA6, PPP1CB, RND3, MYLK, BCAR                      Cell communication 
Inositol Phosphate metabolism PRKCQ, SGK1, MAPK6, CDK6, PLCB1, PLK1, IHPK2, ITPKA, PLCL2, CDC2, INPP1                                  Metabolism 
ECM-receptor interaction CD36, HMMR, ITGA2, COL4A4, COL6A2, COL6A3, AGRN,COL1A1, COL1A2,                                     Signaling molecules  
Cytokine-cytokine receptor 
interaction VEGFB,  BMPR2, CSF3, IL18, TNFSF13, SDF1, CXCL2, CXCL1, CXCL6, XCL1                                             Signaling molecules  
MAPK signaling pathway NGF, RPS6KA5, MAPK12, MAPK6, NTRK2, MYC MRAS, MAPK13, PTPRR                                              Signal Transduction 
Apoptosis NGF, CDC2, CCNB2, DDB2, CDK6, BIRC5, FFA, BCL-2, TP53I3, SNAI2                                                     Cell growth and death 
Calcium signaling pathway SLC25A5, PLCB1, ITPR1, MYLK, F2R, ADORA2B, CAMK2D, AGTR1                                                             Signal Transduction 
Ubiquitin mediated proteolysis UBE2C, SYVN1, CDC20, DDB2, PIAS2, UBE2S, UBE2L6, UBE3B                                             Genetic information processing 
T cell receptor MAPK1, PRKCQ, LAT,  CD247, CD8A, CD8B, LCK, MAPK132                                                               Immune system 
p53 signaling pathway CDC2, CCNB2, DDB2, TIMP3, CDK6, TP53I3, SNAI2, SERPINB5                                                                Cell growth and death 
Neuroactive ligand-receptor  
interaction PTGER4, F2RL2, ADORA2B, F2R F2RL1, CALCRL, AGTR1                                                                        Signaling molecules 
GnRH signaling pathway PLCB1, ITPR1, MAPK12,  ITGA6, CAMK2D, MAPK13, MMP2                                                                           Endocrine system 
Cell cycle CDC2, CCNA2, CCNB2, CDC20 , PLK1,CDK6                                                                                                       Cell growth and death 
PPAR signaling pathway FABP5, PPARA, PLTP,  SLC27A4, ACOX2, CD36,                                                                                                Endocrine system 
Insulin signaling pathway PPP1CC, PPARGC1A, PRKCI, PPP1CB, SOCS2                                                                                              Endocrine system 
Long-term potentiation PPP1CC, PLCB1, ITPR1, PPP1CB, CAMK2D                                                                                                        Nervous System 
Glycan structures biosynthesis FUT8, B4GALT4, B3GNT2, ALG8, ALG11                                                                                         Metabolism 
Hematopoietic cell lineage ITGA2, ANPEP, CD8B, CD36, CD8A, CSF3                                                                                          Immune system 
Antigen processing and 
presentation HSPA2, CD8B, LOC508720, CALR, CD8A                                                                                                               Immune system 
Jak-STAT signaling pathway PIAS2, CSF3, STAT5A, SOCS2, MYC                                                                                                                      Signal Transduction 
Cell adhesion molecules JAM2, PDCD1LG2, CD8A, CD8B                                                                                                         Signaling molecules 
VEGF signaling pathway VEGFB, MAPK12, PTGS2, MAPK13                                                                                                  Signal Transduction 
Toll receptor pathway MAPK12, IKBKE, MAPK13, IRF5                                                                                                                             Immune System 
Genes elevated in receptive (CDd7) are indicated in bold face and those enriched in  non-receptive endometrium (NPd7) are lightfaced  
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4.2.1.4 Molecular networks represented in differentially expressed genes between 
receptive and non receptive endometrium at day 7 of the estrous cycle  
 
In addition to ontological classification and KEGG pathway analysis, the biological 
relationships between differentially expressed genes were also assessed using Ingenuity 
Pathway Analysis (www.ingenuity.com). For this, differentially expressed genes were 
uploaded into the program. The biologic relationship of uploaded genes was established 
with IPA software into networks according to the published literature in the database. A 
score was assigned to each network in the data set to estimate the relevance of the network 
to the uploaded gene list. Accordingly, network eligible genes were found to be involved 
in 34 different molecular networks (Appendix 3). The top molecular networks consisting 
of several differentially expressed genes were the cell cycle, cell death or reproductive 
system disease network, genetic disorder network, hematological system development and 
function network, cell cycle, DNA replication, recombination and repair network, post-
translational modification network, endocrine system development and function network, 
antigen presentation network, cell-to-cell signaling network and immune cell trafficking 
network. The two molecular networks with highest score are described in figure 15 and 16.  
The cycle, cell death or reproductive system disease network (Figure 15) consisted of 31 
focus genes, out of which 22 genes were enriched in CDd7 and the central gene, v-myc 
myelocytomatosis viral oncogene homolog (MYC), was reduced in CDd7. This network 
involves two transcriptional regulators (MYC and SUPT3H) which were down regulated 
in CDd7, but increased in NPd7. Apart from this, the enzyme molecules including GART, 
IDH3A, UBE2C, IDH2 have a direct relation to MYC.  In addition, this network showed 
that reduced expression level of MYC in CDd7 was associated with reduction in the 
expression of SUPTH3, TP53I3, PLA1A, PMP2, SFRP1 and TNFSF13. On the other 
hand, a reduction of MYC gene expression was associated with increased expression of a 
number of genes including IDH3A, UBE2C, IDH2, ITAG6, GPC1, CSK2, EMP1 and 
PSAT1 (Figure 15). 
Similarly, the genetic disorder, lymphoid tissue structure and development network 
(Figure 16) was the second high score molecular network identified in differentially 
expressed genes between CDd7 and NPd7. Genes including TIMP1, AP3B1, AP3S2, DST, 
VAMP7 are located in the cytoplasmic vesicle of the cell and VDAC1 is located in 
mitochondrial nucleoid and pore complex. Furthermore, AP3B1, AP3S2, AGTR1, 
VDAC1 and COL18A1 were the central genes of this network. 
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Figure 15: Cell cycle, cell death, reproductive system disease network. Genes in red and 
green background indicated the genes enriched in CDd7 and NPd7, respectively 
 
.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16: The genetic disorder, lymphoid tissue structure and development network. Red 
and green backgrounds indicate the genes enriched in CDd7 and NPd7, 
respectively. 
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4.2.2 Pre-transfer gene expression of receptive and non-receptive endometrium at day 14 
of the estrous cycle 
 
In addition to day 7, the pre-transfer gene expression of receptive and non-receptive 
endometrium was investigated at day 14 of the estrus cycle using endometrial samples 
collected at day 14 of the estrous cycle from heifers resulted in calf delivery (CDd14) and 
from those resulted in no pregnancy (NPd14). The results revealed that   including 5 ESTs, 
only 14 genes were differentially expressed between CDd14 and NPd14 (Figure 17). 
 
Figure 17: Pre-transfer transcriptome alteration between receptive (CDd14) and non-
receptive endometrium (NPd14) at day 14 of the estrous cycle. (A): The 
number and fold change distribution of DE genes that were increased in 
CDd14 or NPd14. (B): The heatmap and hierarchical clustering describing the 
expressional pattern of DE genes in CDd14 and NPd14. Labels on the 
horizontal axis of the heatmap, CDd14-1, CDd14-2 and CDd14-3 represent 
independent biological replicates in receptive endometrium groups and 
NPd14-1, NPd14-2 and NPd14-3 represent independent biological replicates 
from non-receptive endometrium groups at day 14 of the estrous cycle. The 
horizontal dendrogram indicates the expression patterns of transcripts in 
CDd14 and NPd14. Red and green colors reflect the high and low expression, 
respectively. 
A B 
Results 
_________________________________________________________________________ 
 
84 
 
From a total of 14 DE genes, 12 genes exhibited 2 to 4 fold change and 2 genes showed 
above 10 fold change difference between CDd14 and NPd14 (Figure 10A). Among these, 
the expression of C20ORF54 and frizzled homolog 8 (FZD8) was higher in CDd14, while 
the expression of LOC786821, bromodomain and WD repeat domain containing 1 
(BRWD1), ankyrin repeat domain 11 (ANKRD11), solute carrier family 25 (SLC25A12), 
gap junction protein alpha 1 (GJA1), scavenger receptor class A member 5 (SCARA5), 
immunoglobulin lambda-like polypeptide (IIGLL1) and other 5 ESTs was higher in 
NPd14. 
Ontological classification the DE genes showed that those genes were found to be involved 
in G-protein coupled receptor protein signaling pathway and Wnt receptor signaling 
pathway (FZD8), in utero embryonic development (BRWD1 and GJA1), transition metal 
ion transport (SCARA5) and transmembrane transport (SLC25A12). However, the number 
of  differentially expressed and the transcriptomic function alteration detected between 
CDd14 and NPd14 was significantly lower compared to the number of differentially 
expressed genes and transcriptomic functional alteration that has been detected between 
CDd7 and NPd7 (Figure 5). This difference indicates that remarkable molecular alteration 
between the receptive and non-receptive endometrium at day 7 of the estrous cycle than 
day 14 of the estrous cycle. This result also indicates the receptive and non-receptive 
endometriums are molecularly distinguishable during day 7 than day 14 of the estrous 
cycle. 
 
4.3 Diestrus transcriptome dynamics of receptive and non-receptive endometrium  
 
4.3.1 Diestrus transcriptome dynamics of receptive endometrium   
 
To identify transcriptome profile changes that has been occurred in the receptive 
endometrium between day 7 and day 14 of the estrous cycle, the gene expression pattern 
was analyzed using CDd7 and CDd14 endometrial samples. The result indicated that from 
17,368 detected transcripts both in CDd7 and CDd14, 1867 genes were differentially 
expressed between the two groups. Of these, the transcript levels of 1014 genes were 
higher in CDd7 and the transcript level of 853 were increased in CDd14 (Figure 11, 
Appendix 4). The genes including, DGKI, EDN3, SVS8, SPC24, PRODH, PDZK1, PLLP, 
CCNB1, LPL and GDPD1 exhibited a higher fold increase (54 to 397 fold) in CDd7, but the 
transcript level of SLC39A2, DEFB1, TINAGL1, C15H11ORF34, LOC286871, IL8, GPLD1, 
LYZ1 and IGFBP1 was found to be higher (45 to 418 fold) in CDd14. Therefore, the data 
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indicates that the expression profile of receptive endometrium changes as the endometrium 
proceeds from day 7 to day 14 of the estrous cycle.  
 
4.3.1.1 Genes clusters identified between day 7 and day 14 of the estrous cycle in receptive 
endometrium 
 
From a total of 1867 differentially expressed genes identified between CDd7 and CDd14, 
several groups of genes were elevated either in CDd7 or in CDd14. The gene clusters 
elevated in CDd7 compared to CDd14 include the solute carriers (SLC10A3, SLC12A2, 
SLC16A1, SLC22A5, SLC25A1, SLC25A11, SLC27A2, SLC29A1, SLC2A1, SLC30A5, 
SLC31A2, SLC35B1 and others), family with sequence similarity (FAM117A, FAM3A, 
FAM55C, FAM62A, FAM81B, FAM84A, FAM92A1), ectonucleotide pyrophosphatase 
(ENPP1, ENPP2, ENPP3, ENPP4, ENTPD5), fbox genes (FBXL20, FBXO2, FBXO31, 
FBXO31, FBXO36), mitochondrial ribosomal protein (MRPL38, MRPS25, MRPS36, 
MRPS36, MRPS6), nudixes (NUDT12, NUDT22, NUDT5, NUDT5), ring finger proteins 
(RNF144B, RNF149, RNF183, RNF185, ubiquitin specific peptidase (USP12, USP2, USP33, 
USP46, USP7), collagens (COL4A1, COL4A3, COL4A4), the adaptor related proteins 
(AP1S1, AP3B1, AP3M1, AP3S2), eukaryotic translation initiation factor (EIF2C2, EIF4G3, 
EIF4G3), inositol triphosphate (ITPKA, ITPR1, ITPR3). Similarly, gene clusters increased 
in CDd14 were the ankryls (ANKRD22, ANKRD50, ANKS6), Rho proteins (ARHGAP17, 
HGAP21, ARHGAP24, ARHGAP26, ARHGDIB), ATpases (ATP11B, ATP13A4, ATP6V0A2, 
ATP6V0A4), CD molecules (CD14, CD36, CD48, CD53, CD59, CD69, CD83), cyline 
dependant kinases (CDK6, CDK7, CDK8, CDKN1A, CDKN2C), interlukins (IL17RC, IL18, 
IL18BP, IL1RN, IL20RA, IL8), Krupple like factors (KLF10, KLF11,KLF15) and 
phosphodiesters (PDE3B, PDE4B, PDE4DIP, PDE6D). 
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Figure 18: Pre-transfer transcriptome dynamics of the receptive endometrium between day 
7 and 14 of the estrous cycle. (A): The number and fold change distribution of 
DE genes between CDd7 and CDd14. (B): The heatmap describing the 
expression pattern of DE genes between CDd7 and CDd14. Labels on the 
horizontal axis of the heatmap, CDd7-1, CDd7-2 and CDd7-3 represent 
independent biological replicates from receptive endometrium groups at day 7 
of the estrous cycle. CDd14-1, CDd14-2 and CDd14-3 represent independent 
biological replicates from receptive endometrium groups at day 14 of the 
estrous. Red and green colors reflect high and low expression, respectively. 
 
4.3.1.2 Transcriptomic functional alteration between day 7 and 14 of the estrous cycle in 
receptive endometrium 
 
The functional contribution of these genes that has been altered between day 7 and 14 of 
the estrous cycle in receptive endometrium was assessed using the gene ontology database. 
Thus, the differentially expressed genes that were higher in CDd7 and CDd14 were found 
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to be involved in different functions (Figure 19). Those abundantly expressed in CDd7 
were found to be involved in various biological processes including, cellular material 
transport (solute carriers, AP1S1, AP3B1, AP3M1, AP3S2, FDX1, FUT8, GDI1, ITPR1, ITPR3, 
KIF21A, KPNA2), metabolic process (PRODH, LPL, GDPD1, BDH1, PFKFB2, PHGDH), 
phosphorylation, post-translational protein modification (USP2,UBL4A, UBE2S, 
UBE2D4, UBE2A, SRPK2). On the other hand, immune responses (STAT5A, IL8, 
LOC512486, IL1RN, C5, NDRG1, CXCL5, TLR5, HCLS1, SCIN, LCK, IL18, apoptotic process 
(CASP4,LCK, MYC), signal transductions (KDR, RAB3B, F2RL2, NMB, PLAT, IFI6, PLEK, 
ITGB5) were among the main biological processes overrepresented in those genes whose 
transcript level was increased in CDd14. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 19: Biological processes overrepresented in DE genes enriched in CDd7 (left) and 
CDd14 (right) as the receptive endometrium proceeds from day 7 to day 14 of 
the estrous cycle.  
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4.3.1.3 Molecular pathway identified in differentially expressed genes between day 7 and 
14 of the estrous cycle in receptive endometrium  
 
Those differentially expressed genes between CDd7 and CDd14 were found to be involved 
in 21 molecular pathways (Table 7). Among these, the MAPK signaling, Toll-like receptor 
signalling, adipocytokine signaling, cell adhesion molecules and extra cellular matrix 
receptor interaction pathways were enriched by those genes whose expression levels was 
higher in CDd14. On the other hand, PPAR signaling pathway, calcium-signaling pathway, 
neuroactive ligand-receptor interaction, GnRH signaling pathway, glycine, serine and 
threonine metabolism were enriched by those genes whose transcript level was increased 
in CDd7.  Among those, the graphical representation of GnRH signaling pathway and the 
number DE genes involved in this pathway is described in figure 20. 
 
Figure 20: The DE genes between CDd7 and CDd14 are found to be involved in 
Gonadotropin-releasing hormone (GnRH) signaling events. The DE genes 
(MMP2), G/q11 (GNAI1), PLCB, IP3R (ITPR1, ITPR3), CAMK (CAMK2D), 
P38MAPK (MAPK13, MAPK12) are located in the critical streams of the path 
indicating the change in the activity of the GnRH pathway as the endometrium 
proceeds from day 7 to 14 of the estrous cycle. Genes elevated in CDd7 are 
marked by red background and those elevated in CDd14 are marked with blue 
background.  
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 Table 7: List of molecular pathways containing DE genes enriched in CDd7 and/or CDd14  
 
Pathway list 
 
Differentially expressed genes 
 
MAPK signaling pathway 
 
FLNA, MAPK12, ,NGF, RPS6KA5,CD14, ARRB1, FOS, PRKACB, PDGFB, PTPRR, MYC, NFKB1, 
MAPK13, IKBKB, MAP3K8, TGFBR2 
Toll-like receptor signalling  NFKBIA, IKBKE, MAPK12, IL8, CD14, IRF5, FOS, TLR5, NFKB1,MAPK13, IKBKB, TLR2, MAP3K8 
Glycan structures- biosynthesis 1 B3GNT2, FUT8, ALG11, ALG8, B4GALT4, CSGALNACT2, MGAT4A CHST1, C1GALT1, HS6ST1 
Adipocytokine signaling pathway ADIPOR2, PPARGC1A, NFKBIA, PPARA, ACSL5, IKBKB, NFKBIE, NFKB1, PRKAA2, CD36, SLC2A1 
Insulin signaling pathway PPARGC1A, PRKAR2B, ARAF, PPP1CB, PFKM, IKBKB, PRKACB, PRKAA2, SOCS2 
Calcium signaling pathway ITPR1, F2R, HRH1, SLC25A5, ITPR3, ADORA2B. CAMK2D, PRKACB,  ADRB2 
Regulation of actin cytoskeleton ITGA2, F2R, ARAF, LIMK2, WASF2, ARHGEF6, PDGFB, SCIN, CD14, ITGB5 
Cell adhesion molecules (CAMs) VCAM1, JAM2, CLDN1, SDC1, BOLA-DMB, PVR, DCD1LG2, SDC2 
Gap junction ITPR1, CDC2, ITPR3, GUCY1A3, TUBB6, GNAI1, PDGFB, PRKACB 
Neuroactive ligand-receptor interaction PTGER4, F2RL1, F2R, HRH1, ADORA2B, PTGER2, ADRB2, F2RL2 
GnRH signaling pathway ITPR1, MAPK12, MMP2, ITPR3, CAMK2D, MAPK13,PRKACB 
Tryptophan metabolism ALDH3A2, HSD17B10, HSD17B4, WARS, WARS2, CYP1A1 
PPAR signaling pathway LPL, SLC27A6, PLTP, FABP5, PPARA, ACSL5, CD36,  SLC27A2 
Focal adhesion ITGA2, VEGFB, FLNA, PPP1CB, PDGFB, ITGB5, MET, KDR 
Jak-STAT signaling pathway IL6ST, IL20RA, STAT5A,  SPRY2, MYC, PIM1, SOCS2 
Glycan structures - biosynthesis 2 B4GALT4, FUT1, B3GNT2, UGCG, 3GALT2, ST3GAL6 
Arginine and proline metabolism PRODH, ARG2, CKB, ASL, GLUD1, GATM, ASS1 
ECM-receptor interaction ITGA2, HMMR, SDC1, AGRN, SDC2, CD36, ITGB5 
Cytokine-cytokine receptor interaction IL6ST, TGFBR2, IL20RA, IL18, MET, KDR, IL8 
Glycine, serine and threonine metabolism PHGDH, PSAT1, PEMT, CBS, GATM, PSPH 
Urea cycle and metabolism of amino acid ARG2, ALDH3A2, SMS, ASL, GATM, ASS1 
        DE genes enriched in CDd7 are indicated in bold face and genes enriched in CDd14 are indicated in light face
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4.3.2 Diestrus transcriptome dynamics of non-receptive endometrium  
 
The transcriptome dynamics of non-receptive endometrium between day 7 and 14 of the 
estrous cycle was investigated by comparing the gene expression of endometrial samples 
collected at day 7 (NPd7) and day 14 of the estrous cycle (NPd14) from heifers resulted in 
no pregnancy. The result revealed that from 17,361 detected transcripts both in NPd7 and 
NPd14, 254 genes were differentially expressed between the two groups (Figure 21). 
Compared to the transcriptome dynamics of receptive endometrium (CDd7 vs. CDd14) 
presented in figure 18, the number of differentially expressed genes detected between 
NPd7 and NPd14 was lower by 1613 genes revealing the transcriptome plasticity of the 
receptive endometrium during the diestrus phase of the estrous cycle. The most top 
elevated genes in NPd7  compared to NPd14 includes, DGKI,  SVS8, SPC24, SPOP, 
COL6A1, TXNDC6,  NTRK2,  APOD and some of top genes  down regulated in NPd7, but 
increased in NPd14 include (PLEK,  FMNL3, TLN2, CCL11, NPNT, SPP1, BNBD4, SDS, IL8, 
SLC39A2). The description of 100 top differentially expressed genes is described in 
appendix 5. 
 
4.3.2.1 Transcriptomic functional alteration between day 7 and 14 of the estrous cycle in 
non-receptive endometrium 
 
The differentially expressed genes between NPd7 and NPd14 were found to be involved in 
different biological and molecular functions. For instance, those which showed an increase 
expression level in NPD7 compared to NPd14 were found to be involved in several 
biological process including ion transport (CHRNE, KCNMA1, COL1A1, COL1A2, COL3A1, 
COL6A1), cell cycle process (CDK5, SPC24, MLF1, Sep-04), nervous system development 
(DPYSL2, CDK5, SERPINF1), phosphorelation (CDK5, PRKAR2B, MYLK, RPS6KA5, 
MAPK10), transferase activity (NTRK2, DGKI, TXNDC6, RPS6KA5, MAPK10, MYLK, 
CDK5). On the other hand, immune system (TLR2, IL8, IL1RN, GBP5), cytokine activity 
(SPP1, IL1RN, IL8), transcriptional regulator (FOS. ELF1, BHLHB2, ATF3), pyrophosphate 
activity (MX1, TUBB2A, GBP5, CFT, RNF213) were among the biological or molecular 
functions overrepresented in genes elevated in NPd14. 
The KEGG pathway analysis also indicated only three pathways to be significantly 
affected by those genes. The DE genes that were increased in NPd7 compared to NPd14 
were found to be involved in focal adhesion (COL1A2, MYLK, MAPK10 and COL1A1), 
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B A 
MAPK signaling pathway (NTRK2, MAPK10 and RPS6KA5) and cell communication 
pathway (COL1A2 and COL1A1). On the other hand, those genes that increased in NPd14 
were found to involve in toll-like receptor signaling pathway (FOS, TLR2, SPP1 and IL8). 
 
Figure 21: Pre-transfer transcriptome dynamics in non-receptive endometrium between 
day 7 and 14 of the estrous cycle. (A): The number and fold change 
distribution of DE genes identified between NPd7 and NPd14. (B): The 
heatmap describing the expression pattern of DE genes between NPd7 and 
NPd14. Labels on the horizontal axis of the heatmap, NPd7-1, NPd7-2 and 
NPd7-3 represent independent biological replicates from non-receptive 
endometrium groups at day 7 of the estrous cycle. NPd14-1, NPd14-2 and 
NPd14-3 represent independent biological replicates in non-receptive 
endometrium groups at day 14 of the estrous. Red and green colors reflect 
high and low expression, respectively. 
 
4.3.3 Endometrial genes elevated at day 7 or day 14 of the estrous cycle irrespective of 
endometrial receptivity 
 
After investigating the transcriptome dynamics of receptive and non-receptive 
endometrium between day 7 and 14 of the estrous cycle, the common genes that were 
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elevated at day 7 or 14 of the estrous cycle in both endometrial statuses were identified. 
The result revealed that 121 genes were differentially expressed both in CDd7 vs. CDd14 
and NPd7 vs. NPd14. Among those, 86 genes elevated at day 14 and 35 genes were 
elevated at day 7 of the estrous (Figure 22). This result shows that the expression pattern of 
121 genes between day 7 and 14 of the estrous cycle is independent of the endometrial 
receptivity. Those genes that were elevated at day 7 were found to be involved in 
regulation of transferase activity, protein kinase activity, phosphorylation, protein 
metabolic process and phosphate metabolic process. However, those increased in day 14 of 
the estrous cycle were found to be involved mainly in immune response, cytoskeleton 
organization and biological adhesion. 
 
 
 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 22: Genes elevated at day 7 or 14 of the estrous cycle both in receptive and non 
receptive endometrium. 
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4.4 Expression profile of selected candidate genes across the estrous cycle and early 
gestation period 
 
Following detection of differentially expressed genes between the receptive (CDd7) and 
non-receptive (NPd7) endometrium, the genes involved in signal transduction (PTGER4, 
AGTR1, ITPR1, ADORA2B and WNT11), metalloendopeptidase activity (MMP2 and 
TIMP3), transcriptional factor activity (IRF6 and STAT5A), cell cycle (CDC20) and 
prostaglandin-endoperoxide synthase activity (PTGS2/COX-2) were analyzed in the 
endometrial samples collected from heifers slaughtered at different days of the estrous 
cycle and at day 50 of gestation period. The expression profile of those genes across the 
estrous cycle revealed that, the transcript level of IRF6, STAT5A, PTGER4, AGTR1, 
ITPR1, ADORA2B, WNT11, MMP2 and TIMP3 was found to be higher (p < 0.05) at day 7 
and 14, but was lower (p < 0.05) at day 19 and 0 of the estrous cycle (Figure 23). Unlike 
other candidate genes, the expression pattern of PTGS2/COX-2 exhibited a dramatic 
increased (p < 0.05) from day 19 to day 0 followed by a decrease at day 3 and  after wards 
it reached peak at day 7 and 14 of the estrous cycle ( Figure 23). On the other hand the 
expression of CDC-20 was higher (p < 0.05) a day 3 of the estrous cycle. When the 
expression profile was extended until day 50 gestation period, the IRF6, ITPR1, STAT5A 
and AGTR1 exhibited an increase trend from proestrus to diestrus and reached peak in 
pregnant endometrium, but the expression of PTGER4, PTGS2/COX-2, TIMP3 and 
ADORAB2B was reduced in pregnant endometrium compared to the expression detected 
at day 7 and 14 of the estrous cycle of cyclic heifers (Figure 23). This shows that those 
genes exhibited higher or lower expression level during the estrous cycle can be further 
enhanced or reduced following embryo implantation. 
The spatio-temporal expression of those candidate genes at different region of the 
endometrium also revealed lower expression (p < 0.05) in the corpus region compared to 
other endometrial region during the estrous cycle (Appendix 6). In addition, the majority 
of the candidate genes showed no significant difference between the ispislateral and contra 
lateral position of the endometrium at each day of the estrous cycle and early pregnancy 
(Appendix 6). 
 
 
 
 
Results 
_________________________________________________________________________ 
 
94 
 
 
Figure 23: The expression pattern of selected candidate genes across the estrous cycle and 
at day 50 gestation period (P). The vertical axis indicates the relative mRNA 
expression level of candidate genes normalized to the mRNA level of 
GAPDH. Bars show mean ± s.e.m. Bars with different letters are statistically 
significant (p < 0.05). 
4.5 Protein expression of selected candidate genes 
 
Parallel to the mRNA quantification, the immunohistochemical localization of IRF6, 
ITPR1, PTGS2, MMP2 and TIMP3 was performed in the tissue sections taken at the 
ipsilateral middle part of the uterus. The result revealed the presence of spatio-temporal 
differences in protein signal intensities of those gens during the estrous cycle and early 
pregnancy (Figure 24). For instance strong intensity of ITPR1 protein was detected in day 
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3, 7, 14 and pregnant endometrium. The PTGS2 protein revealed strong signals in luminal 
epithelium (LE) and glandular epithelium (GE) at day 0 and 3. However, it was lower in 
LE and higher in GE at day 7, 14 and pregnant endometrium. Similarly, stronger signal 
MMP2 protein signal was detected in GE at day 0, 14 and pregnant endometrium. 
However, at day 7 and 19 the MMP2 protein was stronger in LE and stroma cells of the 
endometrium suggesting variation in expression in different layers of the endometrium. 
Lower protein signals of TIMP3 were detected at day 0 and pregnant endometrium. 
Moreover, except at day 0 and pregnant endometrium, strong signal was detected in LE, 
GE and stroma cells of the endometrium (Figure 24). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 24: Immunohistochemical localization of selected candidate genes across the 
estrous cycle and day 50 gestation period (P). The green and red colors 
indicate the protein signal and the blue colors describe nuclear staining, 
respectively. NC = Negative control, sGE = Superficial glandular epithelium, 
GE = Glandular epithelium, LE = Luminal epithelium, S = stroma cells, D = 
day. 
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4.6 Progestrone level and mRNA expression of differentially expressed genes  
 
Serum progesterone was assessed at each day of the estrous cycle to evaluate whether the 
expression of those differentially expressed genes were influenced by the level of 
progesterone. Following this, a correlation analysis was performed between the 
progesterone level and the mRNA expression of selected candidate genes (Table, 9). 
Among those, the STAT5A mRNA expression exhibited a significant positive correlation 
with progestrone level. However, STAT5A was down regulated in receptive endometrium 
and conversely upregulated in non-receptive endometrium. Other genes including IRF6, 
PTGER4 and ITPR1 showed a higher correlation coefficient but the correlation was not 
reached to 5% significant level (Table 8).  
 
Table 8: Correlation between progestrone level and mRNA expression of DE genes during 
the estrus cycle 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gene Correlation 
coefficient (r) 
p value 
 
IRF6 
 
0.85 
 
0.06 
STAT5A 0.98 0.002 
AGTR1 0.58 0.29 
PTGR4 0.86 0.06 
ITPR1 0.86 0.06 
ADORA2B 0.79 0.11 
WNT11 0.73 0.15 
COX-2 0.01 0.98 
MMP2 0.72 0.17 
TIMP3 0.67 0.20 
CD20 0.48 0.40 
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4.7 Gene expression difference between embryo biopsies that resulted in calf delivery and 
no pregnancy  
 
In addition to endometrial gene expression, the transcriptome abundance difference 
between embryo biopsies that resulted in calf delivery or no pregnancy was determined 
using embryo biopsies that were retained prior to embryo transfer. For this, the 
transcriptional differences of embryo biopsies resulted in calf delivery were compared with 
those embryos biopsies resulted in no pregnancy using preimplantation embryo specific 
cDNA array in a series of six hybridization experiments (three biological replicates with 
dyeswap).  The microarray data analysis using LIMMA revealed that including 9 ESTs, a 
total of 70 genes were differentially expressed between the two embryo groups. The 
average linkage clustering analysis (Figure 25) reveals that there were many subgroups 
within the up or down regulated gene (or clusters) sharing similar expression patterns. 
Such co-expressed genes may possibly sharing common biological function. Furthermore, 
the expression of each gene in each biological replication remains uniform indicating the 
reproducibility of the data (Figure 25). 
The magnitude of differentially expressed (DE) genes showed that 20% of the of them 
exhibited two or more fold change difference and 80 % showed 1.5-2 fold change 
difference between the two embryo groups. Furthermore, the transcript level of 32 genes 
including SPAG17 (PF6), UBE2D3P, DFNB31, AMD1, DTNBP1NUP35, GDE1 (MIR16), 
ARL6IP, NUDT2, FAM161A, LGMN,LEO1, CCL16AP2B1, PTDSS1 and  HSPA8 was 
abundant in those embryos resulted in calf delivery (Figure 25). On the other hand, the 
transcript level of 38 genes including SGK1, GBF1, FADS1, KRT8, RIF1, GART, DTX2, 
WDR26, RNF34, KPNA4, ARL8B, RYBP and WDR13 was higher in embryos resulted in no 
pregnancy. This differences indicated that the embryos that resulted in calf delivery are 
molecularly distinguishable from those resulted in no pregnancy. 
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Figure 25: Hierarchical clustering of differentially expressed genes between embryo biopsies that resulted in calf delivery and no pregnancy. 
Embryo biopsies resulted in calf delivery were clustered in one group (left), while the embryo resulted in no pregnancy were 
clustered in the second group (left). A, B and C on the top of the heatmaps represent three biological replicates during hybridization 
and D, E and F describe the dyeswap hybridization for A, B and C replicates. Positive and negative numbers indicate genes increased 
in embryo biopsies resulted in calf delivery and no pregnancy groups, respectively. FC = Fold change, ACC. No = Gene bank 
accession numbers. 
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4.7.1 Functional classification of differentially expressed genes between embryo biopsies 
resulted in calf delivery and no pregnancy  
 
The functions and relevance of the differentially expressed genes between the two 
embryo groups were assessed using the public databases, the gene ontology 
http://www.geneontology.org/ and DAVID functional annotation bioinformatics 
microarray analysis (http://david.abcc.ncifcrf.gov/). Thus, only 45 genes have known 
ontological function. Those gene were found to be  involved in different biological and 
molecular functions (Table 9) including, protein binding, transferase activity, 
chemokine activity and cell to cell signalling, signal transduction, physiological 
response to stimulus, protein/mRNA transport, regulation of transcription, 
adenosylmethionine decarboxylase activity and apoptosis. Moreover, 17 DE genes 
were mapped to the known KEGG pathways (Figure 26). 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
Figure 26: List of molecular signaling and metabolic pathways involved by DE genes 
between embryo biopsies resulted in calf delivery and no pregnancy. Red 
and green arrows indicated genes enriched and reduced, respectively in 
embryo biopsies resulted in calf delivery compared to embryo resulted in no 
pregnancy. 
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 Table 9: Molecular function and biological process of DE genes between embryo biopsies resulted in calf delivery and no pregnancy 
 
Acc. No Gene symbol 
 
Gene bank name 
 
Molecular function Biological process 
XM_615649 SPAG17 Sperm associated antigen 17 Protein binding - 
AL138895 DFNB31 Deafness, autosomal recessive 31 Protein binding Response to stimulus 
NM_173990 AMD1 S-adenosylmethionine decarboxylase 1 Adenosylmethionine decarboxylase activity Spermidine biosynthetic process 
BC113232 DTNBP1 Dystrobrevin binding protein 1 Identical protein binding Response to stimulus 
XM_588545 NUP35 Nucleoporin 35 - mRNA and protein transport 
BC102273 GDE1 Glycerophosphodiester phosphodiesterase 1  Glycerophosphodiester  Glycerol metabolic process 
NM_015161 ARL6IP  Adp-ribosylation factor-like 6 interacting protein 
Protein binding 
 
Co-translational protein 
targeting to membrane 
BC114149 NUDT2 Nucleoside diphosphate linked moiety X GTP binding 
 
Induction of apoptosis 
BC111117 LGMN Legumain Protein serine/threonine kinase 
activity  Proteolysis 
XM_865076 LEO1 Leo1, paf1/RNA polymerase II complex 
component, homolog  Protein binding Regulation of transcription 
XM_868834 CCL16 Chemokine (C-C motif) ligand 16 Chemokine activity,  cell-cell 
signaling 
Immune response 
inflammatory response 
NM_005402 RALA Ras-related protein GTP binding,  signal transduction  Chemotaxis 
BC105196 FABP5 Fatty acid binding protein 5 Fatty acid binding,  protein binding,  transporter activity 
Lipid metabolic process 
 transport 
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Acc. No Gene symbol Gene bank name Molecular function Biological process 
XM_866869 AP2B1 Adaptor-related protein complex 2, beta 1 
subunit  protein transporter activity - 
XM_586866 PTDSS1 Phosphatidylserine synthase 1 Transferase activity - 
BC102150 MS4A8B Membrane-spanning 4-domains, 
subfamily a, member 8B Receptor activity - 
BC105182 HSPA8 Heat shock 70kd protein 8 ATP and protein binding  Protein folding 
NM_015190 DNAJC9 DNAJ (HSP40) homolog, subfamily c, 
member 9 Heat shock protein binding - 
XM_876108 RBMX RNA binding motif protein, X-linked RNA and protein binding,  RNA splicing Nuclear mRNA splicing 
XM_861603 ZNF638 Zinc finger protein 638 DNA binding RNA splicing 
BC102286 GNB2L1 Guanine nucleotide binding protein (G- protein), beta polypeptide 2-like 1 Receptor binding - 
NM_004853 STX8 Syntaxin 8 - Transport 
BC103298 CCT2 Chaperonin containing tcp1, subunit 2  ATP and  unfolded protein binding Protein folding 
NM_001013599 TAGLN2 Transgelin 2 Protein binding - 
NM_175800 NDUFS4 NADH dehydrogenase (ubiquinone) fe-s protein 
NADH dehydrogenase  
activity Electron transport 
NM_001040520 RPL7A Ribosomal protein l7A RNA binidng  Ribosome biogenesis translational elongation 
XM_859286 HNRNPA2B1 Heterogeneous nuclear ribonucleoprotein A2/B1 RNA splicing factor activity  RNA splicing and transport 
AY610165 SFRS10  Splicing factor, arginine/serine-rich 10 RNA splicing factor activity  RNA splicing 
AF239741 SYT1 Synaptotagmin 1 Calcium and calmodulin binding Synaptic transmission 
Table 9: Cont. 
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Acc. No Gene symbol Gene bank name Molecular function  Biological process 
BC114026 KIF20A Kinesin family member 20A ATP and nucleotide  binding  Protein transport 
NM_001035385 OLFML1 Olfactomedin-like 1  Regulation of cell  proliferation 
XM_537731 ZNF207 Zinc finger protein 207 Transcription factor activity Transcription regulation   
BC050407 ZNF83 Zinc finger protein 83 Transcription factor activity  Transcription regulation  
XM_864644 SGK1 Serum/glucocorticoid regulated kinase1 Protein serine/threonine kinase 
activity,  transferase activity 
Apoptosis 
sodium ion transport 
XM_612534 GBF1 Golgi brefeldin a resistant guanine 
nucleotide exchange factor 1 
ARF guanyl-nucleotide 
exchange factor activity  
Regulation of ARF protein 
signal transduction 
AL512760 FADS1 Fatty acid desaturase 1 Oxireductase activity Cell to cell signaling 
BC103339 KRT8 Keratin 8 Protein binding Apoptosis 
XM_615269 RIF1 Rap1 interacting factor 1 homolog Binding Cell cycle 
NM_001040473 GART Phosphoribosylglycinamide formyltransferase Transferase activity Biosynthetic process 
BT021146 DTX2 Deltex homolog 2 Metal and protein ion binding Notch signaling pathway 
BC109897 WDR26 Wd repeat domain 26 - Cell signal transduction 
BT020924 RNF34 Ring finger protein 34 Ligase activity, protein  and  
metal ion binding Apoptosis 
XM_856615 KPNA4 Karyopherin alpha 4 Protein transporter activity  intracellular protein transport 
NM_018184 ARL8B Adp-ribosylation factor-like 8B Nucleotide binding 
 
Small GTPase mediated signal 
transduction 
AB029551 RYBP RING1 and YY1 binding protein Apoptosis 
 
Regulation of transcription 
Table 9: Cont. 
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4.8 Validation of microarray data using real time quantitative PCR (qPCR) 
 
4.8.1 Validation of differentially expressed genes between receptive and non receptive 
endometrium at day 7 of the estrous cycle 
 
A total of 36 DE genes between CDd7 and NPd7 were randomly selected. Hence, the 
qPCR data revealed that 32 out of 36 DE genes (89%) to be according to the microarray 
results (Table 10, Appendix 7). However, CAMK2D exhibited a reverse trend and NGF 
and MYLK were not different between the two groups.  
 
 Table 10: Validation of DE genes between receptive (CDd7) and non-receptive (NPd7) 
endometrium at day 7 of the estrous cycle using qPCR 
Microarray results qPCR results 
Gene name ACC. No 
FC  p value FC p value 
 
ADORA2B 
 
NM_001075925 
 
2.17 
 
0.007 
 
18.81 
 
0.03 
AGTR1 NM_174233 -4.0 0.004 -18.4 0.05 
ALG8 NM_001076125 2.55 0.002 9.34 0.03 
CNB2 NM_174264 4.88 0.02 6.94 0.02 
CDC2 NM_174016 7.42 0.0017 23.84 0.01 
COL1A2 NM_174520 9.18 0.001 5.24 0.09 
FUT8 NM_177501 2.15 0.03 5.85 0.006 
MAPK12 NM_001098953 2.97 0.03 11.17 0.04 
PLCB1 NM_174817 3.24 0.017 8.61 0.05 
PTGER4 NM_174589 2.72 0.01 4.94 0.05 
WNT11 NM_001082456 5.99 0.04 176 0.02 
IL18 NM_174091 -2.49 0.002 -2.95 0.12 
TIMP3 NM_174473 5.32 0.015 5.3 0.03 
MMP2 NM_174745 -2.58 0.014 -7.1 0.12 
ITPR1 NM_174841 5.35 0.01 3.12 0.05 
IRF6 NM_001076934 3.39 0.04 80 0.03 
FC= Fold change,   p value ≤ 0.05 considered as significant, positive and negative values 
indicate genes elevated in CDd7 and NPd7, respectively. 
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4.8.2 Validation of differentially expressed genes between day 7 and 14 of the estrous 
cycle in receptive endometrium  
 
A total of 28 DE genes between day 7 (CDd7) and day 14 (CDd14) in receptive 
endometrium were selected. These genes were also differentially expressed between CDd7 
and NPd7. The qPCR data revealed 24 genes from 28 genes (85%) followed a similar 
trend to microarray results, but four genes, namely IL18, S100A13, TLR6 and PLK4 
showed no fold change difference between the two groups (Table 11). 
Table 11: Validation of DE genes between CDd7 and CDd14 in receptive endometrium 
using qPCR 
  Microarray results qPCR results 
Gene symbol ACC. No  FC p value FC p value 
 
S100B 
 
NM_001034555 
 
3.14 
 
0.009 
 
14.5 
 
0.05 
MMP2 NM_174745 2.82 0.009 43.9 0.09 
PTGS2 NM_174445 14.13 0.01 3.2 0.06 
WNT11 NM_001082456 14.5 0.007 93.0 0.007 
IFR6 NM_001076934 3.53 0.035 31.2 0.03 
TIMP3 NM_174473 15.0 0.009 6.72 0.02 
PTGER4 NM_174589 6.0 0.0003 4.0 0.05 
CDC20 NM_001082436 16.0 0.005 130.0 0.01 
ADORA2B NM_001075925 2.2 0.007 12.78 0.07 
ALG8 NM_001076125 2.7 0.001 44.0 0.03 
CDC2 NM_174016 2.88 0.007 38.3 0.04 
FUT8 NM_177501 2.0 0.04 21.67 0.09 
ITPR1 NM_174841 16.0 0.009 23.0 0.07 
STAT5A NM_001012673 -2.59 0.02 -2.48 0.07 
IL18 NM_174091 -2.45 0.0003 1.09 0.96 
S100A3 NM_205800 -2.16 0.23 -1.16 0.84 
TLR6 NM_001001159 -2.3 0.023 -1.15 0.94 
FC= Fold change, p value ≤ 0.05 considered as significant, positive and negative 
values indicate genes elevated in CDd7 and CDd14, respectively  
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4.8.3 Validation of differentially expressed genes between embryo biopsies resulted in calf 
delivery and no pregnancy 
 
Eight differentially expressed genes between the embryo biopsies resulted in calf delivery 
and no pregnancy, namely AMD1, HSPA8, STX8, SGK1, DTX2, RNF34, ARL8B and  
UBE3D2P were validated using qPCR and the results indicated that the microarray result 
and the qPCR was fitting to each other (Table 12). 
  
Table 12: Validation of DE genes between embryo biopsies resulted in calf delivery and 
no pregnancy using qPCR 
 
  Microarray results qPCR results 
Gene symbol ACC. No FC p value FC 
 
 p value 
 
 
AMD1 
 
NM_173990 
 
2.35 
 
0.03 
 
3.22 
 
0.02 
HSPA8 BC105182 1.65 0.03 2.93 0.2 
STX8 NM_004853 -1.5 0.02 -57.8 0.02 
SGK1 XM_864644 -1.7 0.04 -2.59 0.05 
DTX2 BT021146 -1.9 0.05 -1501 < 0.0001 
RNF34 BT020924 -2.0 0.002 -55.1 0.02 
ARL8B NM_018184 -2.5 0.028 -7.61 0.25 
UBE3D2P XM_614356 2.6 0.01 83.7 0.4 
           FC= Fold change, p value ≤ 0.05 was considered as significantly different. Positive and 
negative values indicate genes enriched in embryos resulted in calf delivery and embryos 
resulted in no pregnancy, respectively. 
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5 Discussion 
 
5 .1 Transcriptome difference between receptive and non-receptive bovine endometrium 
 
Although embryo transfer has been widely used to utilize genetically superior cows and 
circumvent infertility, several recipients end up with no pregnancy after embryo transfer. 
This pregnancy failure has been exerting a challenge on selecting and maintaining suitable 
recipients for embryo transfer. Successful pregnancy is the result of coordinated and 
synchronized crosstalk between the blastocyst and the endometrium in a temporal and cell 
specific manner (Bowen and Burghardt 2000, Simon et al. 2000, Spell et al. 2001). The 
dynamic interaction between the embryo and endometrium can be stimulated provided 
both the endometrium and embryos are enriched with key molecular mediators and 
signaling pathways at the time of arrival of the embryo into the uterus. Thus, 
understanding the molecular changes that occur in endometrium and embryo during the 
time of embryo transfer is fundamental to understand the molecular mechanisms related 
establishment of pregnancy. Therefore, in the present study a direct connection was 
established between the bovine pre-transfer endometrial and embryonic gene expression 
and the pregnancy outcome to identifying maternal and embryonic genes that could 
presumably associated with pregnancy success. For this, the pre-transfer endometrial 
samples collected at day 7 and 14 of the estrous cycle were used to investigate the 
endometrial genes associated with pregnancy establishment and the transcriptome of the 
embryo biopsies retained from transferred embryos were analyzed to identify embryonic 
genes associated with pregnancy establishment. 
The gene expression from pre-transfer endometrial samples evidenced noticeable 
endometrial gene expression differences between heifers that resulted in calf delivery 
(receptive endometrium) and those resulted in no pregnancy (non-receptive endometrium) 
at day 7 of the estrous cycle. Detailed bioinformatics and literature mining approach was 
applied to characterize those differentially expressed genes with respect to bovine 
endometrial receptivity and embryo implantation. Thus, KEGG pathway analysis, 
biological processes and molecular functions analysis of gene ontology and molecular 
network analysis using IPA evidenced the presence of transcriptomic functional alteration 
between receptive and non-receptive endometrium at day 7 of the estrous cycle (Figures 9, 
10, 11, 12, 13, Table 6, Appendix 3). However, the two groups of the endometrium tended 
to exhibit minimum transcriptome expression profile and transcriptomic functional 
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alteration at day 14 of the estrous cycle (Figure 17). Here the fundamental question to be 
raised is what contributes for higher transcriptome profile and transcriptomic function 
alteration in receptive and non receptive endometrium at day 7 than day 14 of the estrous 
cycle. Although further experimentation is necessary to answer this question, the higher 
gene expression differences between receptive and non-receptive endometrium at day 7 
than day 14 of the estrous cycle may be attributed to the degree of endometrial response to 
the circulating progesterone. The progressively increasing level of progestrone may induce 
the expression of two sets of genes in receptive endometrium. One set to be those genes 
triggered in the expectation of embryo and the second groups to be those associated with 
induction of follicular waves. Therefore, unlike the non-receptive endometrium, at day 7 of 
the estrous cycle, the receptive endometrium may be enriched with several molecules that 
are associated with the establishment of pregnancy. However, from day 14 onwards, the 
progesterone that regulates the uterine environment loses its ability to block formation of 
oxytocin (Senger 2003). The endometrial PGF2α then starts to increase on day 14 and 
reaches its peak from day 15 to day 17 of the estrous cycle consequently resulting in 
luteolysis of corpus luteum (Shemesh and Hansel 1975). Therefore, those groups of genes 
induced or reduced in receptive endometrium in the expectation of the incoming embryo 
during day 7 of the estrous may gradually decline during day 14 of the estrous cycle. This 
may consequently result in little or no gene expression differences between receptive and 
non-receptive endometrium at day 14 of the estrous cycle. Thus, this result may suggest 
that the receptive and non-receptive endometrium can be molecularly distinguishable at 
day 7 than day 14 of the estrous cycle. Therefore, the discussion part of this finding mainly 
focuses on transcriptional difference between the receptive and non-receptive 
endometrium that has been occurred at day 7 of the estrous cycle where 1126 genes and 
uncharacterized expresses sequences tags were exhibited difference in transcriptome 
abundances between the two statuses of the endometrium. Therefore, in the following 
section, the biological relevance of differentially expressed gene clusters in relation to 
endometrial receptivity and embryo implantation is presented.  
 
5.1.1 Differentially expressed gene clusters between receptive and non-receptive    
endometrium at day 7 of the estrous cycle  
 
Once the embryo reaches the uterus for implantation, the molecular dialogue between the 
implanting conceptus and the endometrium is mediated by several molecules of 
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endometrial and/or embryo origin (Dey et al. 2004, Paria et al. 2002, Tabibzadeh and 
Babaknia 1995, Wang and Dey 2006, Wolf et al. 2003). Identifying those molecules in 
endometrium and embryo prior to embryo transfer may help to select receptive 
endometrium and embryos with higher implantation potential. In line to this, in the present 
study 1126 genes consisting of several gene clusters were differentially expressed between 
the receptive and non-receptive endometrium at day 7 of the estrous cycle (Figures 5, 6, 7 
and 8, Appendix 2). This may suggest that the occurrence of different molecular events in 
the endometrium whose expression is either induced or turned off in the expectation of 
blastocysts arrival into the uterus. 
 
5.1.1.1 The solute carriers and transmembrane proteins 
 
In the current study, 18 solute carrier (SLC) genes (SLC10A3, SLC16A13, SLC1A1, 
SLC25A11, SLC25A13, SLC25A22, SLC25A29, SLC25A40, SLC25A5, SLC35B1, SLC38A7, 
SLC39A8, SLC39A9, SLC4A8, SLC5A6, SLC6A20 ,SLC6A8, SLC7A5 and SLCO3A1) were 
among  several gene clusters that has been increased in receptive endometrium (CPd7) 
compared to non-receptive endometrium (NPd7) (Figure 7). Among those, SLC1A1 was 
found to be higher in pregnant compared to non-pregnant heifers (Bauersachs et al. 2006). 
Moreover, SLC1A1 and SLC6A8 were reported to be up regulated in receptive human 
endometrium (Riesewijk et al. 2003) and during window human implantation (Kao et al. 
2002), respectively.  
The gene ontological classification showed that the solute carriers (SLC) are involved in 
transport of cellular materials across the cell membrane (Fig 13A). Furthermore, the SLC 
genes are generally believed to be involved in transport of cellular materials across the cell 
membrane (Ishida and Kawakita 2004, Kanai and Hediger 2004, McKie and Barlow 2004, 
Palmieri 2004). This result may suggest the increased solute and protein transportation 
across the cell membrane of the receptive endometrium compared to non-receptive 
endometrium. In addition, other gene cluster with similar function to SLC, including 
transmembrane proteins (TMEM141, TMEM144, TMEM163, TMEM16K, TMEM171 
and TMEM79) and the voltage- dependant anion channel 1 (VDAC1) were enriched in 
receptive endometrium. The report of (Abu-Hamad et al. 2006, Abu-Hamad et al. 2009) 
also indicated that cells with low levels of VDAC1 were found to exhibit reduced ATP-
synthesis capacity and limited metabolite exchange between mitochondria and cytosol. 
This in turn suggests increased level of solute carriers or transmembrane proteins or 
gatekeepers genes are required to efficient removal or entrance of molecule from the cell. 
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Therefore, the enrichment of solute carrier genes, transmembrane and other mitochondrial 
gatekeeper genes in receptive compared to the non-receptive endometrium at day 7 of the 
estrous cycle may suggest the presence of effective metabolite exchange between 
mitochondria and cytoplasm in receptive endometrium. 
  
5.1.1.2   Cargo protein sorters, transporter and neuro transmitter gene clusters 
 
In addition to the SLC, transmembrane gene clusters, the transcript level of adaptor related 
protein and their subunits (AP1-S1, AP3-B1, AP3-M1 and AP3-S2) were increased in the 
receptive compared to the non-receptive endometrium (Figure 7). Among the four adapter 
related proteins (AP1, AP3, AP2 and AP4) known in mammalian cells (Boehm and 
Bonifacino 2001, Boehm and Bonifacino 2002), the current study identified the first two to 
be higher in receptive compared to non-receptive bovine endometrium at day 7 of the 
estrous cycle. Although their function contribution is not yet known in bovine endometrial 
receptivity, ontological classification indicated that adaptor related protein and their 
subunits were found to be involved in protein localization (transport) and cellular 
localization (Figure 10B and C) and also they are central foucs genes in genetic disorder, 
lymphoid tissue and development molecular network (Figure 16). Similarly, other authors 
(Boehm and Bonifacino 2001, Newell-Litwa et al. 2007) indicated that adaptor related 
proteins are required for protein cargo sorting, trafficking of integral membrane proteins 
and neurotransmission. For instance, adapter related protein 1 (AP1) is reported to be 
involved in the organization and transport of proteins within the cell (Montpetit et al. 
2008). In addition, the AP-1 is associated with the trans-Golgi network for transport 
proteins to the endosomal/lysosomal system and to the cell surface (Kim and Hersh 2004). 
Furthermore, it also generates vesicles from the trans-Golgi network for transporting 
cargoes to late-endosome and lysosome compartments, whereas AP-1 adaptors found in 
endosomes generate vesicles transporting to the cell surface or back to the Golgi complex  
(Newell-Litwa et al. 2007). Similarly, adapter related protein 3 (AP3) is believed to be 
essential for neurotransmitting and ion transport (Newell-Litwa et al. 2007), trafficking 
proteins to lysosomes and formation of lysosome-related organelles (Kantheti et al. 1998, 
Newell-Litwa et al. 2007, Simpson et al. 1997). In addition, AP-3 is important in neuronal 
protein trafficking and functions in the formation of synaptic vesicles from endosomes 
(Kim and Hersh 2004).  
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Similarly, the expression level of seven kinesin genes (KIF20A/MKLP2, KIF21A, KIF24, 
KIF4A, KIF22/KID, KIF2A and KIF2C/MCAK) which have similar function to adapter 
related proteins were found to be higher in receptive compared to non-receptive 
endometrium (Figure 7). According to gene ontological classification, those kinesin gene 
clusters were found to be involved in cellular localization (Figure 10C). Kinesins are 
motor proteins required to regulate cargo transporting of intra cellular components, 
vesicles and several organelles including mitochondria (Fisher and Kolomeisky 2001, 
Hirokawa et al. 2009). For instance, kinesin family member 20A (KIF20A) is required to 
control the intra-Golgi transport. Kinesin family member 4A (KIF4A) and kinesin family 
member C2 (KIFC2) are implicated in neuron functioning in which the former is required 
for transporting cell adhesion molecule required in axonal elongation (Peretti et al. 2000) 
and the later may involve in  transporting of multi vesicular body like (mvb-like) 
organelles in dendrites (Saito et al. 1997). Therefore, it is possible to speculate that the 
increased expression level of adapter related proteins and kinesin in receptive may 
required to enhance neurotransmission or to increase accumulation and transduction of 
energy by trafficking of integral membrane proteins and cellular materials including 
adhesion molecule, organelles and vesicles. Apart from this, the increased level of adapter 
related protein in receptive bovine endometrium might be associated with increased 
number of lysosomes that could be required for uterine receptivity and embryo 
implantation.   
 
5.1.1.3 The cell cycle, anti and pro apoptosis genes  
 
 In the current study, the cell cycle gene clusters (CDC2, CDC20, CDC25C, CDC42SE2, 
CDCA2 and CDCA4) and other cell cycle related genes CCNA2, CCNB2, AURKB, 
CDCA2, NUSAP1, CKS2 and JAG2 were increased in receptive endometrium compared 
to non receptive endometrium. The involvement of these genes during cell cycle has been  
reported by different authors (Amabile et al. 2009, Borysov and Guadagno 2008, Ge et al. 
2009, Katsuno et al. 2009, Turowski et al. 2003, Wolthuis et al. 2008, Yoon et al. 2004). 
Therefore, the increased expression of cell cycle related genes in receptive endometrium 
could be associated with increase in the size and development of luminal and glandular 
epithelium of the receptive endometrium that may be required for preparing the uterus for 
implantation.  
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In the current study, the increased level of cell cycle related genes was accompanied by 
increased expression level of anti apoptosis genes (BCL2, VEGFB, EDN1, MYB, CDC2, 
BIRC5, VDAC1 and GCLC) and reduced expression level of the pro-apoptotic genes 
(PRKRA, CASP4, PYCARD, LCK, TP53I3/PIG3 and MYC). Apoptosis normally involves 
several biochemical events resulting in morphological changes to the cell membrane such 
as loss of membrane asymmetry and attachment, cell shrinkage, nuclear fragmentation, 
chromatin condensation and chromosomal DNA fragmentation. Although, the balance 
between cell death and proliferation is not well known during the receptive phase of 
bovine endometrium just before embryo implantation, the increase level of anti-apoptotic 
and reduced level of pro-apoptotic genes in receptive endometrium may provide a specific 
advantage for the epithelial cell of the receptive endometrium to escape the apoptosis 
induced signals and consequently can exhibit lower frequency of apoptosis accompanied 
by proliferation. For example, (Daikoku 1998) indicated that the BCL2 deficient mice 
exhibited many apoptotic. Similarly, strong expression of BCL2 protein in the 
endometrium glands was also reported (Gompel et al. 1994). Moreover, the BCL2 may be 
an essential gene product for the survival of endometrial glandular cells (Tabibzadeh et al. 
1995). Similarly, survivin (BIRC5) is required fore endometriotic implant growth 
promotion (Tarkowski et al. 2001). Contradictory reports are available on the importance 
of survivin during pregnancy and implantation. In one report, it has been described that 
high survivin expression in abortion cases than the normal pregnancy in rats (Garcia et al. 
2007). However, (Fest et al. 2008) reported similar survivin expression pattern between 
non pregnant and aborted counter parts. Furthermore, these authors indicated a 5-fold 
increase in the expression of survivin in pregnant compared to non-pregnant rat suggesting 
the involvement of survivin during implantation. The vascular growth factor B (VGEFB), 
which shares a high degree of sequence homology with vascular growth factor (VEGF) 
and phosphatidylinositol glycan anchor biosynthesis class F (PIGF), is a potent apoptosis 
inhibition by suppressing the expression of BH3 protein (Li et al. 2008). Increased level of 
VEGFB stimulates endothelial cell growth and proliferation (Olofsson et al. 1998). 
The pro-apoptotic genes may influence the preparation of the uterus for receptivity and 
implantation by facilitating the death of cells than they divide ultimately leading to loss of 
endometrial epithelial cells. This may in turn resulted in loss of endometrial receptivity for 
implantation. Hence, in the current finding, the down-regulation of pro-apoptotic genes in 
receptive endometrium may suggest faster proliferation than cell death in endometrial 
cells. For instance, in the current result, one of the pro-apoptotic gene v-myc 
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myelocytomatosis viral oncogene homolog (v-MYC) was down regulated in receptive 
endometrium compared to non receptive endometrium. This gene is believed control 
several genes in embryonic stem cells that function in biological processes (Kidder et al. 
2008). Similarly, in the current study, MYC was found to be the central gene influencing 
in the number genes involving in cell cycle, cell death and reproductive system diseases 
network (Figure 15).  Furthermore, in appropriate expression of MYC leads to enhanced 
apoptosis or inappropriate expression is correlated with a wide array of human 
malignancies (Askew et al. 1991, Evan et al. 1992, O'Connell et al. 2003, Shi et al. 1992) 
due to accumulation of p53 (Tabibzadeh et al. 1995). Moreover, over-expression and 
localization of the myc product may have an important role in the initiation, differentiation 
and progression of endometrial carcinoma (Bai et al. 1994). Furthermore, elevated levels 
of MYC gene expression in neoplastic cells from all seven bovine leukemia viruses 
induced bovine tumors (Gupta et al. 1986). This may suggest that the reduced level of v-
MYC including other proapoptotic genes and increased level of anti-apoptotic genes in 
receptive endometrium may suggest faster cellular proliferation and differentiation to 
prepare the endometrium for substantial remodelling.  
 
5.1.1.4  The protein phosphatases and protein kinases 
 
The protein phosphatases (PPM1G/PP2CG, PPP1CB, PPP1R10/PNUT3 and PPP2R5A) and 
protein kinases (PRKCQ, PRKCI, PRKAG2) (Figure 7) were among several clusters of 
genes increased in receptive compared to endometrium. The functional contribution of 
protein phosphatases and protein kinases in preparing mammalian endometrium for 
receptivity and embryo implantation is not yet well documented. The protein phosphatases 
and protein kinases gene clusters are believed to function together in a coordinated manner 
to dictate the level of protein phosphorylation in the cell. The protein phosphatases 
involves in protein phosphorylation and posttranslational modification and protein kinases 
acts as effectors of phosphorylation (Eyster et al. 2007). The coordinated activity of 
protein kinase C (PRKC) and protein phosphatases during the pregnancy period of rat have 
been also documented by several authors (Eyster 1993, Eyster et al. 1998, Gibori et al. 
1988).  For example, the protein phosphatase gamma (PPM1G) regulates protein stability 
(Suh et al. 2009) and smooth muscle cell survival (Tchivilev et al. 2008). On the other 
hand, protein phosphatase 1 regulatory subunit 10 (PPP1R10) controls the expression of 
genes that are critical for certain physiological and pathological processes including Rb-
Discussion 
_________________________________________________________________________ 
 
113 
 
phosphatase activity and apoptosis (De Leon et al. 2008, Lee et al. 2009). Similarly, 
among the protein kinases, kinase AMP-activated gamma 2 (PRKAG2) regulates chemical 
pathways in restoring the balance of ATP during chemical reactions that require ATP and 
protein kinase C (PKC) is known to be against apoptosis and required for cell proliferation 
(Grossoni et al. 2007). Apart from this, those protein kinases and phosphatases enriched in 
receptive endometrium were found to be the main constituent of the tight junction pathway 
(Figure 14, table 6). Tight junction pathway involves in various signaling events including 
controlling cell-to-cell-adhesion, cell signaling and membrane trafficking (Kohler and 
Zahraoui 2005). Therefore, in figure 14, it has been implicated that the protein kinases 
(aPKC) and protein phosphatases form the main components of the cytoplasmic plaque of 
the pathway towards cell proliferation, regulation of actin cytoskeleton and regulation of 
gene regulation. From this it is possible to speculate that although exact information is 
lacking on the mechanism how those genes function in the endometrium during the bovine 
implantation period, the simultaneous upregulation of those genes in receptive 
endometrium may be useful in maintaining the balance of protein phosphorylation and 
dephosphorylation in receptive endometrium for a wide range of cellular processes. 
 
5.1.1.5  Cluster of differentiation (CD) and chemokine molecules gene clusters 
 
The embryo during implantation and throughout pregnancy is considered as foreign and 
unlikely to avoid the scrutiny of immune cells that continually infiltrate the endometrium 
and scavenge the uterine lumen (Roberts et al. 1996). The high rate of early embryonic 
mortality in cattle and other animals may be maternal immunological attack against 
conceptus antigens of paternal origin (Thatcher et al. 1984). Therefore, reduced level of 
immune response of the maternal environment may be required to maintain the conceptus 
during the entire gestation period. In the present study, cluster of differentiation molecules 
(CD247/CD3Z, CD36, CD8A, CD8B), chemokine molecules (XCL1, CCL28, CXCL2, 
CXCL12, CXCL5), (Figure 11D) were found to be reduced in receptive compared to non- 
receptive endometrium. Several authors (Patel et al. 2007, Walter and Santamaria 2005, 
Whitcomb et al. 2007) have described the functional contribution of CD molecules in 
immune system.  For instance, CD36 has been found to be involved in innate immune 
response in mouse (Patel et al. 2007, Silverstein and Febbraio 2009), it interacts with the 
Toll-like receptors (TLR) to process the inflammatory responses (Erdman et al. 2009). 
Lower level of CD247/CD3-zeta expression in maternal serum has been demonstrated in 
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normal pregnancies (Lam et al. 2003). Similarly, CD8 believed to contribute to initiation, 
progression and regulation of autoimmune responses (Walter and Santamaria 2005). In 
addition, CD8A, CD8B and CD247 were found to be involved in T-receptor signaling 
pathway (Table 6) and CD8A and CD8B were found to be involved in antigen presentation 
network (Appendix 3). The importance of chemokine genes during immune response has 
been previously described (Ogawa et al. 2004, Whitcomb et al. 2007). In addition, all 
differentially expressed chemokine genes were found to be involved in cytokine-cytokine 
receptor interaction pathway (table 6) suggesting their involvement in immune system. 
Among them, elevated concentrations of CXCL5 had been associated with higher risk of 
miscarriage in human (Whitcomb et al 2007).  
Apart from those CD and kemokine molecules several DE genes related to the immune 
system, colony stimulating factor 3 (CSF3), IL18, non-classical MHC class I antigen 
(BOLA-NC1), tumor necrosis factor super family member 13 (TNFSF13), complement 
factor D (CFD/DF) were reduced in the receptive endometrium. Previous reports also 
indicated lower IL18 mRNA expression in pregnant compared with non-pregnant women 
and reduced pregnancy rate was reported in IL18  positive women compared to IL18 
negative group (Kruse et al. 2000, Ledee-Bataille et al. 2004). Moreover, detection of IL18 
is suggested to be used as non-invasive and simple method to predicted inadequate uterine 
receptivity, independent of embryo quality (Ledee-Bataille et al. 2004). Therefore, the 
reduced level of CD molecules, kemokines and other immune related genes in receptive 
compared to non- receptive endometrium may suggest that the receptive endometrium can 
adjust the immune system to create conducive environment for immune tolerance of the 
incoming embryo. 
 
5.1.1.6  S100 gene clusters and endometrial receptivity 
 
With the exception of S100B, the expression pattern of the S100 proteins including 
S100A12, S100A13, S100A14, S100A16 and S100A8 was reduced in receptive 
endometrium compared to the non-receptive endometrium. The contribution of S100 genes 
in bovine endometrial receptivity and embryo implantation is not known. However, some 
evidences indicate that S100 genes may be function in the immune system similar to 
chemokine or CD molecules. For instance, S100 genes including S100A8, S100A9, 
S100A12 and S100A13 are believed to function as a cytokine-like manner (Foell et al. 
2007, Sedaghat and Notopoulos 2008). Similarly, the expression of S100A12 and S100A8 
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were found to be higher in inflamed tissue, where neutrophils and monocytes belong to the 
most abundant cell types (Foell et al. 2007). Moreover, 100% of homozygous null for 
S100A8 gene in rats caused rapid and synchronous embryo resorption at day 9.5 embryo 
development (Passey et al. 1999). This may suggest that the S100AB null embryos had lost 
the immune system to overcome the mother immune scrutiny. Some of S100 proteins 
down regulated in receptive endometrium (S100A13, S100A8, S100A14, S100A16) may 
associated with endometriosis, tumorigenesis and progression and can be used as  a marker 
of actively progressing endometriotic process (Hayrabedyan et al. 2005, Yao et al. 2007a, 
Yao et al. 2007b). Therefore, the reduced level of S100 those genes in receptive 
endometrium may have two fold advantage, for one thing it may be associated with 
suppression of tumerigenesis  and secondly it may required for modulation of the maternal 
immune system in the endometrium to be hospitable for the incoming embryo.  
 
5.1.1.8  The extracellular matrix (ECM): The Collagens, TIMP3, TIMP1 and MMP2 
 
The collagens, tissue inhibitors of matrix metalloproteinase (TIMP) and matrix 
metalloproteinase (MMP) are among the main components of ECM and abnormalities in 
those ECMs can be associated with implantation defects (Iwahashi et al. 1996b, Jokimaa et 
al. 2002, Skinner et al. 1999). In current study, several collagens including, collagen type I 
(COL1A1,COL1A2), collagen type VI (COL6A1), collagen type XII (COL12A1), collagen 
type IVIII (COL18A1), collagen type XXI (COL21A1) and collagen type XXVII 
(COL27A1) were reduced and collagen type IV alpha 3 and alpha 4 (COL4A3, COL4A4) 
were increased in receptive compared to non-receptive endometrium (Figure 8). According 
to the gene ontological classification, those DE collagens were involved in extra matrix 
remodeling (Figure 11E). Moreover, COL1A1, COL1A2, COL4A4, COL6A2, COL6A3 were 
found to be involved in focal adhesion and ECM receptor interaction pathway (Table 6).  
Among these, collagen type I, IV, VI and  collagen type XVIII have been detected in 
human and bovine endometrium (Aplin et al. 1988, Boos 2000, Gaide Chevronnay et al. 
2009, Iwahashi et al. 1996, Stovall et al. 1992). Similar to the current study, other report 
also indicated very low collagen type VI in the decidual stroma indicating loss of stromal 
type VI collagen contributes to the remodelling of the maternal extracellular matrix of 
pregnancy (Mylona et al. 1995). Moreover, the expression level of collagen type I 
(COL1A1, COL1A2) and collagen type VI (COL6A1) were reported to be higher in non 
pregnant cow compared to pregnant cow (Bauersachs et al. 2006). The reduced level of 
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collagen type I (COL1A1) may be associated with its minor role in the maintenance of 
uterine tensile strength of the cyclic cow (Boos 2000). 
 Unlike other collagen families, the expression of collagen type IV alpha 3 (COL4A3) and 
collagen type IV alpha 4 (COL4A4) were elevated in receptive compared to non- receptive 
endometrium (Figure 11E). Collagen IV is a common constituent of basement membrane 
(Boos 2000) and it has been suggested to enhance trophoblast invasion by providing a 
substratum for cell migration (Aplin 1996, Irving et al. 1995). Besides collagen IV was 
found to be detected in stromal cells and the basement membrane of glands and blood 
vessels in fertile women and it was absent in women suffering from unexplained infertility 
(Bilalis et al. 1996).  
In addition to collagens abundances, the ECM is regulated by two groups of enzymes, 
matrix metalloproteinases and their inhibitors, tissue inhibitors of metalloproteinases 
(TIMP) and cystatins respectively (Jokimaa et al. 2002). Inline to this, the current study 
identified the expression level of matrix metalloproteinase (MMP2) and tissue inhibitors of 
metalloproteinases 1 (TIMP1) to be lower and tissue inhibitors of metalloproteinases 3 
(TIMP3) to be higher in receptive compared to non- receptive endometrium. Higher mRNA 
levels of TIMP1 and MMP2 were associated with unexplained infertility and recurrent 
miscarriages in humans (Jokimaa et al. 2002). Therefore, higher expression of those genes 
may be associated with infertility in both humans and cattle. Apart from this, higher TIMP3 
expression level can be indicative of normal functioning endometrium while lower level of 
TIMP3 was observed in endometriosis cases (Jokimaa et al. 2002). The expression of 
TIMP3 may play an important role in regulating the depth of trophoblast invasion during 
embryo implantation (Li et al. 2000). Moreover, higher expression of TIMP3 in maternal 
cells surrounding invading embryonic tissue and absence of TIMP1 or TIMP2 in the 
embryo proper, trophoblasts, or the area of the uterine decidual reaction was demonstrated 
during mouse embryo implantation indicating the importance of TIMP3 in implantation 
process (Reponen et al. 1995). Therefore, the increased or reduced expression of collagens, 
TIMPs and MMP2 in the receptive endometrium may be associated with maintenance of 
endometrial integrity by maintaining normal turnover of extracellular matrix proteins.  
 
5.1.1.9  Junctional adhesion, gap junction or connexin in receptive endometrium 
 
Junctional adhesion, gap junction or connexin expression are a biological marker for 
endometrial receptivity in human (Grummer and Winterhager 1998). In this study, the 
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mRNA level of junctional adhesion molecules 2 and 3 (JAM2/JAMB and JAM3/JAM-C) 
was found to be increased in receptive compared to the non-receptive endometrium. The 
higher expression of JAM3/JAM-C can be associated with increased in the number of 
uterine natural killer cells that are required to enhance blood flow to the implantation site, 
which may be required in the development of the placenta during implantation (Hanna et 
al. 2006, Herington and Bany 2007, Herington and Bany 2006). Moreover, those genes are 
believed to enhance cell-to-cell adhesion and control the flow of solutes and water between 
cells of epithelium (Aurrand-Lions et al. 2000, Aurrand-Lions et al. 2001, Ueki et al. 
2008). Moreover, the junctional genes along with claudins are the main components of the 
transmembrane proteins of tight junctional pathway (Figure 14).  
Among the gap junctional proteins, gap junction protein beta 5 (GJB5) or connexin-31 
(CX31.1) and gap junction protein beta 6 (GJB6) or connexin-30 (CX30) were elevated 
but gap junction protein alpha-1 or connexin 43 (GJA1/CX43) was reduced in receptive 
compared to non- receptive endometrium. Among these, GJB5/CX31.1 is believed to be 
required for normal placental development (Zheng-Fischhofer et al. 2006). GJB6/CX30 is 
found to be abundant in late pregnant epithelium (Locke et al. 2007). Unlike other 
connexins, connexin 43 (GJA1/CX43) was expressed at lower level in receptive 
endometrium compared to the non- receptive endometrium. Similar to our result, the 
expression of CX43 was found to be reduced in the receptive phase of the endometrium. A 
decrease in CX43 gene expression in endometrium at the time of implantation may be 
required to reduce cell-to-cell communication and to facilitate the invasion of 
trophectoderm through the stroma cells (Granot et al. 2000). This may suggest that low 
level of CX43 is required during the receptive period of the endometrium.  
Other families of cell adhesion molecules which were increased in receptive compared to 
non-receptive endometrium were the alpha integrin 2 (ITGA2) and alpha 6 integrin 
(ITGA6). Similar reports in humans have shown increased expression of ITGA2 and 
ITGA6 during window of implantation (Bischof et al. 1993, Lanteri et al. 1998). 
Moreover, the up regulation of ITGA6 expression was speculated to be related to its 
involvement in the attachment of cells to the extracellular matrix and induction of cell 
migration and invasion (Vernet-Tomas Mdel et al. 2006). Therefore, the increased level of 
these integrin in receptive endometrium compared to non-receptive endometrium may 
suggest the importance of appropriate integrin expression for establishment of uterine 
receptivity and embryo implantation. 
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5.2  Diestrus dynamics of receptive and non- receptive endometrium 
 
In addition to investigating transcriptome difference between receptive endometrium and 
non-receptive endometrium, in the current study, the diestrus period transcriptome 
dynamics of receptive or non-receptive endometrium was addressed to get insight into the 
temporal transcriptome accumulation or degradation of the receptive and non-receptive 
endometrium. Therefore, the transcriptome dynamics of receptive or non-receptive 
endometrium was compiled between endometrial biopsies collected at day 7 and 14 post 
estrus. The data  showed that more than 1800 gene transcripts were differentially 
expressed between day 7 and 14 in receptive endometrium, but only 254 transcripts were 
differentially expressed between day 7 and 14 in non-receptive endometrium suggesting 
mRNA dynamics (degradation or induction) is seven times higher in receptive 
endometrium than the non-receptive endometrium. This can be related to the fact that, the 
non-receptive endometrium has few or no genes that support the incoming embryo at any 
stage of the estrous cycle. However, in receptive endometrium the expression level of 
several genes that reached peak or reduced at day 7 of the estrous cycle in the expectation 
of the incoming embryo alter their expression pattern at day 14 of the estrous cycle. 
Therefore, unlike the non-receptive endometrium, the transcriptome abundance of those 
genes that are associated with endometrial receptivity can be changed at day 14 post estrus 
resulting in higher transcriptome abundance difference between day 7 and 14 in receptive  
compared to non-receptive endometrium.  
To understand the functional alteration changes that occured in the receptive endometrium 
between day 7 and 14 of the estrous cycle, those genes which changed their expression 
between the two time points were subjected to gene ontology for gene enrichment analysis. 
Accordingly, the receptive endometrium at day 7 of the estrous cycle is mostly associated 
with expression of genes that are responsible for cellular material transport, metabolic 
process, phosphorylation, post-translational protein modification. However, as it reaches to 
day 14 of the estrous cycle, the receptive endometrium starts to be enriched by genes, 
which are responsible for the immune responses, apoptotic process and signal 
transductions (Figure 9). Although no report is available on the transcriptome dynamics of 
the receptive endometrium, the existing data on bovine endometrial gene expression also 
indicated transcriptomic alteration changes of bovine, human and rabbit endometrium 
during the different phases of the estrous cycle (Bauersachs et al. 2005, Kao et al. 2002, 
Mitko et al. 2008). Moreover, changes in transcriptome alteration of the bovine receptive 
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endometrium were also accompanied by changes in metabolic, cytokine and signaling 
pathways. The enrichment of those molecular pathways varies whether the endometrium is 
at day 7 or 14 of the estrous cycle (Table 7). For instance, the gonadotropin releasing 
hormone pathway was among the 21 molecular pathways involved by those genes whose 
expression level is variable as receptive endometrium is forwarding from day 7 to day 14 
of the estrous cycle (Figure 20). This pathway is associated with in activation of 
transcription factors gonadotropin expression and secretion that can regulate the 
production and release of gonadotropins, LH and FSH. Moreover, this pathway has slots 
towards other 3 signaling pathways, namely MAPK and cytokine-cytokine signaling 
pathways (dominated by genes enriched in day 14) and nueroactive ligand receptor 
interaction pathway (dominated by genes enriched at day 7 of the estrous cycle).  This may 
suggest that as the receptive endometrium proceeds from day 7 to day 14 of the estrous 
cycle, the molecular pathways change towards the direction of transcription of genes 
required for production of hormones, cell proliferation and differentiation.  
Following global gene expression profiling between receptive and non-receptive 
endometrium, or between day 7 and 14 of the estrous cycle in receptive or non-receptive 
endometrium, the expression patterns of selected DE genes was determined across the 
estrous cycle and at 50 days gestation period (P). These was aimed at investigating 
whether up or down regulating genes in receptive endometrium during the estrous cycle 
will continue or decay during early gestation period. The data on selected genes showed 
that IRF6, ITPR1, STAT5A and AGTR1 exhibited an increase trend from proestrus to 
diestrus and reached peak in pregnant endometrium (Figure 23), whereas the expressions 
of PTGER4, PTGS2/COX-2, TIMP3 and ADORAB2B were reduced in during early 
pregnancy period compared to day 7 and 14 of the estrous cycle. This may suggest that 
those genes which were increased in receptive endometrium during the receptive phase of 
the endometrium can be increased further or reduce their expression after embryo 
implantation. For instance, interferon regulatory factor 6 (IRF6) was among the genes 
increased during pregnancy. This gene is believed to play critical roles in endometrial gene 
expression, conceptus trophectoderm growth and differentiation, regulator of keratinocyte 
proliferation and differentiation during embryogenesis (Fleming et al. 2009). Therefore, 
the increased level of IRF6 in pregnant endometrium may suggest the requirement of IRF6 
during per and postimplantation periods. Similarly, the expression profile of STAT5A also 
indicated an increase level in pregnant endometrium even if it was down regulated in 
receptive endometrium. During early pregnancy in cattle and other ruminants, 
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progesterone (P4) from the corpus luteum and interferon tau (IFNτ) from the conceptus act 
on the endometrium regulate genes important uterine receptivity and conceptus growth 
(Gray et al. 2006). STAT5A is one of the genes increased by IFNτ (Gray et al. 2006). The 
increased level of STAT5A at pregnant endometrium might be then driven by activation of 
IFNT on STAT5 gene during the implantation. Therefore, the down regulation of STAT5A 
in receptive endometrium during the estrous cycle may be compensated by the time 
embryo starts to produce IFNτ. On the other hand, cyclooxygenase-2 or PTGS2 was 
upregulated in receptive endometrium and exhibited lower expression in pregnant 
endometrium compared to the expression detected at day 7 and 14 of the estrous cycle 
suggesting reduction of its expression after implantation. This can be also associated with 
effect IFNτ. As described in several reports (Binelli et al. 2000, Pru et al. 2001, Xiao et al. 
1999), the expression level of PTGS2 is reduced following IFNτ exposure. For instance, 
the expression level of PTGS2 down-regulated at day 14 of pregnancy in sheep and by 
treatment of ewes with IFNτ suggesting the effect of IFNτ on the reduction of PTGS2 gene 
during pregnancy (Binelli et al. 2000, Chen et al. 2006, Xiao et al. 1999). This together 
with the current result can suggest that the up-regulation of PTGS2 during the receptive 
phase may be maintained to lower level by the effect of the embryo following during 
implantation. 
 
5.3 Transcriptome alternation in embryos resulted in calf delivery and no pregnancy 
 
Embryo competency for implantation and uterine receptivity are two distinct processes that 
are equally important for successful implantation (Carson et al. 2000, Dey et al. 2004, 
Wang and Dey 2006). Thus the embryo can functions as an active unit with its own 
molecular program of cell growth and differentiation (Carson et al. 2000, Dey et al. 2004). 
Therefore, in the current study, in addition to endometrial gene expression, the 
transcriptome differences between embryo biopsies resulted in calf delivery and biopsies 
resulted in no pregnancy was analyzed to generate candidate genes associated with those 
embryo implantation potential. Subsequently, significantly differentially expressed genes 
between the two groups of embryo that were involved in several biological and molecular 
functions have been identified (Figure 25, Figure 26, Table 9). This shows that embryos 
that result in calf delivery can be molecularly distinguishable from embryos ended up in no 
pregnancy. However, the number of differentially expressed genes and molecular 
signatures derived from comparing the two groups of embryo biopsies was by far fewer 
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compared to the differentially expressed genes obtained from comparing the endometrial 
biopsies resulted in calf delivery and no pregnancy. This does not imply that the 
endometrium or the maternal environment is more important than the embryo during 
embryo pregnancy establishment. However, this was indeed related to differences in the 
microarray platform utilized in the two experiments.  
Among the DE genes that were identified between the two embryo groups, CXCL16, 
AMD1, SPAG17, PF6, UBE2D3P, DFNB31, DTNBP1 and NUP35  were found to be higher in 
embryo biopsies resulted in calf delivery compared to those resulted in no pregnancy. 
Among these, reports have also shown the importance of CXCL16 and AMD1 in 
cytotrophoblast invasion, placentation, cell migration and mouse embryo development 
(Huang 2006, Lin et al. 2009, Nishimura et al. 2002). On the other hand, eukaryotic 
translation elongation factor 1 alpha 1 (EEF1A1), was found to be higher in embryo 
biopsies derived from blastocysts resulted in no pregnancy. Similar study in our lab (El-
Sayed et al. 2006), showed higher abundance of EEF1A1 expression in embryo biopsies 
derived from in vitro produced blastocysts that resulted in no pregnancy. This shows the 
presence of common genes related to the progressive development of embryo derived 
either from in vivo or in vitro condition.  
Collectively, the present data uncovered the pattern of the bovine pre-transfer endometrial 
and embryo gene expression in relation to pregnancy establishment. To that end, 
endometrium that resulted in calf delivery displayed different transcriptome profile 
compared to the endometrium that resulted in no pregnancy at day 7 of the estrous cycle. 
Those differences were accompanied by qualitative and quantitative alteration of major 
biological processes and molecular pathways. Along with the endometrial gene expression, 
the embryo that developed to term displayed different patterns of gene expression 
compared to those embryos failed to establish pregnancy suggesting the potential 
contribution of embryo transcripts during pregnancy establishment. Therefore, our data 
provide a global perspective of the endometrium and embryo transcriptome in relation to 
the possible pregnancy outcomes. The data generated in the present study can be utilized 
for selecting candidate genes for further investigation aiming at developing molecular 
markers related to endometrial receptivity and embryo competency. However, future 
functional studies will be necessary to understand the key functional contribution of 
differentially expressed genes with respect to pregnancy success. Apart from this, in-depth 
investigation may be required to fully understand to what extent endometrial state can 
repeat it self with regard to its molecular signatures during consecutive estrous cycles. 
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6 Summary 
 
The intrinsic factors associated the aberrant gene expression in the uterine endometrium 
and embryo has been one of the major causes of pregnancy failure in cattle. Therefore, 
selecting cows with adequate endometrial receptivity and implantation competent embryos 
based on gene expression pattern may increase the number of calves borne following 
embryo transfer. Hence, investigating the endometrial and embryonic gene expression 
before embryo transfer and relating this information to the pregnancy outcome provides a 
unique opportunity for generating molecular marker that are associated with endometrial 
receptivity and embryo implantation. Therefore, in the current study, a direct connection 
has been established between pre-transfer endometrial and embryo gene expression and 
pregnancy outcome using endometrial and embryo biopsy techniques. For this, 54 
Simmental cyclic heifers were estrus synchronized and endometrium biopsies were taken 
at day 7 and 14 of the estrous cycle during the pre-transfer period. In the next cycle, in 
vivo produced day 7 blastocysts stage embryos were transferred to the recipients at day 7 
of the estrous cycle after taking 30-40% parts of the blastocyst as a biopsy for 
transcriptome analysis. After pregnancy diagnosis and at the end of gestation period, 
heifers were grouped according to the pregnancy outcome. Those heifers returned to heat 
after 21 days were classified as no pregnancy group (non-receptive endometrium) and 
those heifers ended up with successful pregnancy were classified as calf delivery group 
(receptive endometrium). The embryos that were biopsied from blastocysts transferred to 
the recipients and endometrial biopsies collected during the pre-transfer period were then 
categorized based on the pregnancy success. The embryo biopsies were classified as those 
biopsies resulted in successful calf delivery and those resulted in no pregnancy. Similarly, 
the endometrial biopsies taken at days 7 and 14 of the estrous cycle during the pre-
transferred period from heifers resulted in successful calf delivery were designated as 
CDd7 and CDd14, respectively. Similarly, endometrial samples collected at days 7 and 14 
of the estrous cycle from heifers resulted in no pregnancy groups were designated as NPd7 
and NPd14, respectively. Following this, the gene expression difference between receptive 
and endometrium during day 7 and 14 of the estrous cycle, the transcriptome dynamics of 
receptive endometrium and non-receptive endometrium were established using 
GeneChip® Bovine Genome Array. Furthermore, the transcriptome abundance difference 
between the embryo biopsies resulted in calf delivery and those resulted in no pregnancy 
were investigated using the bovine preimplantation specific cDNA array. 
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The pre-transfer endometrial gene expression difference between heifers resulted in calf 
delivery (receptive endometrium) and heifers resulted no pregnancy (endometrium) at day 
7 of the estrous cycle was investigated by comparing the transcriptome abundance of 
CDd7 and NPd7. The result revealed that 1126 genes were differentially expressed 
between the two groups of endometrium of which 612 genes were elevated in receptive 
endometrium (CDd7) and 514 were elevated in non-receptive endometrium (NPd7). From 
those, CDC20, GCLC, PLLP, COL4A4, TMEM163, MTTP, NETO2, CDC2, COX6B2 
and PPP2R5A were strongly expressed in CDd7 whereas five or more folds in NPd7 
elevated HOXA9, COL1A2, NTRK2, COL3A1, GJA1, COL21A1, LHFP, IGJ, SPOP, 
OGN, COL6A1 and SPARC. In addition to individual genes, several gene clusters were 
found to be differentially expressed between the two groups of endometrium. Among 
those, the solute carrier gene cluster, cell division cycle clusters, adaptor related protein 
complex, kinesin clusters, leucine rich repeats, coiled domains, ATPases, protein kinases 
and phosphatase clusters, transmembrane proteins, junctional adhesion molecules and 
integrins were abundantly expressed in receptive endometrium (CDd7) groups. However, 
gene clusters including, cluster of differentiation molecules, chemokine molecules, 
homeobox genes, collagen families, S100 calcium binding protein and zinc finger proteins 
were enriched in endometrium (NPd7). Functional classification of the differentially 
expressed genes indicated that those genes whose expression level was elevated in CDd7 
groups were found to be involved several functions including macromolecule localization, 
protein/cellular localization, transmembrane transport,  post transcriptional modification, 
binding activities (nucleotide, ion, ATP), signal transduction, metabolic process, anti-
apoptosis, gene transcription and cell cycle. However, the genes elevated in NPd7 were 
mainly involved in cellular metabolic processes, responding to stimuli, immune response, 
chemokine and cytokine activity and induction of apoptosis. Furthermore, the regulator 
pathway annotation analysis performed based the Kyoto encyclopedia of genes and 
genomes database revealed that the genes enriched in CDd7 mainly involve the tight 
junction, integrin signalling, inositol phosphate metabolism, calcium signalling pathway, 
focal adhesion, apoptosis, GnRH, VEGFB and PPAR signalling pathways. On the other 
hand, the genes abundantly expressed in NPd7 were mainly found to involve in T cell 
receptor pathway, cytokine–cytokine receptor, p53 signalling pathway and focal adhesion 
pathways. Moreover, the Ingenuity Pathway Analysis revealed that, the differentially 
expressed genes between CDd7 and NPd7 were grouped into a set of 34 different 
molecular networks. The relevant functions that repeatedly appear in the different 
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molecular networks were cell cycle network, cell death, reproductive system disease, 
genetic disorder, cellular movement, DNA replication recombination and repair network, 
lipid metabolism, molecular transport network, antigen presentation network, post-
translational modification, cellular assembly and organization, cell signaling, cellular 
movement, immune cell trafficking, neurological disease, RNA post-transcriptional 
modification. Therefore, the differences in regulatory pathways and biological processes 
and molecular functions evidenced the presence of transcriptomic functional and 
molecular signaling alteration between receptive and non-receptive endometrium at day 7 
of the estrous cycle during the pre-transfer period. 
In addition to day 7 of the estrous cycle, the pre-transfer gene expression difference 
between receptive endometrium and  endometrium was investigated at day 14 of the 
estrous cycle using endometrial biopsies taken during day 14 of the estrous from those 
eventually resulted in calf delivery and from those resulted in no pregnancy groups. For 
this, the transcriptome abundance of CDd14 and NPd14 was compared. The result showed 
that only 14 DE genes between the two groups of the endometrium in which the expression 
level of 2 genes (C20ORF54 and FZD8) to be higher in CDd14, while the expression of 12 
genes (LOC786821, BRWD1, ANKRD11, SLC25A12, GJA1, SCARA5, IIGLL1 and 
other 5 ESTs) to be higher in NPd14. Therefore, this result showed that the number of 
genes and molecular signals altered between CDd14 and NPd14 was significantly lower 
compared to the number of genes and molecular signals altered between CDd7 and NPd7. 
This shows that minimum difference in transcriptomic functional alteration between 
receptive and non-receptive endometrium at day 14 of the estrous cycle and pronounced 
difference in day 7 of the estrous cycle. This remarkable difference in transcriptomic 
functional alteration between receptive and non-receptive endometrium at day 7 of the 
estrous cycle indicates the endometrium that eventually result in calf delivery and 
endometrium result in no pregnancy can be molecularly distinguishable at day 7 than day 
14 of the estrous cycle. 
Following investigating the transcriptome difference between the receptive and non-
receptive endometrium at day 7 and 14 of the estrous cycle, the temporal transcriptome 
dynamics of the receptive endometrium was examined to understand the transcriptome 
changes that undergoes as the receptive endometrium proceeds from day 7 to day 14 of the 
estrous cycle. For this, the endometrial gene expression was analyzed using day 7 
endometrial samples (CDd7) and day 14 endometrial samples (CDd14) collected from 
heifers resulted in calf delivery. The result indicated that 1867 genes were differentially 
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expressed between the CDd7 and CDd14. Of these the transcript level of 1014 genes was 
elevated in CDd7 while the transcript level of 853 were increased in CDd14 indicating 
pronounced transcriptome changes of the receptive endometrium between day 7 and 14 of 
the estrous cycle. The functional classification also revealed that those genes elevated in 
CDd7 were involved in various functions including, cellular material transport, 
phosphorylation, post-translational protein modification. On the other hand, the immune 
responses, apoptotic process and signal transductions were among the main biological 
processes in those genes whose transcript level was increased in CDd14 compared to 
CDd7. Moreover, 21 molecular pathways were affected as endometrium progresses from 
day 7 to day 14 of the estrous cycle. The MAPK signaling, Toll-like receptor signalling, 
adipocytokine signaling, cell adhesion molecules (CAMs) and extra cellular matrix 
(ECM)-receptor interaction pathways were enriched by the genes abundantly expressed in 
CDd7. On the other hand, the PPAR signaling, calcium signaling, neuroactive ligand-
receptor interaction, arginine and proline metabolism, GnRH signaling, urea cycle and 
metabolism of amino acid, tryptophan metabolism, Glycine, serine and threonine 
metabolism pathways were enriched by the genes abundantly expressed in CDd14.  
Similar to the receptive endometrium, the transcriptome changes of the non-receptive 
between day 7 and 14 of the estrous cycle was investigated by comparing NPd7 and 
NPd14 endometrial biopsy samples. From this analysis, it was evidenced that 254 genes to 
be differentially expressed between NPd7 and NPd14 groups. Compared to the 
transcriptome dynamics of the receptive endometrium (CDd7 vs. CDd14), the number of 
differentially expressed genes and functional categories identified in NPd7 vs. NPd14 was 
lower by 1613 genes indicating the transcriptome plasticity of receptive endometrium 
during the day 7 and 14 of the estrous cycle.  
Once the pre-transfer endometrial gene expression of receptive and non-receptive 
endometrium was uncovered, the mRNA and protein expression pattern of some selected 
candidate genes were assessed at five different days of the estrous cycle (at days 19, 0 (21) 
3, 7 and 14 of the estrous cycle and day 50 of the gestation period using endometrium 
samples collected from targeted slaughtered heifers. For this, candidate genes that 
exhibited an elevated expression in receptive endometrium (CDd7) namely, (IRF6, 
PTGER-4, ITPR1, ADORA2B, PTGS2/ COX-2, WNT11, CDC20 and TIMP3) and others 
(STAT5A, MMP2 and AGTR1) which were increased in non-receptive endometrium 
(NPd7) were selected. The majority of those candidate genes showed higher expression 
levels at day 7 and 14 of the estrous cycle. In addition, the expression pattern of IRF6, 
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ITPR1, STAT5A and AGTR1 exhibited an increase trend from proestus to diestrus and 
reached peak in pregnant endometrium. However, the expression of PTGER4, 
PTGS2/COX-2, TIMP3 and ADORAB2B was reduced in pregnant endometrium 
compared to the expression observed at day 7 and 14 of the estrous cycle. In addition, 
immunohistochemical localization of IRF6, ITPR1, PTGS2 and MMP2 revealed 
differences in the protein signal intensities during the estrous cycle and early pregnancy in 
superficial, luminal and glandular epithelial and stroma cells suggesting temporal and 
special expression of those genes. Therefore, this may indicate those genes exhibited 
higher or lower expression during the estrous cycle may induce or switch off their 
expression following implantation.  
The blastocyst competency for implantation is equally important as endometrial receptivity 
to determine the pregnancy outcome. Thus, parallel to transcriptome analysis from the 
endometrial biopsies, the transcriptome abundance differences between embryo biopsies 
resulted in calf delivery and biopsies resulted in no pregnancy was analyzed to generate 
candidate genes that are associated with the blastocysts competency for implantation.  The 
microarray data analysis revealed a total of 70 differentially expressed genes between the 
two embryo groups involving in different function categories including gene expression, 
cell signaling and cell communication, transport of macromolecules, transferase activity 
and chemokine activity. Compared to the transcriptomic alteration difference that has been 
occurred between receptive and non-receptive endometrium, the numbers of genes that 
were differentially expressed and molecular signatures generated while between embryo 
biopsies resulted in successful calf delivery and no pregnancy were by far fewer. However, 
this difference does not guarantee that the endometrium or the maternal environment is 
more important than the embryo for pregnancy establishment. This difference was indeed 
related to differences in the microarray plat form used. 
In conclusion, the present study provides significant mechanistic insight about pre-transfer 
cattle endometrial and embryo gene expression in relation to the pregnancy success. The 
data  highlights the potential of pre-transfer endometrial and embryo biopsy transcripts for 
predicting pregnancy success in cattle which is a step forward in developing molecular 
markers for selecting embryos that are capable of developing further and  recipient cows 
that are presumably become pregnant. Apart from this, the results provided a long list of 
several developmentally important genes that can be utilized for selecting candidate genes 
for further investigation aiming at developing molecular markers for predicting pregnancy 
success in cattle. However, future functional studies will be required to understand the 
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functional contribution of differentially expressed genes with respect to pregnancy success. 
In addition, in-depth investigation may be essential to fully understand to what extent 
endometrial state can repeat it self with regard to its molecular signatures during 
consecutive cycles. Taken together, this data contributes substantial information towards 
increasing pregnancy success in cattle using gene expression as predictor tool. 
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7 Zusammenfassung 
 
Die Hauptgründe für die Trächtigkeitsverluste nach Embryotransfer beim Rind stellen 
inhärente Faktoren verbunden mit der abberanten Genexpression im Endometrium und 
Embryo dar. Durch die Selektion adäquater endometrialen Rezeptivität und Embryonen 
mit hohem Entwicklungspotntial basierend auf dem Genexpressionsmuster, könnten die 
Trächtigkeitsraten vermutlich gesteigert werden. Infolgedessen bietet die Analyse der 
endometrialen und embryonalen Genexpression vor dem Transfer bezogen auf den 
Trächtigkeitserfolg, eine einzigartige Möglichkeit zur Identfizierung molekularer Marker 
für die Rezeptivität des Endometriums und der embryonalen Entwicklungskompetenz. 
In der vorliegenden Arbeit wurde eine direkte Abhängigkeit der Expressionsprofile von 
Endometrium und Embryo vor dem Transfer zum Trächtigkeitserfolg hergestellt. In 
diesem Versuch wurden 54 Simmeltaler Färsen synchronisiert und deren Endometrium an 
Tag 7 und 14 des Vorzykluses biopsiert. Im folgenden Zyklus wurden in vivo Blastozysten 
an Tag 7 gespült und auf diese Empfängertiere übertragen, nachdem ca. 30 – 40% der 
Blastozysten als Biopsieprobe für die Transkriptomanalyse entnommen wurden. Nach der 
Trächtigkeitsuntersuchung und am Ende des Gestationszyklus wurden die Tiere bezüglich 
des Trächtigkeitserfolgs klassifiziert. Färsen, die nach 21 Tagen wieder im Östrus waren 
wurden in die Gruppe nicht Trächtiger (non-rezeptives Endometrium) eingeteilt, während 
Färsen mit einer erfolgreichen Trächtigkeit der Kalb Liefernden Gruppe (rezeptives 
Endometrium) zugeteilt. Die Embryonen wurden ebenfall basierend auf dem 
Trächtigkeitserfolg kategorisiert. Die Biopsieproben der Endometrien gliederten sich 
nochmals innerhalb der Gruppen bezüglich des Zeitpunktes der Probennahme in Tag 7 und 
Tag 14 (CDd7 und CDd14 für die trächtigen Färsen und NPd7 und NPd14 für die nicht-
trächtigen Färsen). Der GeneChip® Bovine Genome Array diente dem Nachweis 
unterschiedlicher Genexpressionen zwischen und innerhalb der Gruppen. Mittels eines 
präimplantations spezifischen cDNA Arrays wurden Unterschiede in der Menge der 
Transkriptome der Embryonen in Abhängigkeit des Trächtigkeitserfolgs untersucht. Der 
Expressionsunterschied der pre-Transfer endometrial Gene zwischen der rezeptive 
Endometrium Gruppe und der nicht-rezeptive Endrometrium Gruppe am Tag 7 des Östrus-
Zykluses wurde durch den Vergleich der Transcriptome von CDd7 und NPd7 untersucht. 
Die Ergebnisse der Genexpressionsanalyse der Endometrien zeigen, dass insgesamt 1126 
Gene unterschiedlich expremiert wurden, wobei 612 Gene im rezeptivem Endrometrium 
(CDd7) und 517 im nicht – rezeptivem Endrometrium (NPd7) hoch reguliert waren. Von 
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diesen waren CDC20, GCLC, PLLP, COL4A4, TMEM163, MTTP, NETO2, CDC2, 
COX6B2 und PPP2R5A sehr stark expremiert in CDd7, wohingegen in NPd7 die Gene 
HOXA9, COL1A2, NTRK2, COL3A1, GJA1, COL21A1, LHFP, IGJ, SPOP, OGN, 
COL6A1 und SPARC fünffach oder mehr hochreguliert waren. Zusätzlich zu den 
einzelnen Genen fanden sich auch Unterschiede in einigen Genclustern, von denen der 
Solute Carrier Gene Cluster, Zellteilungszyklus Cluster, Adaptor related Protein Komplex, 
Kinesin Cluster, leucinreiche Repeats, coiled domains, ATPasen, Proteinkinasen und 
Phosphatasen Cluster, Transmebrnproteine, junktionale Adhäsionsmoleküle, intergrins in 
CDd7 hochexpremiert waren. Im Gegensatz dazu waren Gencluster, wie Cluster of 
differentiation molecules, chemokine Moleküle, Homeobox Gene, Kollagenfamilien, S100 
Calcium binding Protein und das Zinc finger Protein vermehrt in Endometrium von NPd7 
angereichert. Betrachtet man die unterschiedlichen Expressionsmuster bezüglich einer 
funktionalen Klassifizierung wird deutlich dass die hoch regulierten Gene der CDd7- 
Gruppe in verschiedene Prozesse involviert sind, wie Lokalisierung von Makromolekülen, 
Protein/ zelluläre Lokalisation, Transmembrantransport, posttranskriptionale Modifikation, 
Anheftungsaktivitäten (Nukleotide, Ione, ATP), Signaltransduktion, metabolische 
Prozesse, Anti-Apoptose, Gentranskription und Zellzyklus. Die hochregulierten Gene der 
NPd7 Gruppe hingegen sind hauptsächlich an zellulären, metabolischen Prozessen, 
Stimuliantwort, Immunantwort chemokine und cytokine Aktivitäten und Induktion der 
Apoptose beteiligt. 
Des Weiteren zeigte die Regulator Pathway Annotation Analyse, basierend auf dem Kyoto 
Encyclopedia of genes and genomes database, dass die hochregulierten Gene in CDd7 
haupsächlich in thight junction, Integrin Signalisierung, Inositol Phosphat Metabolismus, 
Calcium signalling Pathway, fokale Adhäsion, Apoptose, GnRH, VEGFB und PPAR 
signalling pathway, involviert ist. Die hochregulierten Gene in NPd7 waren größtenteils 
am T cell Rezeptor Pathway, Cytokin-Cytokin Rezeptor, p53 signalling Pathway und an 
fokalen Adhäsionspathways beteiligt. Darüber hinaus brachte die Ingenuity Pathway 
Analyse (Meirelles et al.) hervor, dass die unterschiedlich expremierten Gene zwischen 
CDd7 und NPd7 in eine Reihe von 34 verschiedenen molekularen Netzwerken gruppiert 
werden konnten. Zu den relevanten Funktionen, die immer wieder in diesen Netzwerken 
auftraten, gehören unter anderem, das Zellzyklus Netzwerk, Apoptose, Krankheiten im 
Reproduktionssystem, genetische Fehlsteuerungen, zelluläre Bewegung, DNA- 
replikations,  rekombinations und repair Netzwerk, Fettstoffwechsel, molekulare Transport 
Netzwerk, Antigen Presentation Netzwerk, posttranslationale Modifikationen, zelluläre 
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Anordnung und Organisation, Zellsignalisierung, Immunzellenaustausch, neurologische 
Erkrankungen und RNA posttranskriptionale Modifikationen. Demzufolge bewiesen die 
Unterschiede in regulatorischen Pathways, biologischen Prozessen und molekularen 
Funktionen das Auftreten von transkriptomisch funktionalen und molekularen 
Veränderungen zwischen einem rezeptiven und einem nicht-rezeptiven Endometrium an 
Tag 7 des Zykluses in der Periode vor dem Embryotransfer. In einem weiteren Versuch 
wurde auf gleiche Weise, die Genexpressionsprofile des Endometriums an Tag 14 
untersucht. Hier waren konträr zu Tag 7 nur 14 Gene zwischen den Gruppen CDd14 und 
NPd14 unterschiedlich expremiert. Zwei Gene (C20ORF54 und FZD8) waren in CDd14 
hochreguliert, in NPd14 waren jedoch insgesamt 12 Gene hochreguliert, unter anderem 
LOC786821, BRWD1, ANKRD11, SLC25A12, GJA1, SCARA5, IIGLL1 fünf weitere 
ESTs. Insgesamt sind die Änderungen der Genexpressionsprofile zwischen CDd14 und 
NPd14 signifikant geringer als die Unterschiede an Tag 7. Daraus lässt sich schließen, dass 
an Hand der transkriptomisch funktionalen Änderungen an Tag 7 zwischen rezeptiven und 
nicht – rezeptiven Endometrien der Trächtigkeitserfolg deutlich besser absehbar ist als an 
Tag 14 des Östrus. Im Folgenden wurden die Unterschiede im Transkriptom der rezeptiven 
und nicht-rezeptiven Endometrien an Tag 7 und 14 untersucht, wobei besonders die 
temporäre Transkriptomdynamik des rezeptiven Endometiums betrachtet wurde, um die 
Veränderungen im Endometrium, die zwischen Tag 7 und Tag 14 ablaufen, besser 
verstehen zu können. Hierfür wurden die Genexpressionsprofile von CDd7 und CDd14 
gegenübergestellt. Insgesamt wurden 1867 Gene unterschiedlich expremiert, davon waren 
1014 Gene in CDd7 hochreguliert und 853 in CDd14. Eine funktionale Klassifikation der 
hochregulierten Gene von CDd7 zeigt mannigfaltige Funktionen, wie 
Zellmaterialtransport, Phosphorilierung und posttranslationale Proteinodifikationen. Auf 
der anderen Seite konnten die Gene, die an Tag 14 hochreguliert waren mit Immunantwort, 
Apoptose und Signaltransduktionen in Verbindung gebracht werden. Des Weiteren wurden 
21 molekulare Pathways von den Veränderungen im Endometrium von Tag 7 zu Tag 14 
beeinflusst. Gene der MAPK Signalisierung, Toll-like Rezeptor Signalisierung, 
Adipocytokine Signalisierung, Zell Adhesion Moleküle (CAMs) und extra Zellulare 
Matrix Rezeptoren waren stark bei der Expression im CDd7 Stadium vertreten. Auf der 
anderen Seite, Gene der PPAR Signalisierung, der Kalzium Signalisierung, der 
neuroactiven Ligand-Rezeptor Interaktion, des Arginin und Proline Metabolismus, der 
GnRH Signalisierung, des Urea Zykluses und Metabolismus von Aminosäuren, des 
Tryptophan Metabolismus, Glycine und des Serine und Threonine Metabolismus pathway, 
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waren am häufigsten in der CDd14 Gruppe vertreten. In ähnlicher Weise konnten 
Veränderungen des Transcriptoms im nicht- rezeptiven Endometrium zwischen Tag 7 und 
Tag 14 des Östrus, bei der vergleichenden Untersuchung von NPd7 und NPd14 
Endumetrium Proben, festgestellt werden. Insgesamt wurden 254 Gene unterschiedlich 
zwischen der NPd7 und der NPd14 Gruppe reguliert. Im Vergleich zur 
Transkriptomdynamik der rezeptiven Endrometrium (CDd7 vs. CDd14), war die Anzahl 
der unterschiedlich exprimierten gene und der funktionallen Kategorien die in NPd7 vs. 
NPd14 identifiziert wurden mit 1613 Genen niedriger unter der Angabe der transkriptomen 
Plastizität des rezeptivem Endrometrium während der Tage 7 und 14 des Östrus. Nachdem 
die Genexpressionsprofile der rezeptiven und nicht- rezeptiven Endometrien entschlüsselt 
waren, wurden die mRNA- und Proteinexpressionsprofile von einigen Kandidatengenen zu 
fünf verschiedenen Zeitpunkten des Östruses (Tag 0, 3, 7, 14, 19) sowie an Tag 50 der 
Trächtigkeit, von geschlachteten Färsen, gemessen. Dafür wurden sowohl Kadidatengene 
die im rezeptivem Endrometrium (CDd7) hochreguliert waren (IRF6, PTGER-4, ITPR1, 
ADORA2B, PTGS2/ COX-2, WNT11, CDC20 and TIMP3) sowie Gene (STAT5A, 
MMP2 and AGTR1) die eine erhöhte Expression im nicht – rezeptivem Endrometrium 
zeigten selektiert. Die Mehrheit dieser selektierten Kandidatengene wurde an Tag 7 und 14 
des Östruszykluses hochreguliert. Zusätzlich wurden die Gene IRF6, ITPR1, STAT5A und 
AGTR1 vom Proöstrus zum Diöstrus zunehmend stärker expremiert und erreichten ihren 
Höhepunkt zur Zeit der Trächtigkeit. Im Gegensatz dazu nahm die Expression der Gene 
PTGER4, PTGS2/COX-2, TIMP3 und ADORAB2B, die an Tag 7 und 14 hochreguliert 
waren, mit der Trächtigkeit ab. Des Weiteren zeigte die immunhistologische Lokalisation 
von IRF6, ITPR1, PTGS2 und MMP2 Unterschiede in den Proteinsignalintensitäten an der 
Oberfläche im Verlauf des Östruszykluses und der frühen Trächtigkeit. Die Luminal- und 
Drüsenepithelien sowie die Stromazellen lassen eine temporäre und räumliche Expression 
dieser Gene vermuten. Demzufolge ist es möglich, dass Gene, die im Verlauf des 
Östruszykluses stark oder schwach expremiert werden, die Implantation induzieren oder 
währenddessen abgeschaltet werden. Die Entwicklungskompetenz der Blastozysten ist in 
gleichem Maße entscheidend für den Trächtigkeitserfolg wie die Rezeptivität des 
Endometriums. Neben der Analyse des Endometriums wurden ebenfalls die Unterschiede 
in der Transkriptommenge der Embryobiopsien gemessen, gegliedert in Embryonen, die 
eine Trächtigkeit induzierten und die, die nicht zu einer Trächtigkeit führten. Dadurch 
konnten geeignete Kandidatengene gefunden werden die mit der Entwicklungskompetenz 
der Blastocysten assoziiert werden können. Mittels der Microarray Data Analyse konnten 
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70 Gene detektiert werden, die in den beiden Gruppen unterschiedlich expremiert wurden. 
Die Gene sind in verschieden funktionellen Kategorien wie, Genexpression, 
Zellsignalisierung und Zellkommunikation, Transport von Macromolekülen, Transferase 
und Chemokine Aktivität, involviert. Im Vergleich zur Expressionsanalyse der 
Endometrien, waren die Unterschiede jedoch zwischen den Gruppen der Embryonen 
deutlich geringer. Daraus lässt sich allerdings nicht schließen, dass das Endometrium und 
die maternale Umgebung einen größeren Einfluss auf den Trächtigkeitserfolg haben, als 
der Embryo selbst. Die Unterschiede resultieren vermutlich aus den verschiedenen 
Microarray Platformen. 
In der vorliegenden Arbeit wird ein deutlicher Zusammenhang zwischen den 
Genexpressionprofilen des Endometriums und der Blastozysten zum Trächtigkeitserfolg 
gezeigt. Die Daten heben besonders das Potential der endometrialen und embryonalen 
Transkripte hervor, die als Prediktoren für eine erfolgreiche Trächtigkeit dienen und eine 
Vorstufe für die Entwicklung von Kandidatengenen sind, die eine Selektion von optimalen 
Empfängertieren und potenten Embryonen möglich machen. Es sind jedoch weitere 
Untersuchungen erforderlich, um die exakte funktionale Wirkung der unterschiedlich 
expremierten Gene, die eine Trächtigkeit induzieren, zu verstehen. Zusätzliche 
Untersuchungen sind nötig, um zu verstehen, inwiefern sich die molekulare Signatur in 
aufeinanderfolgenden Zyklen gleicht. Insgesamt bringen diese Daten beachtliche 
Informationen hervor um die Trächtigkeitserfolge beim Rind mittels 
Genexpressionsanalysen vorherzusagen. 
.
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9 Appendices 
 
Appendix 1: The intensity distribution and uniformities between the arrays after normalization. (A): Pearson correlation of the arrays within 
and between the biological replicates. The red and blue colors represent higher and lower correlation, respectively. (B): Box-
plots indicating simple summary of the distribution of probe intensities across all arrays. Each box corresponds to one array.  
The boxes have similar size and Y position (median). (C): Density estimates (smoothed histograms) of the data showing 
similarities in shapes and ranges of the arrays 
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Appendix 2:  List of top differentially expressed genes between receptive (CDd7) and non-
receptive (NPd7) endometrium at day 7 of the estrous cycle. Negative and 
positive fold changes (FC) describe genes increased in CDd7 and NPd7, 
respectively. 
 
UniGene 
ID 
Gen title Gene symbol FC p value 
 
Bt.639 
 
Cell division cycle 20 homolog 
 
CDC20 
 
22.7 
 
0.003 
Bt.1522 Similar to hexokinase domain containing 1 LOC614824 17.2 0.022 
Bt.54026 Glutamate-cysteine ligase, catalytic subunit GCLC 11.0 0.000 
Bt.60335 Plasma membrane proteolipid (plasmolipin) PLLP 10.3 0.004 
Bt.91476 Collagen, type iv, alpha 4 COL4A4 9.8 0.000 
Bt.48435 Transmembrane protein 163 TMEM163 9.5 0.002 
Bt.40997 Hypothetical protein loc510320 LOC510320 9.3 0.001 
Bt.64166 Microsomal triglyceride transfer protein MTTP 9.3 0.001 
Bt.25546 Neuropilin (nrp) and tolloid (tll)-like 2 NETO2 9.1 0.003 
Bt.91771 Cell division cycle 2, g1 to s and g2 to m CDC2 7.4 0.002 
Bt.29868 Cytochrome c oxidase subunit vib testes-
specific  
COX6B2 7.4 0.002 
Bt.47953 Protein phosphatase 2 PPP2R5A 7.3 0.009 
Bt.24664 N-acetylated alpha-linked acidic dipeptidase 2 NAALAD2 7.2 0.012 
Bt.101388 Polo-like kinase 4 PLK4 7.2 0.000 
Bt.92053 Similar to cordon-bleu homolog (mouse) LOC505588 6.8 0.020 
Bt.13670 Alkaline phosphatase, liver/bone/kidney ALPL 6.7 0.043 
Bt.25034 Rab9b, member ras oncogene family RAB9B 6.5 0.000 
Bt.12794 Collagen, type iv, alpha 3 (goodpasture antigen) COL4A3 6.5 0.003 
Bt.20428 Protein regulator of cytokinesis 1 PRC1 6.3 0.002 
Bt.15730 Kinesin family member 2c KIF2C 6.2 0.019 
Bt.52359 Chromosome 9 open reading frame 30 ortholog C8H9orf30 6.2 0.025 
Bt.18700 Chromosome 11 open reading frame 16 C11orf16 6.1 0.019 
Bt.51579 Chromosome 14 open reading frame 37 
ortholog 
C10H14orf37 6.1 0.015 
Bt.21876 Wingless-type mmtv integration site family, 
member 11 
WNT11 5.9 0.045 
Bt.13057 Calcium channel, voltage-dependent, CACNA1H 5. 0.013 
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UniGene ID Gen title Gene symbol FC p value 
 
Bt.23453 
 
Spindle and kt associated 1 
 
SKA1 
 
5.8 
 
0.007 
Bt.65598 Thyroid hormone responsive  THRSP 5.8 0.000 
Bt.6129 Ndc80 homolog, kinetochore complex 
component (s. Cerevisiae) 
NDC80 5.7 0.014 
Bt.53123 Ubiquitin-conjugating enzyme e2c UBE2C 5.6 0.032 
Bt.28359 Hypothetical loc616971 LOC616971 5.5 0.000 
Bt.5578 Cytoskeleton associated protein 2-like CKAP2L 5.5 0.017 
Bt.64294 Aldo-keto reductase family 1, member c4  AKR1C4 5.5 0.047 
Bt.21924 Similar to dermatan/chondroitin sulfate 2-
sulfotransferase 
LOC535975 5.5 0.022 
Bt.26822 Similar to scl/tal1 interrupting locus LOC510012 5.4 0.001 
Bt.22305 Inositol 1,4,5-triphosphate receptor, type 1 ITPR1 5.3 0.017 
Bt.20340 Similar to myotonic dystrophy kinase LOC513675 5.3 0.046 
Bt.10882 Timp metallopeptidase inhibitor 3 (sorsby 
fundus dystrophy, pseudoinflammatory) 
TIMP3 5.3 0.016 
Bt.7037 Sphingosine kinase 1 SPHK1 5.2 0.002 
Bt.16037 Globoside alpha-1,3-n-
acetylgalactosaminyltransferase 1 
GBGT1 5.2 0.013 
Bt.58521 Claudin 5 (transmembrane protein deleted in 
velocardiofacial syndrome) 
CLDN5 5.2 0.001 
Bt.54858 Synovial sarcoma, x breakpoint 2 interacting 
protein 
SSX2IP 5.2 0.028 
Bt.91910 Sorbin and sh3 domain containing 2 SORBS2 5.2 0.007 
Bt.66560 Similar to map/microtubule affinity-
regulating kinase 3 
LOC534872 5.2 0.000 
Bt.48572 Guanine nucleotide binding protein (g 
protein), beta 5 
GNB5 5.1 0.000 
Bt.27994 Alanyl (membrane) aminopeptidase 
(aminopeptidase n, aminopeptidase m, 
microsomal aminopeptidase, cd13, p150) 
ANPEP 5.1 0.000 
Bt.21924 Similar to dermatan/chondroitin sulfate 2-
sulfotransferase 
LOC535975 5.0 0.000 
Bt.12757 Nerve growth factor (beta polypeptide) NGF 5.0 0.042 
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UniGene ID Gen title Gene symbol FC p value 
 
Bt.101478 
 
Granzyme k (granzyme 3; tryptase ii) 
 
GZMK 
 
4.9 
 
0.012 
Bt.38424 Dystonin DST 4.9 0.001 
Bt.28324 Nucleolar and spindle associated protein 1 NUSAP1 4.9 0.017 
Bt.41 Cyclin b2 CCNB2 4.9 0.023 
Bt.27135 Cysteine conjugate-beta lyase  CCBL1 4.8 0.034 
Bt.16830 Leucine zipper, down-regulated in cancer 1 LDOC1 4.8 0.045 
Bt.24872 Kinesin family member 4a KIF4A 4.8 0.000 
Bt.64525 Similar to elongation factor 1 alpha EEF1A1 4.8 0.004 
Bt.44919 Solute carrier family 6, member 20 SLC6A20 4.8 0.037 
Bt.17189 Protein kinase c, theta PRKCQ 4.7 0.005 
Bt.22869 Fatty acid binding protein 5 FABP5 4.7 0.005 
Bt.35560 Glycine n-methyltransferase GNMT 4.6 0.038 
Bt.34944 Phospholipid transfer protein PLTP 4.6 0.007 
Bt.59609 Junctional adhesion molecule 3 JAM3 4.6 0.000 
Bt.42379 Baculoviral iap repeat-containing 5 
(survivin) 
BIRC5 4.5 0.028 
Bt.43706 Actin binding lim protein 1 ABLIM1 4.5 0.001 
Bt.42997 Grancalcin, ef-hand calcium binding protein GCA 4.5 0.003 
Bt.12781 V-myb myeloblastosis viral oncogene 
homolog  
MYB 4.5 0.012 
Bt.12761 Integrin, alpha 2 (cd49b, alpha 2 subunit of 
vla-2  
ITGA2 4.5 0.014 
Bt.7142 Similar to aim1 LOC526200 4.5 0.000 
Bt.37590 Transketolase-like 1 TKTL1 4.5 0.010 
Bt.74758 Similar to chromosome 1 open reading frame  LOC520588 4.5 0.009 
Bt.53189 Tudor and kh domain containing TDRKH 4.4 0.001 
Bt.53256 Phospholipase c-like 2 PLCL2 4.4 0.017 
Bt.35935 Gap junction protein, beta 6, 30kda GJB6 4.4 0.039 
Bt.27397 Centrosomal protein 72kda CEP72 4.4 0.006 
Bt.54995 Synovial apoptosis inhibitor 1, synoviolin SYVN1 4.3 0.008 
Bt.10814 Coagulation factor ii (thrombin) receptor F2R 4.3 0.002 
Bt.38709 Rev3-like, catalytic subunit of dna 
polymerase  
REV3L 4.3 0.001 
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UniGene ID Gen title Gene symbol FC p value 
 
Bt.49510 
 
Inositol hexaphosphate kinase 2 
 
IHPK2 
 
4.3 
 
0.003 
Bt.13798 Hypothetical loc615685 LOC615685 4.3 0.008 
Bt.19592 Aquaporin 9 AQP9 4.3 0.011 
--- Rho-associated, coiled-coil containing 
protein kinase 1 
ROCK1 4.3 0.000 
Bt.21912 Eukaryotic translation initiation factor 2c, 2 EIF2C2 4.3 0.001 
Bt.30182 Chromosome 13 open reading frame 3 
ortholog 
H12C13ORF3 4.2 0.007 
Bt.5091 Diacylglycerol kinase, alpha 80kda DGKA 4.2 0.008 
Bt.76624 Cytoplasmic polyadenylation element 
binding protein 1 
CPEB1 4.1 0.014 
Bt.20920 Peroxisome proliferator-activated receptor 
gamma, coactivator 1 alpha 
PPARGC1A 4.1 0.013 
Bt.76544 Tumor necrosis factor receptor superfamily, 
member 6b, decoy 
TNFRSF6B 4.1 0.043 
Bt.39403 Kn motif and ankyrin repeat domains 2 KANK2 4.1 0.034 
Bt.100379 Non-smc condensin i complex, subunit g NCAPG 4.1 0.021 
Bt.46419 Six transmembrane epithelial antigen of the 
prostate 2 
STEAP2 4.0 0.028 
Bt.22046 Alpha-methylacyl-coa racemase AMACR 4.0 0.034 
Bt.7331 Aurora kinase b AURKB 4.0 0.026 
Bt.53247 Sushi domain containing 2 SUSD2 3.9 0.017 
Bt.56648 Similar to piggybac transposable element 
derived 5 
LOC616498 3.9 0.037 
Bt.66635 Ring finger 144b RNF144B 3.9 0.004 
Bt.64036 Guanylate binding protein 4 GBP4 3.9 0.018 
Bt.22054 Chromosome 20 open reading frame 7 
ortholog 
C13H20ORF7 3.82 0.004 
Bt.29462 Cell division cycle associated 2 CDCA2 3.8 0.010 
Bt.100721 Multiple c2 domains, transmembrane 1 MCTP1 3.8 0.022 
Bt.4747 Nucleoporin 88kda NUP88 3.8 0.021 
Bt.7490 Methylenetetrahydrofolate dehydrogenase  MTHFD1L 3.7 0.026 
Bt.20369 Proline dehydrogenase (oxidase) 1 PRODH 3.7 0.044 
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UniGene ID Gen title Gene symbol FC p value 
Bt.28617 Stomatin STOM 3.7 0.009 
Bt.101348 Ddhd domain containing 2 DDHD2 3.7 0.001 
Bt.44935 Lipase, endothelial LIPG 3.7 0.005 
Bt.4084 Wd repeat domain 51a WDR51A 3.7 0.003 
Bt.91990 Rho-related btb domain containing 1 RHOBTB1 3.7 0.016 
Bt.13573 Cdc28 protein kinase regulatory subunit 2 CKS2 3.6 0.003 
Bt.25030 Transmembrane 9 superfamily member 2 TM9SF2 3.6 0.016 
Bt.25834 Maternal embryonic leucine zipper kinase MELK 3.6 0.018 
Bt.16596 Leucine rich repeat containing 3 LRRC3 3.6 0.027 
Bt.28443 Microtubule associated monoxygenase, 
calponin and lim domain containing 2 
MICAL2 3.6 0.000 
Bt.90915 Sulfotransferase family, cytosolic, 2b, 
member 1 
SULT2B1 3.6 0.003 
Bt.25541 Coiled-coil domain containing 135 CCDC135 3.6 0.003 
Bt.14255 Farnesyl-diphosphate farnesyltransferase 1 FDFT1 3.6 0.039 
Bt.9659 Ectonucleotide 
pyrophosphatase/phosphodiesterase 3 
ENPP3 3.6 0.027 
Bt.8135 Lecithin retinol acyltransferase  LRAT 3.6 0.017 
Bt.25633 Regulator of g-protein signaling 22 RGS22 3.6 0.050 
Bt.14403 Adaptor-related protein complex 3, sigma 2  AP3S2 3.6 0.000 
Bt.8127 Heparanase HPSE 3.5 0.023 
Bt.65104 Heat shock 70kda protein 5 (glucose-
regulated protein, 78kda) 
HSPA5 3.5 0.001 
Bt.58805 Pituitary tumor-transforming 1 PTTG1 3.5 0.039 
Bt.28541 Shugoshin-like 1 (s. Pombe) SGOL1 3.5 0.023 
Bt.5487 Aldehyde dehydrogenase 3 family, member 
a2 
ALDH3A2 3.5 0.007 
Bt.39906 Hypoxia up-regulated 1 HYOU1 3.5 0.010 
Bt.24640 Ilvb (bacterial acetolactate synthase)-like ILVBL 3.5 0.015 
Bt.87527 Potassium channel tetramerisation domain 
containing 17 
KCTD17 3.5 0.037 
Bt.65646 Chromosome 20 open reading frame 195 
ortholog 
C13H20orf19
5 
3.4 0.025 
Bt.16891 Serum/glucocorticoid regulated kinase 1 SGK1 3.4 0.002 
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UniGene ID Gen title Gene symbol FC p value 
 
Bt.27878 
 
Solute carrier family 25, member 13 (citrin) 
 
SLC25A13 
 
3.4 
 
0.005 
Bt.543 Nuclear receptor subfamily 2, group f, 
member 1 
NR2F1 3.4 0.044 
Bt.36484 Stefin c LOC514170 3.4 0.032 
Bt.101226 Sterol regulatory element binding 
transcription factor 1 
SREBF1 3.4 0.008 
Bt.5099 Calponin 3, acidic CNN3 3.4 0.005 
Bt.74139 T-cell lymphoma invasion and metastasis 1 TIAM1 3.4 0.001 
Bt.49563 Rna binding motif (rnp1, rrm) protein 3 RBM3 3.4 0.010 
Bt.28192 Interferon regulatory factor 6 IRF6 3.4 0.041 
Bt.27973 Solute carrier organic anion transporter 
family, member 3a1 
SLCO3A1 3.4 0.048 
Bt.5959 Similar to retinal short chain dehydrogenase  LOC526726 3.4 0.029 
Bt.3699 Dynein, cytoplasmic 1, intermediate chain 1 DYNC1I1 3.4 0.006 
Bt.25924 Hypothetical protein loc540455 LOC540455 3.4 0.036 
Bt.28839 Absent in melanoma 1-like AIM1L 3.4 0.004 
Bt.10412 Opa interacting protein 5 OIP5 3.4 0.015 
Bt.85301 Histone cluster 1, h1c HIST1H1C 3.3 0.021 
Bt.43294 Acid phosphatase 2, lysosomal ACP2 3.3 0.004 
Bt.28185 Rac gtpase activating protein 1 RACGAP1 3.3 0.021 
Bt.16050 Solute carrier family, member 22 SLC25A22 3.3 0.000 
Bt.73560 Chromosome 10 open reading frame 119 
ortholog 
C26H10ORF119 3.3 0.011 
Bt.28476 Monoacylglycerol o-acyltransferase 1 MOGAT1 3.3 0.035 
Bt.44921 Denn/madd domain containing 2a DENND2A 3.3 0.001 
Bt.6685 Methylenetetrahydrofolate dehydrogenase  MTHFD2 3.3 0.010 
Bt.65454 Cytoskeleton associated protein 2 CKAP2 3.3 0.036 
Bt.49548 Mal, t-cell differentiation protein   3.3 0.017 
Bt.448 Phospholipase c, beta 1   3.2 0.018 
Bt.49367 Adaptor-related protein complex 1, sigma 1 
subunit 
AP1S1 3.2 0.026 
Bt.3946 Hypothetical loc509875 LOC509875 -21.8 0.005 
Bt.55266 Similar to procollagen alpha 2(v) LOC782818 -20.0 0.001 
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UniGene ID Gen title Gene symbol FC p value 
 
Bt.48850 
 
Secreted protein, acidic, cysteine-rich  
 
SPARC 
 
-15.6 
 
0.001 
Bt.23508 Collagen, type vi, alpha 1 COL6A1 -11.4 0.000 
Bt.5341 Osteoglycin OGN -11.4 0.002 
Bt.22571 Speckle-type poz protein SPOP -11.37 0.002 
Bt.101852 Immunoglobulin j chain IGJ -11.21 0.026 
Bt.61894 Lipoma hmgic fusion partner LHFP -10.8 0.001 
Bt.21896 Collagen, type xxi, alpha 1 COL21A1 -10.6 0.000 
Bt.15972 Gap junction protein, alpha 1, 43kda GJA1 -9.9 0.000 
Bt.101209 Collagen, type iii, alpha 1 COL3A1 -9.8 0.003 
Bt.64757 Neurotrophic tyrosine kinase, receptor, type 
2 
NTRK2 -9.6 0.000 
Bt.39894 Myosin light chain kinase MYLK -9.4 0.001 
Bt.53485 Collagen, type i, alpha 2 COL1A2 -9.2 0.001 
Bt.27144 Homeobox a9 HOXA9 -8.8 0.001 
Bt.39050 Cannabinoid receptor interacting protein 1 CNRIP1 -8.6 0.001 
Bt.2452 Lumican LUM -8.3 0.001 
Bt.101209 Collagen, type iii, alpha 1  COL3A1 -7.7 0.001 
Bt.4565 Snail homolog 2 (drosophila) SNAI2 -7.3 0.002 
Bt.4011 Transmembrane protein 120a TMEM120A -7.0 0.000 
Bt.2750 Transcription factor ap-2 alpha  TFAP2A -6.9 0.046 
Bt.30575 Scavenger receptor class a, member 5 SCARA5 -6.8 0.000 
Bt.42075 Udp glucuronosyltransferase 2 family UGT2A3 -6.4 0.026 
Bt.357 S100 calcium binding protein a12 (calgranulin 
c) 
S100A12 -6.3 0.018 
Bt.95150 Purinergic receptor p2y, g-protein coupled, 5 P2RY5 -6.3 0.000 
Bt.68159 Collagen, type vi, alpha 3 COL6A3 -6.2 0.002 
Bt.9360 S100 calcium binding protein a8 S100A8 -6.1 0.049 
Bt.18710 Dickkopf homolog 3 (xenopus laevis) DKK3 -6.0 0.005 
Bt.64757 Neurotrophic tyrosine kinase, receptor, type 
2 
NTRK2 -5.9 0.014 
Bt.64625 Apolipoprotein d APOD -5.7 0.007 
Bt.81912 Similar to ob-cadherin-1 CDH11  -5.5 0.001 
Bt.23178 Decorin DCN -5.4 0.002 
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UniGene ID Gen title Gene symbol FC p value 
 
Bt.31739 
 
Abi gene family, member 3 (nesh) binding 
protein 
 
ABI3BP 
 
-5.4 
 
0.005 
Bt.2214 Insulin-like growth factor binding protein 7 IGFBP7 -5.1 0.017 
Bt.11586 Pyd and card domain containing PYCARD -4.7 0.007 
Bt.91101 Metallothionein 1e MT1E -4.7 0.004 
Bt.8880 Sparc-like 1 (mast9, hevin) SPARCL1 -4.7 0.001 
Bt.92589 Roundabout, axon guidance receptor, 
homolog 1  
ROBO1 -4.6 0.011 
Bt.59000 Similar to calcium-activated chloride 
channel-2 
LOC534256 -4.6 0.016 
Bt.2524 Stromal cell-derived factor 1 SDF1 -4.5 0.009 
Bt.89332 Fibroblast growth factor-binding protein (fgf-
bp) 
LOC281812  -4.5 0.000 
Bt.51822 Collagen, type xvi, alpha 1 COL16A1 -4.3 0.020 
Bt.5116 Hypothetical loc506831 LOC506831 -4.3 0.000 
Bt.20385 Phospholipase a1 member a PLA1A -4.3 0.000 
Bt.28406 Fc fragment of igg, low affinity iib, receptor  FCGR2B -4.3 0.023 
Bt.45949 Protein tyrosine phosphatase-like a domain 
containing 2 
PTPLAD2 -4.3 0.047 
Bt.13484 Protein phosphatase 1, regulatory  PPP1R3C -4.2 0.000 
Bt.64897 Insulin-like growth factor binding protein 3 IGFBP3 -4.1 0.014 
Bt.19195 Coagulation factor xiii, a1 polypeptide F13A1 -4.1 0.014 
Bt.46205 Coiled-coil domain containing 68 CCDC68 -4.1 0.003 
Bt.45446 Similar to nonclathrin coat protein zeta-cop LOC616222 -3.9 0.001 
Bt.48113 Doublecortin-like kinase 1 DCLK1 -3.9 0.001 
Bt.4539 Angiotensin ii receptor, type 1 AGTR1 -3.9 0.000 
Bt.6728 Necdin homolog (mouse) NDN -3.9 0.002 
Bt.26788 Hypothetical loc535329 LOC535329 -3.9 0.001 
Bt.4492 Collectin sub-family member 12 COLEC12 -3.8 0.001 
Bt.27022 Homeobox a11 HOXA11 -3.8 0.003 
Bt.8106 Nidogen 1 NID1 -3.7 0.052 
Bt.43948 Cd36 molecule (thrombospondin receptor) CD36 -3.6 0.010 
Bt.9549 Hop homeobox HOPX -3.6 0.027 
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Bt.991 
 
Collagen, type xxvii, alpha 1 
 
COL27A1 
 
-3.5 
 
0.001 
Bt.2717 Fibroblast activation protein, alpha FAP -3.5 0.021 
Bt.17819 Sodium channel, nonvoltage-gated 1, gamma SCNN1G -3.5 0.035 
Bt.28237 Similar to family with sequence similarity 
114,  
LOC511583 -3.4 0.001 
Bt.55899 Solute carrier family 15 (h+/peptide 
transporter 
SLC15A2 -3.4 0.006 
Bt.9675 Similar to extracellular proteinase inhibitor LOC787253 -3.4 0.049 
Bt.47030 Similar to polydom LOC781282 -3.4 0.010 
Bt.45145 Asporin ASPN -3.4 0.000 
Bt.21035 S100 calcium binding protein a16 S100A16 -3.4 0.000 
Bt.643 Similar to mpif-1 LOC508666 -3.3 0.013 
Bt.29568 Ell associated factor 2 EAF2 -3.3 0.015 
Bt.5226 Secreted frizzled-related protein 1 SFRP1 -3.3 0.008 
Bt.48519 Rna binding protein with multiple splicing RBPMS -3.3 0.002 
Bt.62191 Rab interacting lysosomal protein-like 2 RILPL2 -3.3 0.004 
Bt.23618 Spondin 1, extracellular matrix protein SPON1 -3.2 0.007 
Bt.50 Cd8a molecule CD8A -3.2 0.003 
Bt.91540 Keratin 17 KRT17 -3.2 0.010 
Bt.4886 Leucine rich repeat containing 17 LRRC17 -3.2 0.022 
Bt.49620 Tnfrsf16 associated protein 1 NGFRAP1  -3.2 0.014 
Bt.36848 8kda amlexanox-binding protein S100A13 -3.2 0.003 
Bt.48875 Udp-gal:betaglcnac beta 1,3-
galactosyltransferase 
B3GALT2 -3.1 0.020 
Bt.25507 Meis homeobox 2 MEIS2 -3.1 0.012 
Bt.24447 Coagulation factor II recptor-like 2 F2RL2 -3.1 0.008 
Bt.33171 Methionine sulfoxide reductase b3 MSRB3 -3.1 0.018 
Bt.8222 Transmembrane protein 139 TMEM139 -3.1 0.002 
Bt.29642 Nitric oxide synthase 1 (neuronal) adaptor 
protein 
NOS1AP -3.1 0.006 
Bt.9958 Insulin-like growth factor binding protein 6 IGFBP6 -3.1 0.007 
Bt.207 Transthyretin type I TTR -3.1 0.042 
Bt.65440 Hypothetical protein loc781372 LOC781372 -3.0 0.018 
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Bt.11286 Coiled-coil-helix-coiled-coil-helix domain 
containing 6 
CHCHD6 -3.0 0.034 
Bt.9573 Fxyd domain containing ion transport 
regulator 3 
FXYD3 -3.0 0.001 
Bt.78 Crystallin, beta b1 CRYBB1 -3.0 0.024 
Bt.11446 Lim domain binding 2 LDB2 -3.0 0.032 
Bt.62727 Transmembrane protein 204 TMEM204 -2.9 0.002 
Bt.54851 Inhibitor of kappa light polypeptide gene 
enhancer in b-cells, kinase epsilon 
IKBKE -2.9 0.002 
Bt.64122 Supervillin SVIL -2.9 0.013 
Bt.45845 G protein-coupled receptor 77 GPR77 -2.9 0.002 
Bt.14395 Hypothetical protein loc780785 C3orf57 -2.9 0.011 
--- Frizzled homolog 2 (drosophila) FZD2 -2.9 0.008 
Bt.611 Chemokine (c-x-c motif) ligand 2 CXCL2 -2.9 0.020 
Bt.22323 Ras association (ralgds/af-6) domain family  RASSF5 -2.9 0.017 
Bt.1907 Similar to chromosome 11 open reading 
frame 52 
LOC614490 -2.9 0.004 
Bt.3213 Chordin-like 1 CHRDL1 -2.9 0.003 
Bt.2047 Adrenomedullin ADM -2.9 0.026 
Bt.66957 Fibroblast growth factor 2 (basic) FGF2 -2.9 0.002 
Bt.411 Neuregulin 1 NRG1 -2.8 0.031 
Bt.8144 Chemokine (c motif) ligand 1 XCL1 -2.8 0.020 
Bt.56229 T-cell receptor beta chain c region LOC509513  -2.8 0.014 
Bt.10343 Palmdelphin PALMD -2.8 0.030 
Bt.28814 Similar to sulfatase 1 LOC535166 -2.8 0.047 
Bt.12414 CD8b molecule CD8B -2.8 0.000 
Bt.47753 Six homeobox 1 SIX1 -2.8 0.008 
Bt.22534 Peripheral myelin protein 22 PMP22 -2.8 0.031 
Bt.1579 Polymerase i and transcript release factor PTRF -2.7 0.000 
Bt.41201 Poly polymerase family, member 16 PARP16 -2.7 0.002 
Bt.20613 Breast cancer anti-estrogen resistance 3 BCAR3 -2.7 0.006 
Bt.3216 Armadillo repeat containing, x-linked 1 ARMCX1 -2.7 0.001 
Bt.16029 Fucosyltransferase 1 FUT1 -2.7 0.002 
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Bt.36593 Fibromodulin FMOD -2.7 0.045 
Bt.13273 Suppressor of cytokine signaling 2 SOCS2 -2.7 0.010 
Bt.7031 Cytokine receptor-like factor 3 CRLF3 -2.7 0.002 
Bt.18476 Interferon regulatory factor 5 IRF5 -2.7 0.049 
Bt.92434 B-cell cll/lymphoma 11a (zinc finger protein) BCL11A -2.7 0.033 
Bt.45633 Phosphoinositide-3-kinaseinteractingprotein1 PIK3IP1 -2.7 0.010 
Bt.52435 Zinc finger, mynd-type containing 8 ZMYND8 -2.6 0.001 
Bt.11149 Vimentin VIM -2.63 0.014 
Bt.2638 Serpin peptidase inhibitor, clade f , member 1 SERPINF1 -2.6 0.042 
Bt.41326 D component of complement (adipsin) DF -2.6 0.000 
Bt.16738 Iroquois homeobox 3 IRX3 -2.6 0.004 
Bt.41792 Chemokine (c-c motif) ligand 28 CCL28 -2.6 0.002 
Bt.58299 Clmodulin-dependentprotein kinase  II delta CAMK2D -2.6 0.002 
Bt.5313 Matrix metallopeptidase 2  MMP2 -2.6 0.014 
Bt.61846 Tumor protein p53 inducible protein 3 TP53I3 -2.6 0.015 
Bt.8820 Hematopoietic cell-specific lyn substrate 1 HCLS1 -2.6 0.020 
Bt.9832 Musculoskeletal, embryonic nuclear protein1 MUSTN1 -2.6 0.001 
Bt.22381 Phospholipase a2, group x PLA2G10 -2.6 0.001 
Bt.100458 Suppressor of ty 3 homolog (s. Cerevisiae) SUPT3H -2.6 0.006 
Bt.26426 Rna binding motif protein 43 RBM43 -2.6 0.005 
Bt.9563 Ankyrin repeat, and basic leucine zipper 1 ASZ1 -2.6 0.037 
Bt.2966 Dedicator of cytokinesis 11 DOCK11 -2.6 0.013 
Bt.8795 Dysferlin DYSF -2.5 0.002 
Bt.9102 Gtpase, imap family member MGC137405 -2.5 0.014 
Bt.2698 Fk506 binding protein 10, 65 kda FKBP10 -2.5 0.001 
Bt.27976 Timp metallopeptidase inhibitor 1 TIMP1 -2.5 0.000 
Bt.25901 Denn/madd domain containing 4a DENND4A -2.5 0.007 
Bt.11276 Zinc finger protein 503 ZNF503 -2.5 0.008 
Bt.21164 V-myc myelocytomatosis viral oncogene  MYC -2.5 0.001 
Bt.28198 Intestine-specific transcript 1 protein CIST1 -2.5 0.009 
Bt.351 Coronin, actin binding protein, 1a CORO1A -2.5 0.050 
Bt.234 Interleukin 18  IL18 -2.5 0.003 
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Appendix 3: List of molecular networks containing genes elevated (upward red arrow) or 
reduced (downward green arrow) in CDd7 compared to NPd7 
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Cell cycle 
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and development 
Cell cycle, DNA 
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lipid metabolism 
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Endocrine System 
development  
Connective tissue 
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Lipid Metabolism 
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Appendix 4:  List of top differentially expressed genes between day 7 and day 14 of the 
estrous cycle (CDd7 vs. CDd14) in receptive endometrium. Negative and 
positive fold changes (FC) describe genes increased in CDd7 and CDd14, 
respectively 
 
UniGene ID Gene title Gene symbol FC p value 
 
Bt.22642 
 
Diacylglycerol kinase, iota 
 
DGKI 
 
396.8 
 
0.000 
Bt.74713 Hypothetical protein mgc127538 MGC127538 271.6 0.001 
Bt.26462 Endothelin 3 EDN3 208.2 0.001 
Bt.20340 Similar to myotonic dystrophy kinase LOC513675 158.7 0.000 
--- Seminal vesicle secretion 8 SVS8 102.0 0.000 
--- Similar to family with sequence similarity 43, 
member a 
LOC539374 100.4 0.000 
Bt.51579 Chromosome 14 open reading frame 37 
ortholog 
C10H14orf37 83.5 0.000 
Bt.60923 Spc24, ndc80 kinetochore complex 
component, homolog  
SPC24 82.9 0.000 
Bt.20369 Proline dehydrogenase (oxidase) 1 PRODH 78.9 0.000 
Bt.45257 Pdz domain containing 1 PDZK1 74.7 0.008 
Bt.60335 Plasma membrane proteolipid (plasmolipin) PLLP 72.0 0.000 
Bt.15980 Cyclin b1 CCNB1 66.6 0.000 
Bt.5387 Lipoprotein lipase LPL 65.3 0.000 
Bt.46878 Glycerophosphodiester phosphodiesterase 
domain containing 1 
GDPD1 53.5 0.001 
Bt.9602 Death associated protein-like 1 DAPL1 53.3 0.000 
Bt.53247 Sushi domain containing 2 SUSD2 52.7 0.000 
Bt.1539 Gm2 ganglioside activator GM2A 38.9 0.000 
Bt.24904 Adam metallopeptidase with thrombospondin 
type 1 motif, 6 
ADAMTS6 38.6 0.002 
Bt.44919 Solute carrier family 6 (proline imino 
transporter), member 20 
SLC6A20 32.8 0.000 
Bt.49607 3-hydroxybutyrate dehydrogenase, type 1 BDH1 31.5 0.002 
Bt.60335 Plasma membrane proteolipid (plasmolipin) PLLP 29.3 0.001 
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Bt.1207 
 
Solute carrier family 16, member 13  
 
SLC16A13 
 
28.4 
 
0.002 
Bt.16830 Leucine zipper, down-regulated in cancer 1 LDOC1 27.4 0.001 
Bt.17189 Protein kinase c, theta PRKCQ 26.9 0.000 
Bt.3949 6-phosphofructo-2-kinase PFKFB2 26.3 0.000 
Bt.13588 Phosphoserine aminotransferase 1 PSAT1 26.1 0.001 
Bt.35560 Glycine n-methyltransferase GNMT 25.3 0.001 
Bt.35560 Glycine n-methyltransferase GNMT 25.1 0.001 
Bt.5091 Diacylglycerol kinase, alpha 80kda DGKA 25.1 0.000 
Bt.26921 Solute carrier family 27 (fatty acid 
transporter), member 6 
SLC27A6 23.9 0.004 
Bt.22697 Solute carrier family 39 (zinc transporter SLC39A8 23.4 0.000 
Bt.7037 Sphingosine kinase 1 SPHK1 23.3 0.000 
Bt.13057 Calcium channel, voltage-dependent, t type, 
alpha 1h subunit 
CACNA1H 23.2 0.000 
Bt.8135 Lecithin retinol acyltransferase 
(phosphatidylcholine--retinol o-
acyltransferase) 
LRAT 22.4 0.000 
Bt.58521 Claudin 5 (transmembrane protein deleted in 
velocardiofacial syndrome) 
CLDN5 22.2 0.000 
Bt.24664 N-acetylated alpha-linked acidic dipeptidase 
2 
NAALAD2 21.4 0.001 
Bt.16037 Globoside alpha-1,3-n-
acetylgalactosaminyltransferase 1 
GBGT1 21.3 0.000 
Bt.27135 Cysteine conjugate-beta lyase loc781909 CCBL1 21.2 0.001 
Bt.39860 Was interacting protein family, member 3 WIPF3 21.1 0.000 
Bt.52359 Chromosome 9 open reading frame 30 
ortholog 
C8H9orf30 20.5 0.002 
Bt.4844 Pleiotrophin (heparin binding growth factor 8 PTN 19.6 0.007 
Bt.49548 Mal, t-cell differentiation protein /// similar to 
mal, t-cell differentiation protein 
MAL 17.5 0.000 
Bt.53026 Phosphoglycerate dehydrogenase PHGDH 16.8 0.001 
Bt.51909 Adiponectin receptor 2 ADIPOR2 16.7 0.002 
Bt.22305 Inositol 1,4,5-triphosphate receptor, type 1 ITPR1 16.4 0.001 
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Bt.639 
 
Cell division cycle 20 homolog  
 
CDC20 
 
16.3 
 
0.005 
Bt.25235 Mitochondrial ribosomal protein s36 MRPS36 15.3 0.000 
Bt.53600 Cytochrome b5 type b  CYB5B 15.2 0.000 
Bt.10882 Timp metallopeptidase inhibitor 3 (sorsby 
fundus dystrophy, pseudoinflammatory) 
TIMP3 15.2 0.001 
Bt.46878 Glycerophosphodiester phosphodiesterase 
domain containing 1 
GDPD1 15.2 0.002 
Bt.46419 Six transmembrane epithelial antigen of the 
prostate  
STEAP2 15.0 0.001 
Bt.39403 Kn motif and ankyrin repeat domains 2 KANK2 14.8 0.001 
Bt.40997 Hypothetical protein loc510320 LOC510320 14.7 0.000 
Bt.51709 Septin 4 Sep 04 14.6 0.000 
Bt.22399 Arginase, type ii ARG2 14.6 0.002 
Bt.21876 Wingless-type mmtv integration site family, 
member 11 
WNT11 14.5 0.007 
Bt.22336 Teratocarcinoma-derived growth factor 1 TDGF1 14.2 0.005 
Bt.75644 Membrane bound o-acyltransferase domain 
containing 2 
MBOAT2 14.0 0.016 
Bt.52324 Nuclear protein 1 NUPR1 13.7 0.001 
Bt.43717 Hydroxyprostaglandin dehydrogenase 15-
(nad) 
HPGD 13.5 0.006 
Bt.5487 Aldehyde dehydrogenase 3 family, member 
a2 
ALDH3A2 13.3 0.000 
Bt.64525 Similar to elongation factor 1 alpha EEF1A1 12.7 0.000 
Bt.53600 Cytochrome b5 type b  CYB5B 12.3 0.000 
Bt.91476 Collagen, type iv, alpha 4 COL4A4 11.6 0.000 
Bt.54026 Glutamate-cysteine ligase, catalytic subunit GCLC 11.6 0.000 
Bt.45508 Mucolipin 3 MCOLN3 11.4 0.047 
Bt.25034 Rab9b, member ras oncogene family RAB9B 11.4 0.000 
Bt.76544 Tumor necrosis factor receptor superfamily TNFRSF6B 11.2 0.003 
Bt.92053 Similar to cordon-bleu homolog (mouse) LOC505588 11.0 0.006 
Bt.48435 Transmembrane protein 163 TMEM163 10.6 0.002 
Bt.38424 Dystonin DST 10.6 0.000 
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Bt.25525 
 
Ectonucleotide phosphodiesterase 2  
 
ENPP2 
 
10.5 
 
0.000 
Bt.22046 Alpha-methylacyl-coa racemase AMACR 10.4 0.002 
Bt.5193 Acid phosphatase 5, tartrate resistant ACP5 10.4 0.000 
Bt.101236 Two pore segment channel 1 TPCN1 10.3 0.000 
Bt.13798 Hypothetical loc615685 LOC615685 10.2 0.000 
Bt.24640 Ilvb (bacterial acetolactate synthase)-like ILVBL 10.1 0.000 
Bt.25546 Neuropilin (nrp) and tolloid (tll)-like 2 NETO2 10.1 0.003 
Bt.9659 Ectonucleotide 
pyrophosphatase/phosphodiesterase3  
ENPP3 9.9 0.001 
Bt.16596 Leucine rich repeat containing 3 LRRC3 9.9 0.001 
Bt.64882 Dihydropyrimidinase-like 2 DPYSL2 9.8 0.000 
Bt.7490 Methylenetetrahydrofolate dehydrogenase 
(nadp+ dependent) 1-like 
MTHFD1L 9.7 0.001 
Bt.90915 Sulfotransferase family, cytosolic, 2b, 
member 1 
SULT2B1 9.5 0.000 
Bt.87527 Potassium channel tetramerisation domain 
containing 17 
KCTD17 9.5 0.002 
Bt.49702 Visinin-like 1 VSNL1 9.5 0.000 
Bt.64166 Microsomal triglyceride transfer protein MTTP 9.3 0.001 
Bt.92053 Similar to cordon-bleu homolog (mouse) LOC505588 9.2 0.010 
Bt.66560 Similar to map/microtubule affinity-
regulating kinase 3 
LOC534872 9.2 0.000 
Bt.65258 Matrilin 2 MATN2 9.1 0.036 
Bt.91589 Ero1-like ERO1L 9.1 0.002 
Bt.18700 Chromosome 11 open reading frame 16 C11orf16 9.1 0.007 
Bt.25235 Mitochondrial ribosomal protein s36 MRPS36 9.1 0.001 
Bt.49610 S100 calcium binding protein b S100B 8.9 0.001 
Bt.21924 Similar to dermatan/chondroitin sulfate 2-
sulfotransferase 
LOC535975 8.8 0.007 
Bt.7142 Similar to aim1 LOC526200 8.8 0.000 
Bt.22054 Chromosome 20 open reading frame 7  C13H20ORF7 8.7 0.000 
Bt.13798 Hypothetical loc615685 LOC615685 8.7 0.004 
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Bt.7043 
 
Vascular cell adhesion molecule 1 
 
VCAM1 
 
8.6 
 
0.007 
Bt.101039 Similar to kiaa0672 gene product LOC509257 8.7 0.005 
Bt.4998 Procollagen-lysine oxoglutarate dioxygenase  PLOD1 8.5 0.000 
Bt.28476 Monoacylglycerol o-acyltransferase 1 MOGAT1 8.5 0.002 
Bt.2887 Nudix (nucleoside diphosphate linked moiety 
x)-type motif 5 
NUDT5 8.3 0.000 
Bt.42906 Phosphoribosyl pyrophosphate synthetase-
associated protein 1 
PRPSAP1 8.3 0.000 
Bt.36484 Stefin c LOC514170 8.3 0.002 
Bt.62758 Glucuronidase, beta GUSB 8.3 0.001 
Bt.1207 Solute carrier family 16, member 13  SLC16A13 8.1 0.004 
Bt.7142 Similar to aim1 LOC526200 8.0 0.000 
Bt.51597 Thiosulfate sulfurtransferase (rhodanese) TST 8.0 0.000 
Bt.46406 Oxoglutarate (alpha-ketoglutarate) 
dehydrogenase  
OGDH 8.0 0.000 
Bt.91285 Gata binding protein 2 GATA2 7.9 0.000 
Bt.41964 Methionyl aminopeptidase 1 METAP1 7.9 0.000 
Bt.65743 Histamine n-methyltransferase HNMT 7.8 0.000 
Bt.12794 Collagen, type iv, alpha 3 (goodpasture 
antigen) 
COL4A3 7.8 0.002 
Bt.101388 Polo-like kinase 4 PLK4 7.8 0.000 
Bt.3699 Dynein, cytoplasmic 1, intermediate chain 1 DYNC1I1 7.8 0.000 
Bt.23641 Carbonic anhydrase xiii CA13 7.8 0.003 
Bt.17182 Gap junction protein, beta 5, 31.1kda GJB5 7.7 0.000 
Bt.88935 Creatine kinase, brain CKB 7.7 0.003 
Bt.91302 Similar to enpp5 LOC512304 7.7 0.000 
Bt.21101 Aminocarboxymuconate semialdehyde 
decarboxylase 
ACMSD 7.7 0.017 
Bt.9850 Transmembrane protein 171 TMEM171 7.6 0.000 
Bt.8091 Cell division cycle associated 4 CDCA4 7.6 0.000 
Bt.13798 Hypothetical loc615685 LOC615685 7.6 0.002 
Bt.9094 Unc-13 homolog d (c. Elegans) UNC13D 7.5 0.002 
Bt.29868 Cytochrome c oxidase subunit vib  COX6B2 7.4 0.002 
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Bt.396 
 
Cellular retinoic acid binding protein 1 
 
CRABP1 
 
7.3 
 
0.029 
Bt.4747 Nucleoporin 88kda NUP88 7.3 0.002 
Bt.53189 Tudor and kh domain containing TDRKH 7.2 0.000 
Bt.20428 Protein regulator of cytokinesis 1 PRC1 7.2 0.001 
Bt.20920 Peroxisome proliferator-activated receptor 
gamma, coactivator 1 alpha 
PPARGC1A 7.1 0.000 
Bt.87354 Six transmembrane epithelial antigen of the 
prostate 1 
STEAP1 7.1 0.014 
Bt.20013 Elovl family member 7, elongation of long 
chain fatty acids (yeast) 
ELOVL7 7.1 0.006 
Bt.43706 Actin binding lim protein 1 ABLIM1 7.1 0.000 
Bt.19643 Potassium large conductance calcium-
activated channel, subfamily,   beta member  
4 
KCNMB4 6.8 0.005 
Bt.13399 Beta-1,4-n-acetyl-galactosaminyl transferase 
2 
B4GALNT2 6.8 0.026 
Bt.64734 Armadillo repeat containing 8 ARMC8 6.7 0.000 
Bt.48867 Cytochrome p450, family 2, subfamily  CYP2C87 6.7 0.033 
Bt.37565 Ribosomal protein s6 kinase, 90kda, 
polypeptide 5 
RPS6KA5 6.7 0.000 
Bt.57528 Similar to ikappabkinase complex-associated 
protein 
LOC505465 6.6 0.000 
Bt.33887 Surfactant, pulmonary-associated protein d  CL-46  6.6 0.023 
Bt.9662 Prostaglandin e receptor 4 (subtype ep4) PTGER4 6.5 0.000 
Bt.24154 Transcription factor dp-2  TFDP2 6.4 0.000 
Bt.34944 Phospholipid transfer protein PLTP 6.4 0.002 
Bt.13798 Hypothetical loc615685 LOC615685 6.4 0.001 
Bt.27994 Alanyl (membrane) aminopeptidase  ANPEP 6.4 0.000 
Bt.92594 Chromosome 4 open reading frame 34 
ortholog 
C6H4orf34 6.3 0.001 
Bt.49270 Receptor accessory protein 4 REEP4 6.2 0.000 
Bt.7142 Similar to aim1 LOC526200 6.2 0.000 
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Bt.11180 
 
Leucine rich repeat neuronal 5 precursor 
 
LRRN5 
 
6.2 
 
0.001 
Bt.12757 Nerve growth factor (beta polypeptide) NGF 6.2 0.026 
Bt.26607 Glypican 1 GPC1 6.2 0.000 
Bt.15730 Kinesin family member 2c KIF2C 6.2 0.020 
Bt.44571 Similar to tumor necrosis factor, alpha-
induced protein 2 
LOC786672 6.1 0.006 
Bt.38709 Rev3-like, catalytic subunit of DNA 
polymerase zeta  
REV3L 6.1 0.000 
Bt.12781 V-myb myeloblastosis viral oncogene  MYB 6.1 0.004 
Bt.74139 T-cell lymphoma invasion and metastasis 1 TIAM1 6.1 0.000 
Bt.37590 Transketolase-like 1 TKTL1 6.1 0.004 
Bt.58988 Solute carrier family 31 (copper transporters), 
member 2 
SLC31A2 6.1 0.002 
Bt.7133 Ornithine decarboxylase 1 ODC1 6.1 0.000 
Bt.41728 Solute carrier family 39 (zinc transporter), 
member 2 
SLC39A2 -418.0 0.001 
Bt.132 Defensin, beta 1 DEFB1 -160.3 0.000 
Bt.1300 Tubulointerstitial nephritis antigen-like 1 TINAGL1 -157.1 0.004 
Bt.6410 Chromosome 11 open reading frame 34 
ortholog 
C15H11ORF3
4 
-130.6 0.007 
Bt.594 Uterine milk protein precursor LOC286871 -97.4 0.005 
Bt.49740 Interleukin 8 IL8 -91.5 0.001 
Bt.452 Glycosylphosphatidylinositol specific 
phospholipase D1 
GPLD1 -91.3 0.003 
Bt.67194 Lysozyme 1 LYZ1 -72.0 0.005 
Bt.190 Insulin-like growth factor binding protein 1 IGFBP1 -45.2 0.006 
Bt.594 Uterine milk protein precursor LOC286871 -41.5 0.005 
Bt.27007 Unc-45 homolog B (C. Elegans) UNC45B -40.5 0.016 
Bt.7393 Nephronectin NPNT -38.3 0.001 
Bt.13029 Hypocretin (orexin) receptor 1 HCRTR1 -36.5 0.006 
Bt.40113 Solute carrier family 16, member 1  SLC16A1 -32.8 0.004 
Bt.31841 Talin 2 TLN2 -28.0 0.000 
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Appendix 4: Cont.   
UniGene ID Gene title Gene symbol FC p value 
 
Bt.13772 
 
Cytochrome P450, subfamily I (aromatic 
compound-inducible), polypeptide 1 
 
CYP1A1 
 
-23.0 
 
0.017 
Bt.13860 Kinase insert domain receptor (a type III 
receptor tyrosine kinase) 
KDR -22.1 0.005 
Bt.23889 Microtubule-associated protein 2 MAP2 -20.2 0.011 
Bt.6087 Transmembrane 4 L six family member 1 TM4SF1 -18.8 0.001 
Bt.28230 Complement factor H-related 3 CFHR3 -17.5 0.011 
Bt.6410 Chromosome 11 open reading frame 34 
ortholog 
H15C11ORF3
4 
-17.4 0.031 
Bt.49470 Solute carrier family 5  SLC5A11 -16.8 0.005 
Bt.11462 Syndecan 2 SDC2 -15.9 0.001 
Bt.27910 Chromosome 20 open reading frame 54 C20orf54 -14.8 0.000 
Bt.468 Cystic fibrosis transmembrane conductance 
regulator  
CFTR -14.7 0.001 
Bt.12967 Cadherin 16, KSP-cadherin CDH16 -14.2 0.010 
Bt.15758 Prostaglandin-endoperoxide synthase 2 
(prostaglandin G/H synthase and 
cyclooxygenase) 
PTGS2 -14.1 0.018 
Bt.21896 Collagen, type XXI, alpha 1 COL21A1 -14.0 0.000 
Bt.5318 Retinol binding protein 4, plasma RBP4 -13.8 0.008 
Bt.6087 Transmembrane 4 L six family member 1 TM4SF1 -13.4 0.000 
Bt.9632 Deleted in malignant brain tumors 1 DMBT1 -12.8 0.001 
Bt.4645 Similar to c1orf24 LOC504817 -12.6 0.001 
Bt.13860 Kinase insert domain receptor (a type III 
receptor tyrosine kinase) 
KDR -12.0 0.004 
Bt.89332 Fibroblast growth factor-binding protein  LOC281812  -12.0 0.000 
Bt.26155 N-acetylneuraminate pyruvate lyase  NPL -11.9 0.004 
Bt.50127 Similar to RAD21-like 1 (S. Pombe) LOC512408 -11.5 0.001 
Bt.357 S100 calcium binding protein A12  S100A12 -11.4 0.004 
Bt.28620 Solute carrier family 27  SLC27A2 -10.8 0.022 
Bt.31739 ABI gene family, member 3 binding protein ABI3BP -10.2 0.001 
Bt.49731 Carbonic anhydrase II CA2 -10.0 0.029 
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Appendix 4: Cont.   
UniGene ID Gene title Gene symbol FC p value 
 
Bt.88771 
 
Transmembrane protein 45B 
 
TMEM45B 
 
-9.9 
 
0.006 
Bt.60687 Formin-like 3 FMNL3 -9.5 0.004 
Bt.20477 Raftlin, lipid raft linker 1 RFTN1 -9.1 0.017 
Bt.388 RAB3B, member RAS oncogene family RAB3B -9.0 0.033 
Bt.64122 Supervillin SVIL -8.9 0.000 
Bt.24447 Coagulation factor II (thrombin) receptor-like  F2RL2 -8.8 0.000 
Bt.49269 Myotubularin related protein 11 MTMR11 -8.7 0.002 
Bt.42032 Cell division cycle associated 7 CDCA7 -8.7 0.041 
Bt.62650 Ubiquitin D UBD -8.7 0.001 
Bt.49579 Solute carrier family 29, member 1 SLC29A1 -8.5 0.018 
Bt.9675 Similar to Extracellular proteinase inhibitor LOC787253 -8.3 0.004 
Bt.35472 Tetratricopeptide repeat domain 21B  SCN1A  -8.3 0.013 
Bt.15782 CD59 molecule, complement regulatory 
protein 
CD59 -8.2 0.015 
Bt.5484 Very low density lipoprotein receptor vldlr -8.1 0.020 
Bt.12140 Mucin 13, cell surface associated MUC13 -8.0 0.000 
Bt.23497 Myosin, light chain 3, alkali; ventricular, 
skeletal, slow 
MYL3 -7.8 0.033 
Bt.23889 Microtubule-associated protein 2 MAP2 -7.7 0.051 
Bt.88773 Cystatin E/M CST6 -7.7 0.014 
Bt.8282 Dipeptidyl-peptidase 4 (CD26, adenosine  DPP4 -7.5 0.005 
Bt.27973 Solute carrier organic anion transporter 
family, member 3A1 
SLCO3A1 -7.4 0.005 
Bt.43651 SLAM family member 7 SLAMF7 -7.4 0.037 
Bt.25099 Phosphoserine phosphatase PSPH -7.2 0.028 
Bt.46545 Similar to putative ISG12(a) protein ISG12(A) -7.1 0.002 
Bt.63426 UDP glucuronosyltransferase 2 family, 
polypeptide B10 
UGT2B10 -6.7 0.017 
Bt.52393 Cathepsin H CTSH -6.6 0.007 
Bt.25663 Copine VIII CPNE8 -6.4 0.004 
Bt.56845 Cysteine rich transmembrane BMP regulator1  CRIM1 -6.3 0.004 
Bt.16087 Nidogen 2 (osteonidogen) NID2 -6.2 0.024 
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Appendix 4: Cont.   
UniGene ID Gene title Gene symbol FC p value 
 
Bt.10630 
 
Neuromedin B 
 
NMB 
 
-6.2 
 
0.024 
Bt.19932 Similar to cystin cilia-associated protein LOC616812 -6.1 0.007 
Bt.7724 Septin 11 Sep 11 -6.1 0.013 
Bt.33922 Radical S-adenosyl methionine containing 2 RSAD2 -5.9 0.012 
Bt.60918 Similar to Interferon-induced  LOC512486 -5.8 0.030 
Bt.62067 Folate receptor 1 (adult) FOLR1 -5.8 0.006 
Bt.193 Mannosyl (alpha-1,3-)-glycoprotein beta-1,4-
N-acetylglucosaminyltransferase, isozyme A 
MGAT4A -5.6 0.007 
Bt.25459 Atpase type 13A4 ATP13A4 -5.6 0.010 
Bt.91165 Similar to ATP-binding cassette transporter  LOC617079 -5.5 0.008 
Bt.12302 Plasminogen activator, tissue PLAT -5.5 0.000 
Bt.25511 RAD51-like 1 (S. Cerevisiae) RAD51L1 -5.5 0.004 
Bt.22624 Leucine rich repeat containing 8 family, 
member D 
LRRC8D -5.4 0.000 
Bt.62794 Transmembrane protein 117 TMEM117 -5.4 0.003 
Bt.4646 Solute carrier family 2, member 1 SLC2A1 -5.3 0.024 
Bt.39963 Neurochondrin NCDN -5.3 0.014 
Bt.12967 Cadherin 16, KSP-cadherin CDH16 -5.2 0.016 
Bt.13456 Actin binding LIM protein family, member 3 ABLIM3 -5.1 0.028 
Bt.95150 Purinergic receptor P2Y, G-protein coupled,5  P2RY5 -5.1 0.001 
Bt.13084 Met proto-oncogene  MET -5.0 0.000 
Bt.53071 Phosphodiesterase 4B, camp-specific PDE4B -5.0 0.008 
Bt.64706 Cold shock domain containing C2 CSDC2 -4.9 0.017 
Bt.44795 Nuclear receptor coactivator 7 NCOA7 -4.9 0.001 
Bt.92569 Solute carrier family 5, member 1 SLC5A1 -4.9 0.046 
Bt.611 Chemokine (C-X-C motif) ligand 2 CXCL2 -4.8 0.002 
Bt.1370 Argininosuccinate synthetase 1 ASS1 -4.8 0.018 
Bt.411 Neuregulin 1 NRG1 -4.8 0.004 
Bt.8544 CD69 molecule CD69 -4.7 0.014 
Bt.2801 Leprecan 1 LOC539976 -4.7 0.002 
Bt.52082 Arrestin, beta 1 ARRB1 -4.6 0.006 
Bt.4199 Interleukin 1 receptor antagonist IL1RN -4.6 0.007 
Bt.16118 Similar to C-type lectin domain family 2,  LOC504309 -4.6 0.002 
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Appendix 5: List of top differentially expressed genes between day 7 and 14 of the estrous 
cycle (NPd7 vs. NPd14) in non-receptive endometrium. Negative and 
positive fold changes (FC) describe genes increased in NPd7 and NPd14, 
respectively. 
 
UniGene ID Gene title Gene symbol FC p value 
 
Bt.22642 
 
Diacylglycerol kinase, iota 
 
DGKI 
 
13.80 
 
0.014 
--- Seminal vesicle secretion 8 SVS8 12.86 0.010 
Bt.60923 SPC24, NDC80 kinetochore complex 
component, homolog (S. Cerevisiae) 
SPC24 10.61 0.010 
Bt.22571 Speckle-type POZ protein SPOP 10.06 0.003 
Bt.23508 Collagen, type VI, alpha 1 COL6A1 9.40 0.000 
Bt.64594 Thioredoxin domain containing 6 TXNDC6 9.31 0.005 
Bt.96859 Transcribed locus, moderately similar to 
NP_982279.1 apolipoprotein B mrna editing 
enzyme 
--- 8.81 0.004 
Bt.64757 Neurotrophic tyrosine kinase, receptor,type2 NTRK2 8.23 0.005 
Bt.64625 Apolipoprotein D APOD 8.13 0.002 
Bt.46762 Prune homolog 2 (Drosophila) PRUNE2 8.08 0.001 
Bt.55266 Similar to procollagen alpha 2(V) LOC782818 7.70 0.012 
Bt.20399 Hydroxysteroid (17-beta) dehydrogenase 13 HSD17B13 7.43 0.004 
Bt.68159 Collagen, type VI, alpha 3 COL6A3 7.39 0.001 
Bt.61691 PARK2 co-regulated PACRG 6.17 0.011 
Bt.5313 Matrix metallopeptidase 2  MMP2 5.13 0.001 
Bt.54339 Sperm associated antigen 6 SPAG6 4.99 0.015 
Bt.53485 Collagen, type I, alpha 2 COL1A2 4.90 0.010 
Bt.2452 Lumican LUM 4.71 0.007 
Bt.2638 Serpin peptidase inhibitor, clade F (alpha-2 
antiplasmin,  
SERPINF1 4.70 0.004 
Bt.27034 Tektin 1 TEKT1 4.60 0.014 
Bt.20385 Phospholipase A1 member A PLA1A 4.32 0.000 
Bt.39050 Cannabinoid receptor interacting protein 1 CNRIP1 4.08 0.009 
Bt.39894 Myosin light chain kinase MYLK 3.98 0.000 
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Appendix 5: Cont. 
UniGene ID Gene title Gene symbol FC p value 
 
Bt.26488 
 
Transcribed locus 
 
--- 
 
3.97 
 
0.009 
Bt.39738 Transcribed locus --- 3.97 0.015 
Bt.8880 SPARC-like 1 (mast9, hevin) SPARCL1 3.88 0.003 
Bt.53600 Cytochrome b5 type B CYB5B 3.87 0.012 
Bt.25235 Mitochondrial ribosomal protein S36 MRPS36 3.87 0.014 
Bt.98978 Transcribed locus --- 3.87 0.007 
Bt.4539 Angiotensin II receptor, type 1 AGTR1 3.85 0.000 
Bt.101209 Collagen, type III, alpha 1  COL3A1 3.77 0.013 
Bt.26656 Mitogen-activated protein kinase 10 MAPK10 3.75 0.011 
Bt.21766 Myeloid leukemia factor 1 MLF1 3.67 0.011 
Bt.4011 Transmembrane protein 120A TMEM120A 3.61 0.007 
Bt.68595 Transcribed locus --- 3.53 0.014 
Bt.81912 Similar to OB-cadherin-1 /// cadherin 11, 
type 2, OB-cadherin  
CDH11 /// 
LOC535363 
3.47 0.008 
Bt.45145 Asporin ASPN 3.42 0.000 
Bt.23178 Decorin DCN 3.40 0.013 
Bt.30575 Scavenger receptor class A, member 5 SCARA5 3.09 0.012 
Bt.4210 Kininogen 1 KNG1 3.09 0.010 
Bt.18339 Dynein, light chain, roadblock-type 2 DYNLRB2 3.06 0.015 
Bt.23618 Spondin 1, extracellular matrix protein SPON1 3.06 0.009 
Bt.4492 Collectin sub-family member 12 COLEC12 3.03 0.002 
Bt.68368 Transcribed locus --- -2.86 0.001 
Bt.22179 Similar to chromosome 1 open reading 
frame  
LOC507126 -2.87 0.013 
Bt.54463 Early growth response 1 EGR1 -2.90 0.006 
Bt.92871 Transcribed locus --- -2.94 0.001 
Bt.1730 Inhibitor of DNA binding 1, dominant 
negative helix-loop-helix protein 
ID1 -3.00 0.005 
Bt.93483 Transcribed locus --- -3.05 0.000 
Bt.24872 Kinesin family member 4A KIF4A -3.07 0.004 
Bt.24645 Hypothetical LOC613372 LOC613372 -3.08 0.005 
--- Frequently rearranged in advanced T-cell FRAT2 -3.09 0.006 
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Appendix 5: Cont. 
UniGene ID Gene title Gene symbol FC p value 
 
Bt.78960 
 
Transcribed locus 
 
--- 
 
-3.10 
 
0.000 
Bt.16613 Transcribed locus --- -3.11 0.006 
Bt.1220 Transcribed locus --- -3.12 0.012 
Bt.9113 Immediate early response 5 IER5 -3.19 0.007 
Bt.24515 Akt substrate AS250 LOC507082 -3.24 0.004 
Bt.12140 Mucin 13, cell surface associated MUC13 -3.30 0.014 
Bt.96035 Transcribed locus --- -3.34 0.001 
Bt.59370 Leucyl-trna synthetase 2, mitochondrial LARS2 -3.36 0.000 
Bt.8945 Toll-like receptor 2 TLR2 -3.39 0.002 
Bt.91648 Chondroadherin CHAD -3.45 0.015 
Bt.93107 Transcribed locus --- -3.51 0.000 
Bt.93218 Transcribed locus --- -3.55 0.000 
Bt.9482 Rho gtpase activating protein 17 ARHGAP17 -3.61 0.000 
Bt.91133 Ankyrin repeat domain 10 ANKRD10 -3.63 0.001 
Bt.91073 Transcribed locus --- -3.65 0.003 
Bt.16892 Golgi-localized protein GOLSYN -3.69 0.012 
Bt.13084 Met proto-oncogene  MET -3.83 0.002 
Bt.9632 Deleted in malignant brain tumors 1 DMBT1 -3.99 0.012 
Bt.15784 Similar to squamous cell-specific protein LOC786490 -4.03 0.011 
Bt.10209 Serglycin SRGN -4.16 0.014 
Bt.18533 Activating transcription factor 3 ATF3 -4.17 0.003 
Bt.53071 Phosphodiesterase 4B, camp-specific PDE4B -4.35 0.012 
Bt.96346 Transcribed locus --- -4.38 0.011 
Bt.101406 Transcribed locus --- -4.39 0.015 
Bt.367 Oxidized low density lipoprotein  OLR1 -4.69 0.002 
Bt.12304 ISG15 ubiquitin-like modifier ISG15 -4.82 0.009 
Bt.32826 CD68 molecule CD68 -5.24 0.004 
Bt.9632 Deleted in malignant brain tumors 1 DMBT1 -5.24 0.012 
Bt.61441 Transcribed locus --- -5.27 0.005 
Bt.4199 Interleukin 1 receptor antagonist IL1RN -5.34 0.004 
Bt.468 Cystic fibrosis transmembrane conductance 
regulator  
CFTR -5.44 0.012 
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Appendix 5: Cont. 
UniGene ID Gene title Gene symbol FC p. valu 
 
Bt.87242 
 
Steroidogenic acute regulatory protein 
 
STAR 
 
-5.87 
 
0.010 
Bt.33922 Radical S-adenosyl methionine domain 
containing 2 
RSAD2 -6.18 0.010 
Bt.46545 Similar to putative ISG12(a) protein ISG12(A) -5.65 0.005 
Bt.65386 Pleckstrin PLEK -7.37 0.012 
Bt.60687 Formin-like 3 FMNL3 -7.51 0.008 
Bt.22477 Transcribed locus --- -8.69 0.002 
Bt.93099 Transcribed locus --- -9.43 0.000 
Bt.31841 Talin 2 TLN2 -11.6 0.002 
Bt.2408 Chemokine (C-C motif) ligand 2  CCL11 -12.1 0.005 
Bt.7393 Nephronectin NPNT -16.9 0.007 
Bt.10536 Secreted phosphoprotein 1 (osteopontin, 
bone sialoprotein I,  
SPP1 -21.2 0.006 
Bt.13125 Neutrophil beta-defensin 4 /// defensin, beta 
5 /// similar to neutrophil beta-defensin 4 
BNBD-4  -22.2 0.002 
Bt.5878 Serine dehydratase SDS -23.5 0.013 
Bt.49740 Interleukin 8 IL8 -51.9 0.003 
Bt.41728 Solute carrier family 39  SLC39A2 -112 0.005 
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Appendix 6: The spatio-temporal expression of selected candidate genes at different region 
of the endometrium during the estrous cycle and day 50 gestation period (P). 
The vertical axis indicates the relative mRNA expression level of each gene 
normalized GAPDH.  
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Appendix 7: Validation of differentially expressed genes between receptive (CDd7) and  
 non- receptive (NPd7) endometrium at day 7 of the estrous cycle.  
       (A): Genes enriched in CDd7. (B): Genes enriched in NPd7 
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